id	sid	tid	token	lemma	pos
mkg-41075	1	1	189189	189189	NUM
mkg-41075	1	2	dental	dental	ADJ
mkg-41075	1	3	journal	journal	NOUN
mkg-41075	1	4	(	(	PUNCT
mkg-41075	1	5	majalah	majalah	PROPN
mkg-41075	1	6	kedokteran	kedokteran	PROPN
mkg-41075	1	7	gigi	gigi	PROPN
mkg-41075	1	8	)	)	PUNCT
mkg-41075	1	9	2023	2023	NUM
mkg-41075	1	10	september	september	PROPN
mkg-41075	1	11	;	;	PUNCT
mkg-41075	1	12	56(3	56(3	NUM
mkg-41075	1	13	):	):	PUNCT
mkg-41075	1	14	189–196	189–196	NUM
mkg-41075	1	15	review	review	NOUN
mkg-41075	1	16	article	article	NOUN
mkg-41075	1	17	oral	oral	ADJ
mkg-41075	1	18	field	field	NOUN
mkg-41075	1	19	cancerization	cancerization	NOUN
mkg-41075	1	20	:	:	PUNCT
mkg-41075	1	21	genetic	genetic	ADJ
mkg-41075	1	22	profiling	profiling	NOUN
mkg-41075	1	23	for	for	ADP
mkg-41075	1	24	a	a	DET
mkg-41075	1	25	prevention	prevention	NOUN
mkg-41075	1	26	strategy	strategy	NOUN
mkg-41075	1	27	for	for	ADP
mkg-41075	1	28	oral	oral	ADJ
mkg-41075	1	29	potentially	potentially	ADV
mkg-41075	1	30	malignant	malignant	ADJ
mkg-41075	1	31	disorders	disorder	NOUN
mkg-41075	1	32	karlina	karlina	NOUN
mkg-41075	1	33	puspasari1	puspasari1	PROPN
mkg-41075	1	34	,	,	PUNCT
mkg-41075	1	35	togu	togu	NOUN
mkg-41075	1	36	andrie	andrie	VERB
mkg-41075	1	37	simon	simon	PROPN
mkg-41075	1	38	pasaribu1	pasaribu1	PROPN
mkg-41075	1	39	,	,	PUNCT
mkg-41075	1	40	meircurius	meircurius	PROPN
mkg-41075	1	41	dwi	dwi	PROPN
mkg-41075	1	42	condro	condro	PROPN
mkg-41075	1	43	surboyo2	surboyo2	PROPN
mkg-41075	1	44	,	,	PUNCT
mkg-41075	1	45	nurina	nurina	PROPN
mkg-41075	1	46	febriyanti	febriyanti	PROPN
mkg-41075	1	47	ayuningtyas2	ayuningtyas2	PROPN
mkg-41075	1	48	,	,	PUNCT
mkg-41075	1	49	arvind	arvind	PROPN
mkg-41075	1	50	babu	babu	PROPN
mkg-41075	1	51	rajendra	rajendra	PROPN
mkg-41075	1	52	santosh2,3	santosh2,3	PROPN
mkg-41075	1	53	,	,	PUNCT
mkg-41075	1	54	diah	diah	PROPN
mkg-41075	1	55	savitri	savitri	PROPN
mkg-41075	1	56	ernawati2	ernawati2	PUNCT
mkg-41075	2	1	1oral	1oral	NUM
mkg-41075	2	2	medicine	medicine	NOUN
mkg-41075	2	3	specialist	specialist	NOUN
mkg-41075	2	4	program	program	NOUN
mkg-41075	2	5	,	,	PUNCT
mkg-41075	2	6	faculty	faculty	NOUN
mkg-41075	2	7	of	of	ADP
mkg-41075	2	8	dental	dental	ADJ
mkg-41075	2	9	medicine	medicine	NOUN
mkg-41075	2	10	,	,	PUNCT
mkg-41075	2	11	universitas	universita	NOUN
mkg-41075	2	12	airlangga	airlangga	NOUN
mkg-41075	2	13	,	,	PUNCT
mkg-41075	2	14	surabaya	surabaya	PROPN
mkg-41075	2	15	,	,	PUNCT
mkg-41075	2	16	indonesia	indonesia	PROPN
mkg-41075	2	17	2department	2department	NUM
mkg-41075	2	18	of	of	ADP
mkg-41075	2	19	oral	oral	ADJ
mkg-41075	2	20	medicine	medicine	NOUN
mkg-41075	2	21	,	,	PUNCT
mkg-41075	2	22	faculty	faculty	NOUN
mkg-41075	2	23	of	of	ADP
mkg-41075	2	24	dental	dental	ADJ
mkg-41075	2	25	medicine	medicine	NOUN
mkg-41075	2	26	,	,	PUNCT
mkg-41075	2	27	universitas	universita	NOUN
mkg-41075	2	28	airlangga	airlangga	NOUN
mkg-41075	2	29	,	,	PUNCT
mkg-41075	2	30	surabaya	surabaya	PROPN
mkg-41075	2	31	,	,	PUNCT
mkg-41075	2	32	indonesia	indonesia	PROPN
mkg-41075	2	33	3school	3school	PROPN
mkg-41075	2	34	of	of	ADP
mkg-41075	2	35	dentistry	dentistry	NOUN
mkg-41075	2	36	,	,	PUNCT
mkg-41075	2	37	faculty	faculty	NOUN
mkg-41075	2	38	of	of	ADP
mkg-41075	2	39	medical	medical	ADJ
mkg-41075	2	40	sciences	science	NOUN
mkg-41075	2	41	,	,	PUNCT
mkg-41075	2	42	the	the	DET
mkg-41075	2	43	university	university	NOUN
mkg-41075	2	44	of	of	ADP
mkg-41075	2	45	the	the	DET
mkg-41075	2	46	west	west	PROPN
mkg-41075	2	47	indies	indies	PROPN
mkg-41075	2	48	,	,	PUNCT
mkg-41075	2	49	mona	mona	PROPN
mkg-41075	2	50	campus	campus	PROPN
mkg-41075	2	51	,	,	PUNCT
mkg-41075	2	52	kingston	kingston	PROPN
mkg-41075	2	53	,	,	PUNCT
mkg-41075	2	54	jamaica	jamaica	PROPN
mkg-41075	2	55	abstract	abstract	ADJ
mkg-41075	2	56	background	background	NOUN
mkg-41075	2	57	:	:	PUNCT
mkg-41075	2	58	oral	oral	ADJ
mkg-41075	2	59	cancer	cancer	NOUN
mkg-41075	2	60	therapy	therapy	NOUN
mkg-41075	2	61	,	,	PUNCT
mkg-41075	2	62	such	such	ADJ
mkg-41075	2	63	as	as	ADP
mkg-41075	2	64	radiation	radiation	NOUN
mkg-41075	2	65	or	or	CCONJ
mkg-41075	2	66	surgical	surgical	ADJ
mkg-41075	2	67	treatment	treatment	NOUN
mkg-41075	2	68	,	,	PUNCT
mkg-41075	2	69	has	have	VERB
mkg-41075	2	70	pernicious	pernicious	ADJ
mkg-41075	2	71	long	long	ADJ
mkg-41075	2	72	-	-	PUNCT
mkg-41075	2	73	term	term	NOUN
mkg-41075	2	74	effects	effect	NOUN
mkg-41075	2	75	that	that	PRON
mkg-41075	2	76	patients	patient	NOUN
mkg-41075	2	77	suffer	suffer	VERB
mkg-41075	2	78	throughout	throughout	ADP
mkg-41075	2	79	their	their	PRON
mkg-41075	2	80	life	life	NOUN
mkg-41075	2	81	,	,	PUNCT
mkg-41075	2	82	the	the	DET
mkg-41075	2	83	disability	disability	NOUN
mkg-41075	2	84	being	be	AUX
mkg-41075	2	85	considerable	considerable	ADJ
mkg-41075	2	86	with	with	ADP
mkg-41075	2	87	delayed	delayed	ADJ
mkg-41075	2	88	diagnosis	diagnosis	NOUN
mkg-41075	2	89	.	.	PUNCT
mkg-41075	3	1	it	it	PRON
mkg-41075	3	2	is	be	AUX
mkg-41075	3	3	well	well	ADV
mkg-41075	3	4	known	know	VERB
mkg-41075	3	5	that	that	SCONJ
mkg-41075	3	6	many	many	ADJ
mkg-41075	3	7	oral	oral	ADJ
mkg-41075	3	8	cancers	cancer	NOUN
mkg-41075	3	9	develop	develop	VERB
mkg-41075	3	10	from	from	ADP
mkg-41075	3	11	oral	oral	ADJ
mkg-41075	3	12	potentially	potentially	ADV
mkg-41075	3	13	malignant	malignant	ADJ
mkg-41075	3	14	disorders	disorder	NOUN
mkg-41075	3	15	(	(	PUNCT
mkg-41075	3	16	opmds	opmds	NOUN
mkg-41075	3	17	)	)	PUNCT
mkg-41075	3	18	.	.	PUNCT
mkg-41075	4	1	patients	patient	NOUN
mkg-41075	4	2	diagnosed	diagnose	VERB
mkg-41075	4	3	with	with	ADP
mkg-41075	4	4	opmds	opmds	NOUN
mkg-41075	4	5	may	may	AUX
mkg-41075	4	6	have	have	VERB
mkg-41075	4	7	an	an	DET
mkg-41075	4	8	increased	increase	VERB
mkg-41075	4	9	risk	risk	NOUN
mkg-41075	4	10	of	of	ADP
mkg-41075	4	11	developing	develop	VERB
mkg-41075	4	12	cancer	cancer	NOUN
mkg-41075	4	13	anywhere	anywhere	ADV
mkg-41075	4	14	in	in	ADP
mkg-41075	4	15	the	the	DET
mkg-41075	4	16	oral	oral	ADJ
mkg-41075	4	17	cavity	cavity	NOUN
mkg-41075	4	18	.	.	PUNCT
mkg-41075	5	1	early	early	ADJ
mkg-41075	5	2	detection	detection	NOUN
mkg-41075	5	3	and	and	CCONJ
mkg-41075	5	4	intervention	intervention	NOUN
mkg-41075	5	5	could	could	AUX
mkg-41075	5	6	be	be	AUX
mkg-41075	5	7	essential	essential	ADJ
mkg-41075	5	8	prevention	prevention	NOUN
mkg-41075	5	9	strategies	strategy	NOUN
mkg-41075	5	10	to	to	PART
mkg-41075	5	11	inhibit	inhibit	VERB
mkg-41075	5	12	oral	oral	ADJ
mkg-41075	5	13	cancer	cancer	NOUN
mkg-41075	5	14	progression	progression	NOUN
mkg-41075	5	15	.	.	PUNCT
mkg-41075	6	1	opmds	opmds	NOUN
mkg-41075	6	2	may	may	AUX
mkg-41075	6	3	not	not	PART
mkg-41075	6	4	immediately	immediately	ADV
mkg-41075	6	5	develop	develop	VERB
mkg-41075	6	6	into	into	ADP
mkg-41075	6	7	carcinoma	carcinoma	NOUN
mkg-41075	6	8	.	.	PUNCT
mkg-41075	7	1	however	however	ADV
mkg-41075	7	2	,	,	PUNCT
mkg-41075	7	3	this	this	DET
mkg-41075	7	4	condition	condition	NOUN
mkg-41075	7	5	provides	provide	VERB
mkg-41075	7	6	a	a	DET
mkg-41075	7	7	“	"	PUNCT
mkg-41075	7	8	field	field	NOUN
mkg-41075	7	9	”	"	PUNCT
mkg-41075	7	10	of	of	ADP
mkg-41075	7	11	specific	specific	ADJ
mkg-41075	7	12	abnormalities	abnormality	NOUN
mkg-41075	7	13	wherein	wherein	ADJ
mkg-41075	7	14	evolving	evolve	VERB
mkg-41075	7	15	altered	alter	VERB
mkg-41075	7	16	genetic	genetic	ADJ
mkg-41075	7	17	cells	cell	NOUN
mkg-41075	7	18	can	can	AUX
mkg-41075	7	19	be	be	AUX
mkg-41075	7	20	explained	explain	VERB
mkg-41075	7	21	with	with	ADP
mkg-41075	7	22	the	the	DET
mkg-41075	7	23	“	"	PUNCT
mkg-41075	7	24	field	field	NOUN
mkg-41075	7	25	cancerization	cancerization	NOUN
mkg-41075	7	26	”	"	PUNCT
mkg-41075	7	27	concept	concept	NOUN
mkg-41075	7	28	.	.	PUNCT
mkg-41075	8	1	purpose	purpose	NOUN
mkg-41075	8	2	:	:	PUNCT
mkg-41075	8	3	this	this	DET
mkg-41075	8	4	review	review	NOUN
mkg-41075	8	5	aims	aim	VERB
mkg-41075	8	6	to	to	PART
mkg-41075	8	7	describe	describe	VERB
mkg-41075	8	8	the	the	DET
mkg-41075	8	9	“	"	PUNCT
mkg-41075	8	10	field	field	NOUN
mkg-41075	8	11	cancerization	cancerization	NOUN
mkg-41075	8	12	”	"	PUNCT
mkg-41075	8	13	concept	concept	NOUN
mkg-41075	8	14	in	in	ADP
mkg-41075	8	15	oral	oral	ADJ
mkg-41075	8	16	cancer	cancer	NOUN
mkg-41075	8	17	and	and	CCONJ
mkg-41075	8	18	opmd	opmd	ADV
mkg-41075	8	19	,	,	PUNCT
mkg-41075	8	20	which	which	PRON
mkg-41075	8	21	is	be	AUX
mkg-41075	8	22	expected	expect	VERB
mkg-41075	8	23	to	to	PART
mkg-41075	8	24	contribute	contribute	VERB
mkg-41075	8	25	to	to	ADP
mkg-41075	8	26	a	a	DET
mkg-41075	8	27	better	well	ADV
mkg-41075	8	28	clinical	clinical	ADJ
mkg-41075	8	29	management	management	NOUN
mkg-41075	8	30	strategy	strategy	NOUN
mkg-41075	8	31	for	for	ADP
mkg-41075	8	32	oral	oral	ADJ
mkg-41075	8	33	cancer	cancer	NOUN
mkg-41075	8	34	prevention	prevention	NOUN
mkg-41075	8	35	.	.	PUNCT
mkg-41075	9	1	review	review	NOUN
mkg-41075	9	2	:	:	PUNCT
mkg-41075	9	3	“	"	PUNCT
mkg-41075	9	4	oral	oral	ADJ
mkg-41075	9	5	field	field	NOUN
mkg-41075	9	6	cancerization	cancerization	NOUN
mkg-41075	9	7	”	"	PUNCT
mkg-41075	9	8	describes	describe	VERB
mkg-41075	9	9	oral	oral	ADJ
mkg-41075	9	10	cancers	cancer	NOUN
mkg-41075	9	11	that	that	PRON
mkg-41075	9	12	develop	develop	VERB
mkg-41075	9	13	in	in	ADP
mkg-41075	9	14	multifocal	multifocal	ADJ
mkg-41075	9	15	areas	area	NOUN
mkg-41075	9	16	of	of	ADP
mkg-41075	9	17	pre	pre	ADJ
mkg-41075	9	18	-	-	ADJ
mkg-41075	9	19	cancerous	cancerous	ADJ
mkg-41075	9	20	changes	change	NOUN
mkg-41075	9	21	.	.	PUNCT
mkg-41075	10	1	it	it	PRON
mkg-41075	10	2	can	can	AUX
mkg-41075	10	3	be	be	AUX
mkg-41075	10	4	found	find	VERB
mkg-41075	10	5	as	as	ADP
mkg-41075	10	6	histologically	histologically	ADV
mkg-41075	10	7	abnormal	abnormal	ADJ
mkg-41075	10	8	tissue	tissue	NOUN
mkg-41075	10	9	surrounding	surround	VERB
mkg-41075	10	10	the	the	DET
mkg-41075	10	11	tumor	tumor	NOUN
mkg-41075	10	12	,	,	PUNCT
mkg-41075	10	13	suggesting	suggest	VERB
mkg-41075	10	14	that	that	SCONJ
mkg-41075	10	15	oral	oral	ADJ
mkg-41075	10	16	cancer	cancer	NOUN
mkg-41075	10	17	often	often	ADV
mkg-41075	10	18	consists	consist	VERB
mkg-41075	10	19	of	of	ADP
mkg-41075	10	20	multiple	multiple	ADJ
mkg-41075	10	21	independent	independent	ADJ
mkg-41075	10	22	lesions	lesion	NOUN
mkg-41075	10	23	.	.	PUNCT
mkg-41075	11	1	conclusion	conclusion	NOUN
mkg-41075	11	2	:	:	PUNCT
mkg-41075	11	3	the	the	DET
mkg-41075	11	4	oral	oral	ADJ
mkg-41075	11	5	field	field	NOUN
mkg-41075	11	6	cancerization	cancerization	NOUN
mkg-41075	11	7	concept	concept	NOUN
mkg-41075	11	8	should	should	AUX
mkg-41075	11	9	prompt	prompt	VERB
mkg-41075	11	10	healthcare	healthcare	NOUN
mkg-41075	11	11	professionals	professional	NOUN
mkg-41075	11	12	to	to	PART
mkg-41075	11	13	remind	remind	VERB
mkg-41075	11	14	their	their	PRON
mkg-41075	11	15	patients	patient	NOUN
mkg-41075	11	16	that	that	SCONJ
mkg-41075	11	17	frequent	frequent	ADJ
mkg-41075	11	18	oral	oral	ADJ
mkg-41075	11	19	examination	examination	NOUN
mkg-41075	11	20	with	with	ADP
mkg-41075	11	21	histological	histological	ADJ
mkg-41075	11	22	studies	study	NOUN
mkg-41075	11	23	and	and	CCONJ
mkg-41075	11	24	molecular	molecular	ADJ
mkg-41075	11	25	testing	testing	NOUN
mkg-41075	11	26	is	be	AUX
mkg-41075	11	27	mandatory	mandatory	ADJ
mkg-41075	11	28	for	for	ADP
mkg-41075	11	29	those	those	PRON
mkg-41075	11	30	at	at	ADP
mkg-41075	11	31	high	high	ADJ
mkg-41075	11	32	risk	risk	NOUN
mkg-41075	11	33	of	of	ADP
mkg-41075	11	34	developing	develop	VERB
mkg-41075	11	35	malignancies	malignancy	NOUN
mkg-41075	11	36	.	.	PUNCT
mkg-41075	12	1	keywords	keyword	NOUN
mkg-41075	12	2	:	:	PUNCT
mkg-41075	12	3	genetically	genetically	ADV
mkg-41075	12	4	altered	alter	VERB
mkg-41075	12	5	field	field	NOUN
mkg-41075	12	6	;	;	PUNCT
mkg-41075	12	7	oral	oral	ADJ
mkg-41075	12	8	cancer	cancer	NOUN
mkg-41075	12	9	;	;	PUNCT
mkg-41075	12	10	oral	oral	ADJ
mkg-41075	12	11	field	field	NOUN
mkg-41075	12	12	cancerization	cancerization	NOUN
mkg-41075	12	13	;	;	PUNCT
mkg-41075	12	14	oral	oral	ADJ
mkg-41075	12	15	potentially	potentially	ADV
mkg-41075	12	16	malignant	malignant	ADJ
mkg-41075	12	17	disorders	disorder	NOUN
mkg-41075	12	18	article	article	NOUN
mkg-41075	12	19	history	history	NOUN
mkg-41075	12	20	:	:	PUNCT
mkg-41075	12	21	received	receive	VERB
mkg-41075	12	22	30	30	NUM
mkg-41075	12	23	november	november	PROPN
mkg-41075	12	24	2022	2022	NUM
mkg-41075	12	25	;	;	PUNCT
mkg-41075	12	26	revised	revise	VERB
mkg-41075	12	27	5	5	NUM
mkg-41075	12	28	january	january	PROPN
mkg-41075	12	29	2023	2023	NUM
mkg-41075	12	30	;	;	PUNCT
mkg-41075	12	31	accepted	accept	VERB
mkg-41075	12	32	27	27	NUM
mkg-41075	12	33	january	january	PROPN
mkg-41075	12	34	2023	2023	NUM
mkg-41075	12	35	;	;	PUNCT
mkg-41075	12	36	published	publish	VERB
mkg-41075	12	37	1	1	NUM
mkg-41075	12	38	september	september	PROPN
mkg-41075	12	39	2023	2023	NUM
mkg-41075	12	40	correspondence	correspondence	NOUN
mkg-41075	12	41	:	:	PUNCT
mkg-41075	12	42	diah	diah	PROPN
mkg-41075	12	43	savitri	savitri	PROPN
mkg-41075	12	44	ernawati	ernawati	PROPN
mkg-41075	12	45	,	,	PUNCT
mkg-41075	12	46	department	department	NOUN
mkg-41075	12	47	of	of	ADP
mkg-41075	12	48	oral	oral	ADJ
mkg-41075	12	49	medicine	medicine	NOUN
mkg-41075	12	50	,	,	PUNCT
mkg-41075	12	51	faculty	faculty	NOUN
mkg-41075	12	52	of	of	ADP
mkg-41075	12	53	dental	dental	ADJ
mkg-41075	12	54	medicine	medicine	NOUN
mkg-41075	12	55	,	,	PUNCT
mkg-41075	12	56	universitas	universita	NOUN
mkg-41075	12	57	airlangga	airlangga	NOUN
mkg-41075	12	58	.	.	PUNCT
mkg-41075	13	1	jl	jl	PROPN
mkg-41075	13	2	mayjen	mayjen	PROPN
mkg-41075	13	3	prof	prof	PROPN
mkg-41075	13	4	.	.	PUNCT
mkg-41075	14	1	dr	dr	PROPN
mkg-41075	14	2	.	.	PROPN
mkg-41075	14	3	moestopo	moestopo	PROPN
mkg-41075	15	1	no	no	NOUN
mkg-41075	15	2	.	.	PROPN
mkg-41075	16	1	47	47	NUM
mkg-41075	16	2	,	,	PUNCT
mkg-41075	16	3	surabaya	surabaya	NOUN
mkg-41075	16	4	,	,	PUNCT
mkg-41075	16	5	60132	60132	NUM
mkg-41075	16	6	,	,	PUNCT
mkg-41075	16	7	indonesia	indonesia	PROPN
mkg-41075	16	8	.	.	PUNCT
mkg-41075	16	9	email	email	NOUN
mkg-41075	16	10	:	:	PUNCT
mkg-41075	16	11	diah-s-e@fkg.unair.ac.id	diah-s-e@fkg.unair.ac.id	NOUN
mkg-41075	16	12	introduction	introduction	NOUN
mkg-41075	16	13	oral	oral	ADJ
mkg-41075	16	14	cancer	cancer	NOUN
mkg-41075	16	15	is	be	AUX
mkg-41075	16	16	one	one	NUM
mkg-41075	16	17	of	of	ADP
mkg-41075	16	18	the	the	DET
mkg-41075	16	19	most	most	ADV
mkg-41075	16	20	common	common	ADJ
mkg-41075	16	21	malignancies	malignancy	NOUN
mkg-41075	16	22	worldwide	worldwide	ADV
mkg-41075	16	23	,	,	PUNCT
mkg-41075	16	24	with	with	ADP
mkg-41075	16	25	approximately	approximately	ADV
mkg-41075	16	26	5	5	NUM
mkg-41075	16	27	%	%	NOUN
mkg-41075	16	28	of	of	ADP
mkg-41075	16	29	those	those	PRON
mkg-41075	16	30	with	with	ADP
mkg-41075	16	31	diagnosed	diagnose	VERB
mkg-41075	16	32	cancer	cancer	NOUN
mkg-41075	16	33	coming	come	VERB
mkg-41075	16	34	from	from	ADP
mkg-41075	16	35	developing	develop	VERB
mkg-41075	16	36	countries	country	NOUN
mkg-41075	16	37	.	.	PUNCT
mkg-41075	17	1	the	the	DET
mkg-41075	17	2	prevalence	prevalence	NOUN
mkg-41075	17	3	of	of	ADP
mkg-41075	17	4	head	head	NOUN
mkg-41075	17	5	-	-	PUNCT
mkg-41075	17	6	and	and	CCONJ
mkg-41075	17	7	-	-	PUNCT
mkg-41075	17	8	neck	neck	NOUN
mkg-41075	17	9	squamous	squamous	ADJ
mkg-41075	17	10	cell	cell	NOUN
mkg-41075	17	11	carcinoma	carcinoma	NOUN
mkg-41075	17	12	(	(	PUNCT
mkg-41075	17	13	hnscc	hnscc	NOUN
mkg-41075	17	14	)	)	PUNCT
mkg-41075	17	15	worldwide	worldwide	ADV
mkg-41075	17	16	is	be	AUX
mkg-41075	17	17	about	about	ADV
mkg-41075	17	18	20	20	NUM
mkg-41075	17	19	cases	case	NOUN
mkg-41075	17	20	per	per	ADP
mkg-41075	17	21	100,000	100,000	NUM
mkg-41075	17	22	population	population	NOUN
mkg-41075	17	23	per	per	ADP
mkg-41075	17	24	year.1	year.1	NOUN
mkg-41075	17	25	oral	oral	ADJ
mkg-41075	17	26	cancer	cancer	NOUN
mkg-41075	17	27	,	,	PUNCT
mkg-41075	17	28	notably	notably	ADV
mkg-41075	17	29	that	that	SCONJ
mkg-41075	17	30	induced	induce	VERB
mkg-41075	17	31	by	by	ADP
mkg-41075	17	32	tobacco	tobacco	NOUN
mkg-41075	17	33	and	and	CCONJ
mkg-41075	17	34	alcohol	alcohol	NOUN
mkg-41075	17	35	consumption	consumption	NOUN
mkg-41075	17	36	,	,	PUNCT
mkg-41075	17	37	may	may	AUX
mkg-41075	17	38	develop	develop	VERB
mkg-41075	17	39	from	from	ADP
mkg-41075	17	40	an	an	DET
mkg-41075	17	41	oral	oral	ADJ
mkg-41075	17	42	potentially	potentially	ADV
mkg-41075	17	43	malignant	malignant	ADJ
mkg-41075	17	44	disorder	disorder	NOUN
mkg-41075	17	45	(	(	PUNCT
mkg-41075	17	46	opmd	opmd	ADV
mkg-41075	17	47	)	)	PUNCT
mkg-41075	17	48	or	or	CCONJ
mkg-41075	17	49	pre	pre	ADJ
mkg-41075	17	50	-	-	ADJ
mkg-41075	17	51	cancerization	cancerization	NOUN
mkg-41075	17	52	lesion.2–4	lesion.2–4	NOUN
mkg-41075	17	53	some	some	DET
mkg-41075	17	54	opmds	opmds	NOUN
mkg-41075	17	55	might	might	AUX
mkg-41075	17	56	disappear	disappear	VERB
mkg-41075	17	57	,	,	PUNCT
mkg-41075	17	58	while	while	SCONJ
mkg-41075	17	59	others	other	NOUN
mkg-41075	17	60	result	result	VERB
mkg-41075	17	61	in	in	ADP
mkg-41075	17	62	oral	oral	ADJ
mkg-41075	17	63	cancer	cancer	NOUN
mkg-41075	17	64	.	.	PUNCT
mkg-41075	18	1	the	the	DET
mkg-41075	18	2	proportion	proportion	NOUN
mkg-41075	18	3	of	of	ADP
mkg-41075	18	4	cases	case	NOUN
mkg-41075	18	5	of	of	ADP
mkg-41075	18	6	opmd	opmd	ADJ
mkg-41075	18	7	in	in	ADP
mkg-41075	18	8	oral	oral	ADJ
mkg-41075	18	9	cancers	cancer	NOUN
mkg-41075	18	10	ranges	range	VERB
mkg-41075	18	11	from	from	ADP
mkg-41075	18	12	3–50%.5	3–50%.5	NUM
mkg-41075	18	13	while	while	SCONJ
mkg-41075	18	14	the	the	DET
mkg-41075	18	15	management	management	NOUN
mkg-41075	18	16	of	of	ADP
mkg-41075	18	17	opmd	opmd	ADV
mkg-41075	18	18	might	might	AUX
mkg-41075	18	19	improve	improve	VERB
mkg-41075	18	20	the	the	DET
mkg-41075	18	21	outcome	outcome	NOUN
mkg-41075	18	22	,	,	PUNCT
mkg-41075	18	23	standard	standard	ADJ
mkg-41075	18	24	therapy	therapy	NOUN
mkg-41075	18	25	does	do	AUX
mkg-41075	18	26	not	not	PART
mkg-41075	18	27	prevent	prevent	VERB
mkg-41075	18	28	cancer	cancer	NOUN
mkg-41075	18	29	transformation	transformation	NOUN
mkg-41075	18	30	from	from	ADP
mkg-41075	18	31	opmd.6	opmd.6	ADP
mkg-41075	18	32	oral	oral	ADJ
mkg-41075	18	33	cancer	cancer	NOUN
mkg-41075	18	34	therapies	therapy	NOUN
mkg-41075	18	35	have	have	VERB
mkg-41075	18	36	pernicious	pernicious	ADJ
mkg-41075	18	37	long	long	ADJ
mkg-41075	18	38	-	-	PUNCT
mkg-41075	18	39	term	term	NOUN
mkg-41075	18	40	effects	effect	NOUN
mkg-41075	18	41	throughout	throughout	ADP
mkg-41075	18	42	the	the	DET
mkg-41075	18	43	life	life	NOUN
mkg-41075	18	44	of	of	ADP
mkg-41075	18	45	patients	patient	NOUN
mkg-41075	18	46	.	.	PUNCT
mkg-41075	19	1	these	these	DET
mkg-41075	19	2	effects	effect	NOUN
mkg-41075	19	3	are	be	AUX
mkg-41075	19	4	substantial	substantial	ADJ
mkg-41075	19	5	when	when	SCONJ
mkg-41075	19	6	the	the	DET
mkg-41075	19	7	diagnosis	diagnosis	NOUN
mkg-41075	19	8	is	be	AUX
mkg-41075	19	9	delayed.7	delayed.7	NOUN
mkg-41075	19	10	the	the	DET
mkg-41075	19	11	hnscc	hnscc	NOUN
mkg-41075	19	12	5	5	NUM
mkg-41075	19	13	-	-	PUNCT
mkg-41075	19	14	year	year	NOUN
mkg-41075	19	15	survival	survival	NOUN
mkg-41075	19	16	rate	rate	NOUN
mkg-41075	19	17	is	be	AUX
mkg-41075	19	18	the	the	DET
mkg-41075	19	19	lowest	low	ADJ
mkg-41075	19	20	among	among	ADP
mkg-41075	19	21	aggressive	aggressive	ADJ
mkg-41075	19	22	cancers	cancer	NOUN
mkg-41075	19	23	.	.	PUNCT
mkg-41075	20	1	the	the	DET
mkg-41075	20	2	prognosis	prognosis	NOUN
mkg-41075	20	3	of	of	ADP
mkg-41075	20	4	oral	oral	ADJ
mkg-41075	20	5	squamous	squamous	ADJ
mkg-41075	20	6	cell	cell	NOUN
mkg-41075	20	7	carcinoma	carcinoma	NOUN
mkg-41075	20	8	(	(	PUNCT
mkg-41075	20	9	oscc	oscc	ADJ
mkg-41075	20	10	)	)	PUNCT
mkg-41075	20	11	depends	depend	VERB
mkg-41075	20	12	on	on	ADP
mkg-41075	20	13	the	the	DET
mkg-41075	20	14	presence	presence	NOUN
mkg-41075	20	15	of	of	ADP
mkg-41075	20	16	new	new	ADJ
mkg-41075	20	17	tumor	tumor	NOUN
mkg-41075	20	18	growth.1	growth.1	PROPN
mkg-41075	20	19	in	in	ADP
mkg-41075	20	20	1953	1953	NUM
mkg-41075	20	21	,	,	PUNCT
mkg-41075	20	22	slaughter	slaughter	NOUN
mkg-41075	20	23	published	publish	VERB
mkg-41075	20	24	an	an	DET
mkg-41075	20	25	article	article	NOUN
mkg-41075	20	26	emphasizing	emphasize	VERB
mkg-41075	20	27	the	the	DET
mkg-41075	20	28	importance	importance	NOUN
mkg-41075	20	29	of	of	ADP
mkg-41075	20	30	examining	examine	VERB
mkg-41075	20	31	and	and	CCONJ
mkg-41075	20	32	investigating	investigate	VERB
mkg-41075	20	33	the	the	DET
mkg-41075	20	34	“	"	PUNCT
mkg-41075	20	35	field	field	NOUN
mkg-41075	20	36	”	"	PUNCT
mkg-41075	20	37	surrounding	surround	VERB
mkg-41075	20	38	an	an	DET
mkg-41075	20	39	oral	oral	ADJ
mkg-41075	20	40	cancer	cancer	NOUN
mkg-41075	20	41	lesion.8	lesion.8	NOUN
mkg-41075	20	42	this	this	PRON
mkg-41075	20	43	should	should	AUX
mkg-41075	20	44	be	be	AUX
mkg-41075	20	45	done	do	VERB
mkg-41075	20	46	at	at	ADP
mkg-41075	20	47	the	the	DET
mkg-41075	20	48	risk	risk	NOUN
mkg-41075	20	49	-	-	PUNCT
mkg-41075	20	50	assessment	assessment	NOUN
mkg-41075	20	51	stage	stage	NOUN
mkg-41075	20	52	and	and	CCONJ
mkg-41075	20	53	must	must	AUX
mkg-41075	20	54	be	be	AUX
mkg-41075	20	55	part	part	NOUN
mkg-41075	20	56	of	of	ADP
mkg-41075	20	57	the	the	DET
mkg-41075	20	58	comprehensive	comprehensive	ADJ
mkg-41075	20	59	management	management	NOUN
mkg-41075	20	60	of	of	ADP
mkg-41075	20	61	oral	oral	ADJ
mkg-41075	20	62	cancer	cancer	NOUN
mkg-41075	20	63	.	.	PUNCT
mkg-41075	21	1	since	since	SCONJ
mkg-41075	21	2	then	then	ADV
mkg-41075	21	3	,	,	PUNCT
mkg-41075	21	4	many	many	ADJ
mkg-41075	21	5	studies	study	NOUN
mkg-41075	21	6	have	have	AUX
mkg-41075	21	7	used	use	VERB
mkg-41075	21	8	molecular	molecular	ADJ
mkg-41075	21	9	techniques	technique	NOUN
mkg-41075	21	10	to	to	PART
mkg-41075	21	11	explore	explore	VERB
mkg-41075	21	12	this	this	DET
mkg-41075	21	13	concept	concept	NOUN
mkg-41075	21	14	.	.	PUNCT
mkg-41075	22	1	the	the	DET
mkg-41075	22	2	nature	nature	NOUN
mkg-41075	22	3	of	of	ADP
mkg-41075	22	4	oral	oral	ADJ
mkg-41075	22	5	cancer	cancer	NOUN
mkg-41075	22	6	is	be	AUX
mkg-41075	22	7	genetically	genetically	ADV
mkg-41075	22	8	altered	alter	VERB
mkg-41075	22	9	cells	cell	NOUN
mkg-41075	22	10	.	.	PUNCT
mkg-41075	23	1	during	during	ADP
mkg-41075	23	2	cancerization	cancerization	NOUN
mkg-41075	23	3	,	,	PUNCT
mkg-41075	23	4	several	several	ADJ
mkg-41075	23	5	epithelial	epithelial	ADJ
mkg-41075	23	6	cells	cell	NOUN
mkg-41075	23	7	may	may	AUX
mkg-41075	23	8	undergo	undergo	VERB
mkg-41075	23	9	an	an	DET
mkg-41075	23	10	altered	altered	ADJ
mkg-41075	23	11	genetic	genetic	ADJ
mkg-41075	23	12	makeup	makeup	NOUN
mkg-41075	23	13	called	call	VERB
mkg-41075	23	14	a	a	DET
mkg-41075	23	15	field	field	NOUN
mkg-41075	23	16	with	with	ADP
mkg-41075	23	17	a	a	DET
mkg-41075	23	18	typical	typical	ADJ
mkg-41075	23	19	clinical	clinical	ADJ
mkg-41075	23	20	appearance	appearance	NOUN
mkg-41075	23	21	.	.	PUNCT
mkg-41075	24	1	these	these	DET
mkg-41075	24	2	cells	cell	NOUN
mkg-41075	24	3	can	can	AUX
mkg-41075	24	4	provoke	provoke	VERB
mkg-41075	24	5	a	a	DET
mkg-41075	24	6	process	process	NOUN
mkg-41075	24	7	called	call	VERB
mkg-41075	24	8	“	"	PUNCT
mkg-41075	24	9	field	field	NOUN
mkg-41075	24	10	cancerization	cancerization	NOUN
mkg-41075	24	11	.	.	PUNCT
mkg-41075	24	12	”9	”9	PUNCT
mkg-41075	25	1	copyright	copyright	NOUN
mkg-41075	25	2	©	©	ADP
mkg-41075	25	3	2023	2023	NUM
mkg-41075	25	4	dental	dental	ADJ
mkg-41075	25	5	journal	journal	NOUN
mkg-41075	25	6	(	(	PUNCT
mkg-41075	25	7	majalah	majalah	PROPN
mkg-41075	25	8	kedokteran	kedokteran	PROPN
mkg-41075	25	9	gigi	gigi	PROPN
mkg-41075	25	10	)	)	PUNCT
mkg-41075	26	1	p	p	X
mkg-41075	26	2	-	-	PUNCT
mkg-41075	26	3	issn	issn	NOUN
mkg-41075	26	4	:	:	PUNCT
mkg-41075	26	5	1978	1978	NUM
mkg-41075	26	6	-	-	SYM
mkg-41075	26	7	3728	3728	NUM
mkg-41075	26	8	;	;	PUNCT
mkg-41075	26	9	e	e	X
mkg-41075	26	10	-	-	PUNCT
mkg-41075	26	11	issn	issn	ADJ
mkg-41075	26	12	:	:	PUNCT
mkg-41075	26	13	2442	2442	NUM
mkg-41075	26	14	-	-	SYM
mkg-41075	26	15	9740	9740	NUM
mkg-41075	26	16	.	.	PUNCT
mkg-41075	27	1	accredited	accredit	VERB
mkg-41075	27	2	no	no	INTJ
mkg-41075	27	3	.	.	PROPN
mkg-41075	28	1	158	158	NUM
mkg-41075	28	2	/	/	SYM
mkg-41075	28	3	e	e	NOUN
mkg-41075	28	4	/	/	SYM
mkg-41075	28	5	kpt/2021	kpt/2021	NOUN
mkg-41075	28	6	.	.	PUNCT
mkg-41075	29	1	open	open	ADJ
mkg-41075	29	2	access	access	NOUN
mkg-41075	29	3	under	under	ADP
mkg-41075	29	4	cc	cc	NOUN
mkg-41075	29	5	-	-	PUNCT
mkg-41075	29	6	by	by	ADP
mkg-41075	29	7	-	-	PUNCT
mkg-41075	29	8	sa	sa	NOUN
mkg-41075	29	9	license	license	NOUN
mkg-41075	29	10	.	.	PUNCT
mkg-41075	30	1	available	available	ADJ
mkg-41075	30	2	at	at	ADP
mkg-41075	30	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-41075	30	4	doi	doi	NOUN
mkg-41075	30	5	:	:	PUNCT
mkg-41075	30	6	10.20473	10.20473	NUM
mkg-41075	30	7	/	/	SYM
mkg-41075	30	8	j.djmkg.v56.i3.p189–196	j.djmkg.v56.i3.p189–196	ADJ
mkg-41075	30	9	mailto:diah-s-e@fkg.unair.ac.id	mailto:diah-s-e@fkg.unair.ac.id	PROPN
mkg-41075	30	10	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	PROPN
mkg-41075	30	11	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	PROPN
mkg-41075	30	12	190	190	NUM
mkg-41075	30	13	puspasari	puspasari	PROPN
mkg-41075	30	14	et	et	PROPN
mkg-41075	30	15	al	al	PROPN
mkg-41075	30	16	.	.	PROPN
mkg-41075	30	17	dent	dent	PROPN
mkg-41075	30	18	.	.	PUNCT
mkg-41075	31	1	j.	j.	PROPN
mkg-41075	31	2	(	(	PUNCT
mkg-41075	31	3	majalah	majalah	PROPN
mkg-41075	31	4	kedokteran	kedokteran	PROPN
mkg-41075	31	5	gigi	gigi	PROPN
mkg-41075	31	6	)	)	PUNCT
mkg-41075	31	7	2023	2023	NUM
mkg-41075	31	8	september	september	PROPN
mkg-41075	31	9	;	;	PUNCT
mkg-41075	31	10	56(3	56(3	NUM
mkg-41075	31	11	):	):	PUNCT
mkg-41075	31	12	189–196	189–196	NUM
mkg-41075	31	13	some	some	DET
mkg-41075	31	14	oral	oral	ADJ
mkg-41075	31	15	lesions	lesion	NOUN
mkg-41075	31	16	display	display	NOUN
mkg-41075	31	17	field	field	NOUN
mkg-41075	31	18	cancerization	cancerization	NOUN
mkg-41075	31	19	and	and	CCONJ
mkg-41075	31	20	are	be	AUX
mkg-41075	31	21	classified	classify	VERB
mkg-41075	31	22	as	as	ADP
mkg-41075	31	23	opmds	opmds	NOUN
mkg-41075	31	24	or	or	CCONJ
mkg-41075	31	25	pre	pre	ADJ
mkg-41075	31	26	-	-	ADJ
mkg-41075	31	27	cancerization	cancerization	NOUN
mkg-41075	31	28	lesions	lesion	NOUN
mkg-41075	31	29	.	.	PUNCT
mkg-41075	32	1	common	common	ADJ
mkg-41075	32	2	opmds	opmds	NOUN
mkg-41075	32	3	are	be	AUX
mkg-41075	32	4	leukoplakia	leukoplakia	NOUN
mkg-41075	32	5	with	with	ADP
mkg-41075	32	6	a	a	DET
mkg-41075	32	7	transformation	transformation	NOUN
mkg-41075	32	8	possibility	possibility	NOUN
mkg-41075	32	9	of	of	ADP
mkg-41075	32	10	0.13–40.8%,10–12	0.13–40.8%,10–12	NUM
mkg-41075	32	11	erythroplakia	erythroplakia	NOUN
mkg-41075	32	12	with	with	ADP
mkg-41075	32	13	33.1%,13	33.1%,13	NUM
mkg-41075	32	14	and	and	CCONJ
mkg-41075	32	15	oral	oral	ADJ
mkg-41075	32	16	lichen	lichen	NOUN
mkg-41075	32	17	planus	planus	NOUN
mkg-41075	32	18	with	with	ADP
mkg-41075	32	19	1.1–2.28%.14,15	1.1–2.28%.14,15	NUM
mkg-41075	32	20	the	the	DET
mkg-41075	32	21	differences	difference	NOUN
mkg-41075	32	22	in	in	ADP
mkg-41075	32	23	transformation	transformation	NOUN
mkg-41075	32	24	depend	depend	VERB
mkg-41075	32	25	on	on	ADP
mkg-41075	32	26	the	the	DET
mkg-41075	32	27	predisposing	predisposing	NOUN
mkg-41075	32	28	or	or	CCONJ
mkg-41075	32	29	risk	risk	NOUN
mkg-41075	32	30	factors.16	factors.16	PROPN
mkg-41075	32	31	patients	patient	NOUN
mkg-41075	32	32	may	may	AUX
mkg-41075	32	33	develop	develop	VERB
mkg-41075	32	34	cancer	cancer	NOUN
mkg-41075	32	35	in	in	ADP
mkg-41075	32	36	the	the	DET
mkg-41075	32	37	field	field	NOUN
mkg-41075	32	38	of	of	ADP
mkg-41075	32	39	cancerization	cancerization	NOUN
mkg-41075	32	40	.	.	PUNCT
mkg-41075	33	1	unfortunately	unfortunately	ADV
mkg-41075	33	2	,	,	PUNCT
mkg-41075	33	3	this	this	DET
mkg-41075	33	4	condition	condition	NOUN
mkg-41075	33	5	is	be	AUX
mkg-41075	33	6	only	only	ADV
mkg-41075	33	7	confirmed	confirm	VERB
mkg-41075	33	8	with	with	ADP
mkg-41075	33	9	invasive	invasive	ADJ
mkg-41075	33	10	excisional	excisional	ADJ
mkg-41075	33	11	surgery	surgery	NOUN
mkg-41075	33	12	.	.	PUNCT
mkg-41075	34	1	there	there	PRON
mkg-41075	34	2	is	be	VERB
mkg-41075	34	3	no	no	DET
mkg-41075	34	4	effective	effective	ADJ
mkg-41075	34	5	intervention	intervention	NOUN
mkg-41075	34	6	for	for	ADP
mkg-41075	34	7	preventing	prevent	VERB
mkg-41075	34	8	transformation	transformation	NOUN
mkg-41075	34	9	and	and	CCONJ
mkg-41075	34	10	cancerization.17	cancerization.17	DET
mkg-41075	34	11	the	the	DET
mkg-41075	34	12	purpose	purpose	NOUN
mkg-41075	34	13	of	of	ADP
mkg-41075	34	14	this	this	DET
mkg-41075	34	15	review	review	NOUN
mkg-41075	34	16	is	be	AUX
mkg-41075	34	17	to	to	PART
mkg-41075	34	18	discuss	discuss	VERB
mkg-41075	34	19	oral	oral	ADJ
mkg-41075	34	20	field	field	NOUN
mkg-41075	34	21	cancerization	cancerization	NOUN
mkg-41075	34	22	,	,	PUNCT
mkg-41075	34	23	cancerization	cancerization	NOUN
mkg-41075	34	24	mechanisms	mechanism	NOUN
mkg-41075	34	25	,	,	PUNCT
mkg-41075	34	26	and	and	CCONJ
mkg-41075	34	27	deoxyribonucleic	deoxyribonucleic	ADJ
mkg-41075	34	28	acid	acid	NOUN
mkg-41075	34	29	(	(	PUNCT
mkg-41075	34	30	dna	dna	PROPN
mkg-41075	34	31	)	)	PUNCT
mkg-41075	34	32	,	,	PUNCT
mkg-41075	34	33	ribonucleic	ribonucleic	ADJ
mkg-41075	34	34	acid	acid	NOUN
mkg-41075	34	35	(	(	PUNCT
mkg-41075	34	36	rna	rna	PROPN
mkg-41075	34	37	)	)	PUNCT
mkg-41075	34	38	,	,	PUNCT
mkg-41075	34	39	and	and	CCONJ
mkg-41075	34	40	tissue	tissue	NOUN
mkg-41075	34	41	markers	marker	NOUN
mkg-41075	34	42	to	to	PART
mkg-41075	34	43	be	be	AUX
mkg-41075	34	44	considered	consider	VERB
mkg-41075	34	45	as	as	ADP
mkg-41075	34	46	cancerization	cancerization	NOUN
mkg-41075	34	47	biomarkers	biomarker	NOUN
mkg-41075	34	48	to	to	PART
mkg-41075	34	49	provide	provide	VERB
mkg-41075	34	50	recommendations	recommendation	NOUN
mkg-41075	34	51	for	for	ADP
mkg-41075	34	52	dentists	dentist	NOUN
mkg-41075	34	53	,	,	PUNCT
mkg-41075	34	54	oral	oral	ADJ
mkg-41075	34	55	medicine	medicine	NOUN
mkg-41075	34	56	specialists	specialist	NOUN
mkg-41075	34	57	,	,	PUNCT
mkg-41075	34	58	and	and	CCONJ
mkg-41075	34	59	oral	oral	ADJ
mkg-41075	34	60	surgeons	surgeon	NOUN
mkg-41075	34	61	for	for	ADP
mkg-41075	34	62	better	well	ADJ
mkg-41075	34	63	patient	patient	ADJ
mkg-41075	34	64	management	management	NOUN
mkg-41075	34	65	.	.	PUNCT
mkg-41075	35	1	oral	oral	ADJ
mkg-41075	35	2	cancers	cancer	NOUN
mkg-41075	35	3	the	the	DET
mkg-41075	35	4	carcinogenesis	carcinogenesis	NOUN
mkg-41075	35	5	process	process	NOUN
mkg-41075	35	6	begins	begin	VERB
mkg-41075	35	7	with	with	ADP
mkg-41075	35	8	a	a	DET
mkg-41075	35	9	stem	stem	NOUN
mkg-41075	35	10	cell	cell	NOUN
mkg-41075	35	11	with	with	ADP
mkg-41075	35	12	one	one	NUM
mkg-41075	35	13	or	or	CCONJ
mkg-41075	35	14	more	more	ADV
mkg-41075	35	15	genetic	genetic	ADJ
mkg-41075	35	16	or	or	CCONJ
mkg-41075	35	17	epigenetic	epigenetic	ADJ
mkg-41075	35	18	alterations	alteration	NOUN
mkg-41075	35	19	.	.	PUNCT
mkg-41075	36	1	then	then	ADV
mkg-41075	36	2	,	,	PUNCT
mkg-41075	36	3	a	a	DET
mkg-41075	36	4	clone	clone	NOUN
mkg-41075	36	5	from	from	ADP
mkg-41075	36	6	the	the	DET
mkg-41075	36	7	altered	alter	VERB
mkg-41075	36	8	cells	cell	NOUN
mkg-41075	36	9	forms	form	VERB
mkg-41075	36	10	a	a	DET
mkg-41075	36	11	patch	patch	NOUN
mkg-41075	36	12	or	or	CCONJ
mkg-41075	36	13	cluster	cluster	NOUN
mkg-41075	36	14	.	.	PUNCT
mkg-41075	37	1	due	due	ADP
mkg-41075	37	2	to	to	ADP
mkg-41075	37	3	further	further	ADJ
mkg-41075	37	4	genetic	genetic	ADJ
mkg-41075	37	5	alteration	alteration	NOUN
mkg-41075	37	6	,	,	PUNCT
mkg-41075	37	7	stem	stem	NOUN
mkg-41075	37	8	cells	cell	NOUN
mkg-41075	37	9	deviate	deviate	VERB
mkg-41075	37	10	from	from	ADP
mkg-41075	37	11	standard	standard	ADJ
mkg-41075	37	12	growth	growth	NOUN
mkg-41075	37	13	control	control	NOUN
mkg-41075	37	14	patterns	pattern	NOUN
mkg-41075	37	15	and	and	CCONJ
mkg-41075	37	16	enjoy	enjoy	VERB
mkg-41075	37	17	advantages	advantage	NOUN
mkg-41075	37	18	for	for	ADP
mkg-41075	37	19	the	the	DET
mkg-41075	37	20	development	development	NOUN
mkg-41075	37	21	of	of	ADP
mkg-41075	37	22	expanding	expand	VERB
mkg-41075	37	23	clones	clone	NOUN
mkg-41075	37	24	.	.	PUNCT
mkg-41075	38	1	furthermore	furthermore	ADV
mkg-41075	38	2	,	,	PUNCT
mkg-41075	38	3	lesions	lesion	NOUN
mkg-41075	38	4	develop	develop	VERB
mkg-41075	38	5	and	and	CCONJ
mkg-41075	38	6	become	become	VERB
mkg-41075	38	7	a	a	DET
mkg-41075	38	8	field	field	NOUN
mkg-41075	38	9	that	that	PRON
mkg-41075	38	10	replaces	replace	VERB
mkg-41075	38	11	normal	normal	ADJ
mkg-41075	38	12	epithelium	epithelium	NOUN
mkg-41075	38	13	laterally	laterally	NOUN
mkg-41075	38	14	.	.	PUNCT
mkg-41075	39	1	this	this	DET
mkg-41075	39	2	field	field	NOUN
mkg-41075	39	3	has	have	VERB
mkg-41075	39	4	genetically	genetically	ADV
mkg-41075	39	5	altered	alter	VERB
mkg-41075	39	6	clonal	clonal	ADJ
mkg-41075	39	7	units	unit	NOUN
mkg-41075	39	8	and	and	CCONJ
mkg-41075	39	9	advantages	advantage	NOUN
mkg-41075	39	10	in	in	ADP
mkg-41075	39	11	proliferation	proliferation	NOUN
mkg-41075	39	12	activity	activity	NOUN
mkg-41075	39	13	,	,	PUNCT
mkg-41075	39	14	and	and	CCONJ
mkg-41075	39	15	finally	finally	ADV
mkg-41075	39	16	dominates	dominate	VERB
mkg-41075	39	17	the	the	DET
mkg-41075	39	18	overall	overall	ADJ
mkg-41075	39	19	process	process	NOUN
mkg-41075	39	20	.	.	PUNCT
mkg-41075	40	1	additional	additional	ADJ
mkg-41075	40	2	genetic	genetic	ADJ
mkg-41075	40	3	alterations	alteration	NOUN
mkg-41075	40	4	occur	occur	VERB
mkg-41075	40	5	along	along	ADP
mkg-41075	40	6	with	with	ADP
mkg-41075	40	7	enlargement	enlargement	NOUN
mkg-41075	40	8	of	of	ADP
mkg-41075	40	9	the	the	DET
mkg-41075	40	10	lesion	lesion	NOUN
mkg-41075	40	11	,	,	PUNCT
mkg-41075	40	12	creating	create	VERB
mkg-41075	40	13	various	various	ADJ
mkg-41075	40	14	subclones	subclone	NOUN
mkg-41075	40	15	within	within	ADP
mkg-41075	40	16	the	the	DET
mkg-41075	40	17	field	field	NOUN
mkg-41075	40	18	.	.	PUNCT
mkg-41075	41	1	because	because	SCONJ
mkg-41075	41	2	of	of	ADP
mkg-41075	41	3	divergence	divergence	NOUN
mkg-41075	41	4	and	and	CCONJ
mkg-41075	41	5	clonal	clonal	ADJ
mkg-41075	41	6	selection	selection	NOUN
mkg-41075	41	7	,	,	PUNCT
mkg-41075	41	8	clones	clone	NOUN
mkg-41075	41	9	are	be	AUX
mkg-41075	41	10	altered	alter	VERB
mkg-41075	41	11	at	at	ADP
mkg-41075	41	12	different	different	ADJ
mkg-41075	41	13	times	time	NOUN
mkg-41075	41	14	and	and	CCONJ
mkg-41075	41	15	produce	produce	VERB
mkg-41075	41	16	adequate	adequate	ADJ
mkg-41075	41	17	modified	modify	VERB
mkg-41075	41	18	stem	stem	NOUN
mkg-41075	41	19	cells	cell	NOUN
mkg-41075	41	20	.	.	PUNCT
mkg-41075	42	1	however	however	ADV
mkg-41075	42	2	,	,	PUNCT
mkg-41075	42	3	these	these	DET
mkg-41075	42	4	cells	cell	NOUN
mkg-41075	42	5	share	share	VERB
mkg-41075	42	6	the	the	DET
mkg-41075	42	7	same	same	ADJ
mkg-41075	42	8	clonal	clonal	ADJ
mkg-41075	42	9	origin	origin	NOUN
mkg-41075	42	10	.	.	PUNCT
mkg-41075	43	1	this	this	DET
mkg-41075	43	2	process	process	NOUN
mkg-41075	43	3	culminates	culminate	VERB
mkg-41075	43	4	in	in	ADP
mkg-41075	43	5	invasive	invasive	ADJ
mkg-41075	43	6	cancer	cancer	NOUN
mkg-41075	43	7	formation.18	formation.18	NOUN
mkg-41075	43	8	histologically	histologically	ADV
mkg-41075	43	9	,	,	PUNCT
mkg-41075	43	10	it	it	PRON
mkg-41075	43	11	is	be	AUX
mkg-41075	43	12	considered	consider	VERB
mkg-41075	43	13	a	a	DET
mkg-41075	43	14	local	local	ADJ
mkg-41075	43	15	recurrence	recurrence	NOUN
mkg-41075	43	16	when	when	SCONJ
mkg-41075	43	17	the	the	DET
mkg-41075	43	18	distance	distance	NOUN
mkg-41075	43	19	between	between	ADP
mkg-41075	43	20	tumors	tumor	NOUN
mkg-41075	43	21	is	be	AUX
mkg-41075	43	22	less	less	ADJ
mkg-41075	43	23	than	than	ADP
mkg-41075	43	24	2	2	NUM
mkg-41075	43	25	cm	cm	NOUN
mkg-41075	43	26	;	;	PUNCT
mkg-41075	43	27	if	if	SCONJ
mkg-41075	43	28	it	it	PRON
mkg-41075	43	29	is	be	AUX
mkg-41075	43	30	more	more	ADJ
mkg-41075	43	31	than	than	ADP
mkg-41075	43	32	2	2	NUM
mkg-41075	43	33	cm	cm	NOUN
mkg-41075	43	34	,	,	PUNCT
mkg-41075	43	35	it	it	PRON
mkg-41075	43	36	is	be	AUX
mkg-41075	43	37	regarded	regard	VERB
mkg-41075	43	38	as	as	ADP
mkg-41075	43	39	a	a	DET
mkg-41075	43	40	second	second	ADJ
mkg-41075	43	41	primary	primary	ADJ
mkg-41075	43	42	tumor.19	tumor.19	NOUN
mkg-41075	43	43	even	even	ADV
mkg-41075	43	44	a	a	DET
mkg-41075	43	45	single	single	ADJ
mkg-41075	43	46	altered	altered	ADJ
mkg-41075	43	47	cell	cell	NOUN
mkg-41075	43	48	caused	cause	VERB
mkg-41075	43	49	by	by	ADP
mkg-41075	43	50	tumorsuppressor	tumorsuppressor	NOUN
mkg-41075	43	51	gene	gene	NOUN
mkg-41075	43	52	inactivation	inactivation	NOUN
mkg-41075	43	53	and	and	CCONJ
mkg-41075	43	54	oncogene	oncogene	NOUN
mkg-41075	43	55	activation	activation	NOUN
mkg-41075	43	56	can	can	AUX
mkg-41075	43	57	overgrow	overgrow	VERB
mkg-41075	43	58	and	and	CCONJ
mkg-41075	43	59	expand	expand	VERB
mkg-41075	43	60	to	to	PART
mkg-41075	43	61	form	form	VERB
mkg-41075	43	62	a	a	DET
mkg-41075	43	63	clonal	clonal	ADJ
mkg-41075	43	64	mass	mass	NOUN
mkg-41075	43	65	of	of	ADP
mkg-41075	43	66	tumor	tumor	NOUN
mkg-41075	43	67	cells	cell	NOUN
mkg-41075	43	68	.	.	PUNCT
mkg-41075	44	1	clinically	clinically	ADV
mkg-41075	44	2	,	,	PUNCT
mkg-41075	44	3	this	this	PRON
mkg-41075	44	4	is	be	AUX
mkg-41075	44	5	a	a	DET
mkg-41075	44	6	dynamic	dynamic	ADJ
mkg-41075	44	7	process	process	NOUN
mkg-41075	44	8	.	.	PUNCT
mkg-41075	45	1	genetic	genetic	ADJ
mkg-41075	45	2	alteration	alteration	NOUN
mkg-41075	45	3	occurs	occur	VERB
mkg-41075	45	4	from	from	ADP
mkg-41075	45	5	the	the	DET
mkg-41075	45	6	accumulation	accumulation	NOUN
mkg-41075	45	7	of	of	ADP
mkg-41075	45	8	cell	cell	NOUN
mkg-41075	45	9	-	-	PUNCT
mkg-41075	45	10	growth	growth	NOUN
mkg-41075	45	11	phases	phase	NOUN
mkg-41075	45	12	and	and	CCONJ
mkg-41075	45	13	progresses	progress	NOUN
mkg-41075	45	14	from	from	ADP
mkg-41075	45	15	the	the	DET
mkg-41075	45	16	benign	benign	NOUN
mkg-41075	45	17	to	to	ADP
mkg-41075	45	18	the	the	DET
mkg-41075	45	19	pre	pre	ADJ
mkg-41075	45	20	-	-	ADJ
mkg-41075	45	21	malignant	malignant	ADJ
mkg-41075	45	22	and	and	CCONJ
mkg-41075	45	23	malignant	malignant	ADJ
mkg-41075	45	24	stages.20	stages.20	PROPN
mkg-41075	45	25	oral	oral	ADJ
mkg-41075	45	26	field	field	NOUN
mkg-41075	45	27	cancerization	cancerization	NOUN
mkg-41075	45	28	the	the	DET
mkg-41075	45	29	terms	term	NOUN
mkg-41075	45	30	“	"	PUNCT
mkg-41075	45	31	field	field	NOUN
mkg-41075	45	32	effect	effect	NOUN
mkg-41075	45	33	”	"	PUNCT
mkg-41075	45	34	and	and	CCONJ
mkg-41075	45	35	“	"	PUNCT
mkg-41075	45	36	field	field	NOUN
mkg-41075	45	37	cancerization	cancerization	NOUN
mkg-41075	45	38	”	"	PUNCT
mkg-41075	45	39	are	be	AUX
mkg-41075	45	40	used	use	VERB
mkg-41075	45	41	when	when	SCONJ
mkg-41075	45	42	the	the	DET
mkg-41075	45	43	pre	pre	ADJ
mkg-41075	45	44	-	-	ADJ
mkg-41075	45	45	neoplastic	neoplastic	ADJ
mkg-41075	45	46	process	process	NOUN
mkg-41075	45	47	is	be	AUX
mkg-41075	45	48	in	in	ADP
mkg-41075	45	49	several	several	ADJ
mkg-41075	45	50	locations.21	locations.21	NOUN
mkg-41075	45	51	this	this	PRON
mkg-41075	45	52	was	be	AUX
mkg-41075	45	53	previously	previously	ADV
mkg-41075	45	54	assumed	assume	VERB
mkg-41075	45	55	to	to	PART
mkg-41075	45	56	be	be	AUX
mkg-41075	45	57	multiple	multiple	ADJ
mkg-41075	45	58	conditions	condition	NOUN
mkg-41075	45	59	developing	develop	VERB
mkg-41075	45	60	independently	independently	ADV
mkg-41075	45	61	.	.	PUNCT
mkg-41075	46	1	however	however	ADV
mkg-41075	46	2	,	,	PUNCT
mkg-41075	46	3	this	this	PRON
mkg-41075	46	4	was	be	AUX
mkg-41075	46	5	challenged	challenge	VERB
mkg-41075	46	6	due	due	ADP
mkg-41075	46	7	to	to	ADP
mkg-41075	46	8	the	the	DET
mkg-41075	46	9	clinical	clinical	ADJ
mkg-41075	46	10	diagnosis	diagnosis	NOUN
mkg-41075	46	11	of	of	ADP
mkg-41075	46	12	a	a	DET
mkg-41075	46	13	second	second	ADJ
mkg-41075	46	14	primary	primary	ADJ
mkg-41075	46	15	tumor	tumor	NOUN
mkg-41075	46	16	located	locate	VERB
mkg-41075	46	17	distant	distant	ADJ
mkg-41075	46	18	from	from	ADP
mkg-41075	46	19	the	the	DET
mkg-41075	46	20	original	original	ADJ
mkg-41075	46	21	tumor	tumor	NOUN
mkg-41075	46	22	,	,	PUNCT
mkg-41075	46	23	found	find	VERB
mkg-41075	46	24	on	on	ADP
mkg-41075	46	25	genetic	genetic	ADJ
mkg-41075	46	26	analysis	analysis	NOUN
mkg-41075	46	27	to	to	PART
mkg-41075	46	28	be	be	AUX
mkg-41075	46	29	arising	arise	VERB
mkg-41075	46	30	from	from	ADP
mkg-41075	46	31	the	the	DET
mkg-41075	46	32	clonal	clonal	ADJ
mkg-41075	46	33	spreading	spreading	NOUN
mkg-41075	46	34	of	of	ADP
mkg-41075	46	35	the	the	DET
mkg-41075	46	36	initial	initial	ADJ
mkg-41075	46	37	lesion.1	lesion.1	PROPN
mkg-41075	46	38	field	field	NOUN
mkg-41075	46	39	pre	pre	NOUN
mkg-41075	46	40	-	-	NOUN
mkg-41075	46	41	cancerization	cancerization	NOUN
mkg-41075	46	42	and	and	CCONJ
mkg-41075	46	43	its	its	PRON
mkg-41075	46	44	correlation	correlation	NOUN
mkg-41075	46	45	with	with	ADP
mkg-41075	46	46	oral	oral	ADJ
mkg-41075	46	47	cancers	cancer	NOUN
mkg-41075	46	48	are	be	AUX
mkg-41075	46	49	explained	explain	VERB
mkg-41075	46	50	in	in	ADP
mkg-41075	46	51	figure	figure	NOUN
mkg-41075	46	52	1	1	NUM
mkg-41075	46	53	.	.	PUNCT
mkg-41075	47	1	figure	figure	NOUN
mkg-41075	47	2	1	1	NUM
mkg-41075	47	3	.	.	PUNCT
mkg-41075	47	4	field	field	NOUN
mkg-41075	47	5	cancerization	cancerization	NOUN
mkg-41075	47	6	shows	show	VERB
mkg-41075	47	7	mucosal	mucosal	ADJ
mkg-41075	47	8	areas	area	NOUN
mkg-41075	47	9	with	with	ADP
mkg-41075	47	10	normal	normal	ADJ
mkg-41075	47	11	cells	cell	NOUN
mkg-41075	47	12	(	(	PUNCT
mkg-41075	47	13	blue	blue	ADJ
mkg-41075	47	14	)	)	PUNCT
mkg-41075	47	15	and	and	CCONJ
mkg-41075	47	16	cells	cell	NOUN
mkg-41075	47	17	with	with	ADP
mkg-41075	47	18	cancer	cancer	NOUN
mkg-41075	47	19	-	-	PUNCT
mkg-41075	47	20	associated	associate	VERB
mkg-41075	47	21	genetic	genetic	ADJ
mkg-41075	47	22	or	or	CCONJ
mkg-41075	47	23	epigenetic	epigenetic	ADJ
mkg-41075	47	24	alterations	alteration	NOUN
mkg-41075	47	25	(	(	PUNCT
mkg-41075	47	26	gray	gray	ADJ
mkg-41075	47	27	)	)	PUNCT
mkg-41075	47	28	.	.	PUNCT
mkg-41075	48	1	a	a	DET
mkg-41075	48	2	pre	pre	ADJ
mkg-41075	48	3	-	-	ADJ
mkg-41075	48	4	neoplastic	neoplastic	ADJ
mkg-41075	48	5	field	field	NOUN
mkg-41075	48	6	is	be	AUX
mkg-41075	48	7	monoclonal	monoclonal	NOUN
mkg-41075	48	8	in	in	ADP
mkg-41075	48	9	origin	origin	NOUN
mkg-41075	48	10	and	and	CCONJ
mkg-41075	48	11	does	do	AUX
mkg-41075	48	12	not	not	PART
mkg-41075	48	13	show	show	VERB
mkg-41075	48	14	invasive	invasive	ADJ
mkg-41075	48	15	growth	growth	NOUN
mkg-41075	48	16	or	or	CCONJ
mkg-41075	48	17	metastatic	metastatic	ADJ
mkg-41075	48	18	behavior	behavior	NOUN
mkg-41075	48	19	,	,	PUNCT
mkg-41075	48	20	which	which	PRON
mkg-41075	48	21	are	be	AUX
mkg-41075	48	22	the	the	DET
mkg-41075	48	23	hallmarks	hallmark	NOUN
mkg-41075	48	24	of	of	ADP
mkg-41075	48	25	invasive	invasive	ADJ
mkg-41075	48	26	carcinoma	carcinoma	NOUN
mkg-41075	48	27	(	(	PUNCT
mkg-41075	48	28	dark	dark	ADJ
mkg-41075	48	29	gray	gray	ADJ
mkg-41075	48	30	cells	cell	NOUN
mkg-41075	48	31	)	)	PUNCT
mkg-41075	48	32	.	.	PUNCT
mkg-41075	49	1	copyright	copyright	NOUN
mkg-41075	49	2	©	©	ADP
mkg-41075	49	3	2023	2023	NUM
mkg-41075	49	4	dental	dental	ADJ
mkg-41075	49	5	journal	journal	NOUN
mkg-41075	49	6	(	(	PUNCT
mkg-41075	49	7	majalah	majalah	PROPN
mkg-41075	49	8	kedokteran	kedokteran	PROPN
mkg-41075	49	9	gigi	gigi	PROPN
mkg-41075	49	10	)	)	PUNCT
mkg-41075	50	1	p	p	X
mkg-41075	50	2	-	-	PUNCT
mkg-41075	50	3	issn	issn	NOUN
mkg-41075	50	4	:	:	PUNCT
mkg-41075	50	5	1978	1978	NUM
mkg-41075	50	6	-	-	SYM
mkg-41075	50	7	3728	3728	NUM
mkg-41075	50	8	;	;	PUNCT
mkg-41075	50	9	e	e	X
mkg-41075	50	10	-	-	PUNCT
mkg-41075	50	11	issn	issn	ADJ
mkg-41075	50	12	:	:	PUNCT
mkg-41075	50	13	2442	2442	NUM
mkg-41075	50	14	-	-	SYM
mkg-41075	50	15	9740	9740	NUM
mkg-41075	50	16	.	.	PUNCT
mkg-41075	51	1	accredited	accredit	VERB
mkg-41075	51	2	no	no	INTJ
mkg-41075	51	3	.	.	PROPN
mkg-41075	52	1	158	158	NUM
mkg-41075	52	2	/	/	SYM
mkg-41075	52	3	e	e	NOUN
mkg-41075	52	4	/	/	SYM
mkg-41075	52	5	kpt/2021	kpt/2021	NOUN
mkg-41075	52	6	.	.	PUNCT
mkg-41075	53	1	open	open	ADJ
mkg-41075	53	2	access	access	NOUN
mkg-41075	53	3	under	under	ADP
mkg-41075	53	4	cc	cc	NOUN
mkg-41075	53	5	-	-	PUNCT
mkg-41075	53	6	by	by	ADP
mkg-41075	53	7	-	-	PUNCT
mkg-41075	53	8	sa	sa	NOUN
mkg-41075	53	9	license	license	NOUN
mkg-41075	53	10	.	.	PUNCT
mkg-41075	54	1	available	available	ADJ
mkg-41075	54	2	at	at	ADP
mkg-41075	54	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-41075	54	4	doi	doi	NOUN
mkg-41075	54	5	:	:	PUNCT
mkg-41075	54	6	10.20473	10.20473	NUM
mkg-41075	54	7	/	/	SYM
mkg-41075	54	8	j.djmkg.v56.i3.p189–196	j.djmkg.v56.i3.p189–196	PROPN
mkg-41075	54	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	PROPN
mkg-41075	54	10	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	PROPN
mkg-41075	55	1	191puspasari	191puspasari	PROPN
mkg-41075	55	2	et	et	PROPN
mkg-41075	55	3	al	al	PROPN
mkg-41075	55	4	.	.	PROPN
mkg-41075	55	5	dent	dent	PROPN
mkg-41075	55	6	.	.	PUNCT
mkg-41075	56	1	j.	j.	PROPN
mkg-41075	56	2	(	(	PUNCT
mkg-41075	56	3	majalah	majalah	PROPN
mkg-41075	56	4	kedokteran	kedokteran	PROPN
mkg-41075	56	5	gigi	gigi	PROPN
mkg-41075	56	6	)	)	PUNCT
mkg-41075	56	7	2023	2023	NUM
mkg-41075	56	8	september	september	PROPN
mkg-41075	56	9	;	;	PUNCT
mkg-41075	56	10	56(3	56(3	NUM
mkg-41075	56	11	):	):	PUNCT
mkg-41075	56	12	189–196	189–196	NUM
mkg-41075	56	13	oral	oral	ADJ
mkg-41075	56	14	cancers	cancer	NOUN
mkg-41075	56	15	,	,	PUNCT
mkg-41075	56	16	especially	especially	ADV
mkg-41075	56	17	osccs	osccs	NOUN
mkg-41075	56	18	,	,	PUNCT
mkg-41075	56	19	develop	develop	VERB
mkg-41075	56	20	in	in	ADP
mkg-41075	56	21	precancerous	precancerous	ADJ
mkg-41075	56	22	cells	cell	NOUN
mkg-41075	56	23	with	with	ADP
mkg-41075	56	24	clonal	clonal	ADJ
mkg-41075	56	25	expansion	expansion	NOUN
mkg-41075	56	26	of	of	ADP
mkg-41075	56	27	normal	normal	ADJ
mkg-41075	56	28	keratinocytes	keratinocyte	NOUN
mkg-41075	56	29	that	that	PRON
mkg-41075	56	30	have	have	AUX
mkg-41075	56	31	been	be	AUX
mkg-41075	56	32	altered	alter	VERB
mkg-41075	56	33	genetically	genetically	ADV
mkg-41075	56	34	.	.	PUNCT
mkg-41075	57	1	the	the	DET
mkg-41075	57	2	genetically	genetically	ADV
mkg-41075	57	3	unstable	unstable	ADJ
mkg-41075	57	4	pre	pre	ADJ
mkg-41075	57	5	-	-	ADJ
mkg-41075	57	6	cancerous	cancerous	ADJ
mkg-41075	57	7	keratinocyte	keratinocyte	NOUN
mkg-41075	57	8	manifests	manifest	NOUN
mkg-41075	57	9	as	as	SCONJ
mkg-41075	57	10	aneuploidy	aneuploidy	NOUN
mkg-41075	57	11	,	,	PUNCT
mkg-41075	57	12	gaining	gain	VERB
mkg-41075	57	13	or	or	CCONJ
mkg-41075	57	14	losing	lose	VERB
mkg-41075	57	15	chromosomal	chromosomal	ADJ
mkg-41075	57	16	material	material	NOUN
mkg-41075	57	17	,	,	PUNCT
mkg-41075	57	18	or	or	CCONJ
mkg-41075	57	19	nucleotide	nucleotide	ADJ
mkg-41075	57	20	sequence	sequence	NOUN
mkg-41075	57	21	alteration	alteration	NOUN
mkg-41075	57	22	.	.	PUNCT
mkg-41075	58	1	the	the	DET
mkg-41075	58	2	instability	instability	NOUN
mkg-41075	58	3	of	of	ADP
mkg-41075	58	4	genomic	genomic	ADJ
mkg-41075	58	5	support	support	NOUN
mkg-41075	58	6	and	and	CCONJ
mkg-41075	58	7	further	further	ADJ
mkg-41075	58	8	acquisition	acquisition	NOUN
mkg-41075	58	9	in	in	ADP
mkg-41075	58	10	genetic	genetic	ADJ
mkg-41075	58	11	alteration	alteration	NOUN
mkg-41075	58	12	leads	lead	VERB
mkg-41075	58	13	to	to	ADP
mkg-41075	58	14	the	the	DET
mkg-41075	58	15	growth	growth	NOUN
mkg-41075	58	16	superiority	superiority	NOUN
mkg-41075	58	17	or	or	CCONJ
mkg-41075	58	18	inferiority	inferiority	NOUN
mkg-41075	58	19	of	of	ADP
mkg-41075	58	20	affected	affected	ADJ
mkg-41075	58	21	cells	cell	NOUN
mkg-41075	58	22	.	.	PUNCT
mkg-41075	59	1	genetically	genetically	ADV
mkg-41075	59	2	inherited	inherit	VERB
mkg-41075	59	3	cells	cell	NOUN
mkg-41075	59	4	eventually	eventually	ADV
mkg-41075	59	5	acquire	acquire	VERB
mkg-41075	59	6	a	a	DET
mkg-41075	59	7	cancerous	cancerous	ADJ
mkg-41075	59	8	phenotype	phenotype	NOUN
mkg-41075	59	9	.	.	PUNCT
mkg-41075	60	1	although	although	SCONJ
mkg-41075	60	2	other	other	ADJ
mkg-41075	60	3	oral	oral	ADJ
mkg-41075	60	4	cancers	cancer	NOUN
mkg-41075	60	5	can	can	AUX
mkg-41075	60	6	develop	develop	VERB
mkg-41075	60	7	from	from	ADP
mkg-41075	60	8	blood	blood	NOUN
mkg-41075	60	9	vessels	vessel	NOUN
mkg-41075	60	10	or	or	CCONJ
mkg-41075	60	11	salivary	salivary	ADJ
mkg-41075	60	12	glands	gland	NOUN
mkg-41075	60	13	,	,	PUNCT
mkg-41075	60	14	this	this	DET
mkg-41075	60	15	mechanism	mechanism	NOUN
mkg-41075	60	16	underlies	underlie	VERB
mkg-41075	60	17	all	all	DET
mkg-41075	60	18	cancer	cancer	NOUN
mkg-41075	60	19	events	event	NOUN
mkg-41075	60	20	.	.	PUNCT
mkg-41075	61	1	the	the	DET
mkg-41075	61	2	probability	probability	NOUN
mkg-41075	61	3	of	of	ADP
mkg-41075	61	4	cancer	cancer	NOUN
mkg-41075	61	5	development	development	NOUN
mkg-41075	61	6	from	from	ADP
mkg-41075	61	7	genetically	genetically	ADV
mkg-41075	61	8	altered	alter	VERB
mkg-41075	61	9	stem	stem	NOUN
mkg-41075	61	10	cells	cell	NOUN
mkg-41075	61	11	depends	depend	VERB
mkg-41075	61	12	on	on	ADP
mkg-41075	61	13	the	the	DET
mkg-41075	61	14	nature	nature	NOUN
mkg-41075	61	15	of	of	ADP
mkg-41075	61	16	the	the	DET
mkg-41075	61	17	stem	stem	NOUN
mkg-41075	61	18	cells	cell	NOUN
mkg-41075	61	19	and	and	CCONJ
mkg-41075	61	20	the	the	DET
mkg-41075	61	21	additional	additional	ADJ
mkg-41075	61	22	alteration	alteration	NOUN
mkg-41075	61	23	.	.	PUNCT
mkg-41075	62	1	the	the	DET
mkg-41075	62	2	proposed	propose	VERB
mkg-41075	62	3	carcinogenesis	carcinogenesis	NOUN
mkg-41075	62	4	model	model	NOUN
mkg-41075	62	5	is	be	AUX
mkg-41075	62	6	based	base	VERB
mkg-41075	62	7	on	on	ADP
mkg-41075	62	8	a	a	DET
mkg-41075	62	9	monoclonal	monoclonal	NOUN
mkg-41075	62	10	origin	origin	NOUN
mkg-41075	62	11	and	and	CCONJ
mkg-41075	62	12	involves	involve	VERB
mkg-41075	62	13	three	three	NUM
mkg-41075	62	14	stages.22,23	stages.22,23	NOUN
mkg-41075	62	15	the	the	DET
mkg-41075	62	16	first	first	ADJ
mkg-41075	62	17	stage	stage	NOUN
mkg-41075	62	18	of	of	ADP
mkg-41075	62	19	patch	patch	ADJ
mkg-41075	62	20	formation	formation	NOUN
mkg-41075	62	21	is	be	AUX
mkg-41075	62	22	the	the	DET
mkg-41075	62	23	conversion	conversion	NOUN
mkg-41075	62	24	of	of	ADP
mkg-41075	62	25	a	a	DET
mkg-41075	62	26	single	single	ADJ
mkg-41075	62	27	stem	stem	NOUN
mkg-41075	62	28	cell	cell	NOUN
mkg-41075	62	29	(	(	PUNCT
mkg-41075	62	30	figure	figure	NOUN
mkg-41075	62	31	2a	2a	NUM
mkg-41075	62	32	)	)	PUNCT
mkg-41075	62	33	into	into	ADP
mkg-41075	62	34	a	a	DET
mkg-41075	62	35	cell	cell	NOUN
mkg-41075	62	36	cluster	cluster	NOUN
mkg-41075	62	37	with	with	ADP
mkg-41075	62	38	genetic	genetic	ADJ
mkg-41075	62	39	alteration	alteration	NOUN
mkg-41075	62	40	and	and	CCONJ
mkg-41075	62	41	without	without	ADP
mkg-41075	62	42	appropriate	appropriate	ADJ
mkg-41075	62	43	growth	growth	NOUN
mkg-41075	62	44	-	-	PUNCT
mkg-41075	62	45	pattern	pattern	NOUN
mkg-41075	62	46	control	control	NOUN
mkg-41075	62	47	.	.	PUNCT
mkg-41075	63	1	the	the	DET
mkg-41075	63	2	second	second	ADJ
mkg-41075	63	3	stage	stage	NOUN
mkg-41075	63	4	,	,	PUNCT
mkg-41075	63	5	or	or	CCONJ
mkg-41075	63	6	clonal	clonal	ADJ
mkg-41075	63	7	expansion	expansion	NOUN
mkg-41075	63	8	,	,	PUNCT
mkg-41075	63	9	is	be	AUX
mkg-41075	63	10	additional	additional	ADJ
mkg-41075	63	11	genetic	genetic	ADJ
mkg-41075	63	12	alteration	alteration	NOUN
mkg-41075	63	13	;	;	PUNCT
mkg-41075	63	14	the	the	DET
mkg-41075	63	15	patch	patch	NOUN
mkg-41075	63	16	proliferates	proliferate	VERB
mkg-41075	63	17	and	and	CCONJ
mkg-41075	63	18	forms	form	VERB
mkg-41075	63	19	a	a	DET
mkg-41075	63	20	field	field	NOUN
mkg-41075	63	21	that	that	PRON
mkg-41075	63	22	replaces	replace	VERB
mkg-41075	63	23	normal	normal	ADJ
mkg-41075	63	24	epithelium	epithelium	NOUN
mkg-41075	63	25	(	(	PUNCT
mkg-41075	63	26	figure	figure	NOUN
mkg-41075	63	27	2b	2b	NOUN
mkg-41075	63	28	)	)	PUNCT
mkg-41075	63	29	.	.	PUNCT
mkg-41075	64	1	after	after	ADP
mkg-41075	64	2	exposure	exposure	NOUN
mkg-41075	64	3	to	to	ADP
mkg-41075	64	4	another	another	DET
mkg-41075	64	5	carcinogenic	carcinogenic	ADJ
mkg-41075	64	6	event	event	NOUN
mkg-41075	64	7	,	,	PUNCT
mkg-41075	64	8	these	these	DET
mkg-41075	64	9	cells	cell	NOUN
mkg-41075	64	10	turn	turn	VERB
mkg-41075	64	11	to	to	ADP
mkg-41075	64	12	cancer	cancer	NOUN
mkg-41075	64	13	cells	cell	NOUN
mkg-41075	64	14	with	with	ADP
mkg-41075	64	15	invasive	invasive	ADJ
mkg-41075	64	16	growth	growth	NOUN
mkg-41075	64	17	or	or	CCONJ
mkg-41075	64	18	metastatic	metastatic	ADJ
mkg-41075	64	19	behavior	behavior	NOUN
mkg-41075	64	20	,	,	PUNCT
mkg-41075	64	21	the	the	DET
mkg-41075	64	22	third	third	ADJ
mkg-41075	64	23	stage	stage	NOUN
mkg-41075	64	24	of	of	ADP
mkg-41075	64	25	tumor	tumor	NOUN
mkg-41075	64	26	transition	transition	NOUN
mkg-41075	64	27	(	(	PUNCT
mkg-41075	64	28	figure	figure	NOUN
mkg-41075	64	29	2c	2c	NUM
mkg-41075	64	30	,	,	PUNCT
mkg-41075	64	31	2d	2d	NOUN
mkg-41075	64	32	)	)	PUNCT
mkg-41075	64	33	.	.	PUNCT
mkg-41075	65	1	surgical	surgical	ADJ
mkg-41075	65	2	treatment	treatment	NOUN
mkg-41075	65	3	is	be	AUX
mkg-41075	65	4	usually	usually	ADV
mkg-41075	65	5	carried	carry	VERB
mkg-41075	65	6	out	out	ADP
mkg-41075	65	7	at	at	ADP
mkg-41075	65	8	this	this	DET
mkg-41075	65	9	stage	stage	NOUN
mkg-41075	65	10	(	(	PUNCT
mkg-41075	65	11	figure	figure	NOUN
mkg-41075	65	12	2e	2e	NUM
mkg-41075	65	13	)	)	PUNCT
mkg-41075	65	14	.	.	PUNCT
mkg-41075	66	1	without	without	ADP
mkg-41075	66	2	proper	proper	ADJ
mkg-41075	66	3	molecular	molecular	ADJ
mkg-41075	66	4	examination	examination	NOUN
mkg-41075	66	5	and	and	CCONJ
mkg-41075	66	6	prediction	prediction	NOUN
mkg-41075	66	7	of	of	ADP
mkg-41075	66	8	field	field	NOUN
mkg-41075	66	9	cancerization	cancerization	NOUN
mkg-41075	66	10	,	,	PUNCT
mkg-41075	66	11	cells	cell	NOUN
mkg-41075	66	12	with	with	ADP
mkg-41075	66	13	cancer	cancer	NOUN
mkg-41075	66	14	-	-	PUNCT
mkg-41075	66	15	associated	associate	VERB
mkg-41075	66	16	genetic	genetic	ADJ
mkg-41075	66	17	or	or	CCONJ
mkg-41075	66	18	epigenetic	epigenetic	ADJ
mkg-41075	66	19	alterations	alteration	NOUN
mkg-41075	66	20	may	may	AUX
mkg-41075	66	21	be	be	AUX
mkg-41075	66	22	left	leave	VERB
mkg-41075	66	23	behind	behind	ADV
mkg-41075	66	24	(	(	PUNCT
mkg-41075	66	25	figure	figure	NOUN
mkg-41075	66	26	2f	2f	NUM
mkg-41075	66	27	)	)	PUNCT
mkg-41075	66	28	.	.	PUNCT
mkg-41075	67	1	over	over	ADP
mkg-41075	67	2	time	time	NOUN
mkg-41075	67	3	,	,	PUNCT
mkg-41075	67	4	with	with	ADP
mkg-41075	67	5	exposure	exposure	NOUN
mkg-41075	67	6	to	to	ADP
mkg-41075	67	7	multiple	multiple	ADJ
mkg-41075	67	8	carcinogenic	carcinogenic	ADJ
mkg-41075	67	9	events	event	NOUN
mkg-41075	67	10	(	(	PUNCT
mkg-41075	67	11	unavoidable	unavoidable	ADJ
mkg-41075	67	12	predisposing	predisposing	NOUN
mkg-41075	67	13	and	and	CCONJ
mkg-41075	67	14	risk	risk	NOUN
mkg-41075	67	15	factors	factor	NOUN
mkg-41075	67	16	)	)	PUNCT
mkg-41075	67	17	,	,	PUNCT
mkg-41075	67	18	the	the	DET
mkg-41075	67	19	remaining	remain	VERB
mkg-41075	67	20	cells	cell	NOUN
mkg-41075	67	21	with	with	ADP
mkg-41075	67	22	cancer	cancer	NOUN
mkg-41075	67	23	-	-	PUNCT
mkg-41075	67	24	associated	associate	VERB
mkg-41075	67	25	genetics	genetic	NOUN
mkg-41075	67	26	can	can	AUX
mkg-41075	67	27	develop	develop	VERB
mkg-41075	67	28	into	into	ADP
mkg-41075	67	29	a	a	DET
mkg-41075	67	30	second	second	ADJ
mkg-41075	67	31	-	-	PUNCT
mkg-41075	67	32	field	field	NOUN
mkg-41075	67	33	tumor	tumor	NOUN
mkg-41075	67	34	,	,	PUNCT
mkg-41075	67	35	becoming	become	VERB
mkg-41075	67	36	overt	overt	ADJ
mkg-41075	67	37	carcinoma	carcinoma	NOUN
mkg-41075	67	38	with	with	ADP
mkg-41075	67	39	invasive	invasive	ADJ
mkg-41075	67	40	growth	growth	NOUN
mkg-41075	67	41	and	and	CCONJ
mkg-41075	67	42	metastases	metastasis	NOUN
mkg-41075	67	43	(	(	PUNCT
mkg-41075	67	44	figure	figure	NOUN
mkg-41075	67	45	2	2	NUM
mkg-41075	67	46	g	g	NOUN
mkg-41075	67	47	,	,	PUNCT
mkg-41075	67	48	2h	2h	NUM
mkg-41075	67	49	)	)	PUNCT
mkg-41075	67	50	.	.	PUNCT
mkg-41075	68	1	markers	marker	NOUN
mkg-41075	68	2	of	of	ADP
mkg-41075	68	3	field	field	NOUN
mkg-41075	68	4	cancerization	cancerization	NOUN
mkg-41075	68	5	carcinogenesis	carcinogenesis	NOUN
mkg-41075	68	6	is	be	AUX
mkg-41075	68	7	a	a	DET
mkg-41075	68	8	complex	complex	ADJ
mkg-41075	68	9	phenomenon	phenomenon	NOUN
mkg-41075	68	10	with	with	ADP
mkg-41075	68	11	multiple	multiple	ADJ
mkg-41075	68	12	genetic	genetic	ADJ
mkg-41075	68	13	lesions	lesion	NOUN
mkg-41075	68	14	and	and	CCONJ
mkg-41075	68	15	interactions.24	interactions.24	NOUN
mkg-41075	68	16	since	since	SCONJ
mkg-41075	68	17	every	every	DET
mkg-41075	68	18	tumor	tumor	NOUN
mkg-41075	68	19	has	have	VERB
mkg-41075	68	20	a	a	DET
mkg-41075	68	21	figure	figure	NOUN
mkg-41075	68	22	2	2	NUM
mkg-41075	68	23	.	.	NOUN
mkg-41075	68	24	second	second	ADJ
mkg-41075	68	25	field	field	NOUN
mkg-41075	68	26	tumor	tumor	NOUN
mkg-41075	68	27	model	model	NOUN
mkg-41075	68	28	;	;	PUNCT
mkg-41075	68	29	a.	a.	NOUN
mkg-41075	68	30	a	a	DET
mkg-41075	68	31	normal	normal	ADJ
mkg-41075	68	32	clonal	clonal	ADJ
mkg-41075	68	33	unit	unit	NOUN
mkg-41075	68	34	.	.	PUNCT
mkg-41075	69	1	a	a	DET
mkg-41075	69	2	stem	stem	NOUN
mkg-41075	69	3	cell	cell	NOUN
mkg-41075	69	4	(	(	PUNCT
mkg-41075	69	5	s	s	NOUN
mkg-41075	69	6	)	)	PUNCT
mkg-41075	69	7	exposed	expose	VERB
mkg-41075	69	8	to	to	ADP
mkg-41075	69	9	the	the	DET
mkg-41075	69	10	carcinogenic	carcinogenic	ADJ
mkg-41075	69	11	event	event	NOUN
mkg-41075	69	12	becomes	become	VERB
mkg-41075	69	13	a	a	DET
mkg-41075	69	14	genetically	genetically	ADV
mkg-41075	69	15	altered	alter	VERB
mkg-41075	69	16	cell	cell	NOUN
mkg-41075	69	17	.	.	PUNCT
mkg-41075	70	1	b.	b.	PROPN
mkg-41075	70	2	transit	transit	NOUN
mkg-41075	70	3	-	-	PUNCT
mkg-41075	70	4	amplifying	amplify	VERB
mkg-41075	70	5	cells	cell	NOUN
mkg-41075	70	6	(	(	PUNCT
mkg-41075	70	7	t	t	NOUN
mkg-41075	70	8	)	)	PUNCT
mkg-41075	70	9	and	and	CCONJ
mkg-41075	70	10	daughter	daughter	NOUN
mkg-41075	70	11	cells	cell	NOUN
mkg-41075	70	12	of	of	ADP
mkg-41075	70	13	the	the	DET
mkg-41075	70	14	stem	stem	NOUN
mkg-41075	70	15	cell	cell	NOUN
mkg-41075	70	16	have	have	VERB
mkg-41075	70	17	the	the	DET
mkg-41075	70	18	same	same	ADJ
mkg-41075	70	19	genetic	genetic	ADJ
mkg-41075	70	20	alteration	alteration	NOUN
mkg-41075	70	21	.	.	PUNCT
mkg-41075	71	1	c.	c.	PROPN
mkg-41075	71	2	genetically	genetically	ADV
mkg-41075	71	3	altered	alter	VERB
mkg-41075	71	4	cells	cell	NOUN
mkg-41075	71	5	with	with	ADP
mkg-41075	71	6	uncontrolled	uncontrolled	ADJ
mkg-41075	71	7	growth	growth	NOUN
mkg-41075	71	8	develop	develop	VERB
mkg-41075	71	9	.	.	PUNCT
mkg-41075	72	1	d.	d.	PROPN
mkg-41075	72	2	cancer	cancer	NOUN
mkg-41075	72	3	cells	cell	NOUN
mkg-41075	72	4	with	with	ADP
mkg-41075	72	5	invasive	invasive	ADJ
mkg-41075	72	6	and	and	CCONJ
mkg-41075	72	7	metastatic	metastatic	ADJ
mkg-41075	72	8	behavior	behavior	NOUN
mkg-41075	72	9	start	start	VERB
mkg-41075	72	10	to	to	PART
mkg-41075	72	11	grow	grow	VERB
mkg-41075	72	12	.	.	PUNCT
mkg-41075	73	1	e.	e.	PROPN
mkg-41075	74	1	the	the	DET
mkg-41075	74	2	surgeon	surgeon	NOUN
mkg-41075	74	3	removes	remove	VERB
mkg-41075	74	4	the	the	DET
mkg-41075	74	5	carcinoma	carcinoma	NOUN
mkg-41075	74	6	.	.	PUNCT
mkg-41075	75	1	f.	f.	PROPN
mkg-41075	75	2	post	post	PROPN
mkg-41075	75	3	-	-	ADJ
mkg-41075	75	4	surgery	surgery	NOUN
mkg-41075	75	5	,	,	PUNCT
mkg-41075	75	6	without	without	ADP
mkg-41075	75	7	a	a	DET
mkg-41075	75	8	proper	proper	ADJ
mkg-41075	75	9	genetic	genetic	ADJ
mkg-41075	75	10	examination	examination	NOUN
mkg-41075	75	11	,	,	PUNCT
mkg-41075	75	12	the	the	DET
mkg-41075	75	13	surgeon	surgeon	NOUN
mkg-41075	75	14	has	have	AUX
mkg-41075	75	15	left	leave	VERB
mkg-41075	75	16	a	a	DET
mkg-41075	75	17	field	field	NOUN
mkg-41075	75	18	behind	behind	ADV
mkg-41075	75	19	.	.	PUNCT
mkg-41075	76	1	g.	g.	VERB
mkg-41075	76	2	a	a	DET
mkg-41075	76	3	cell	cell	NOUN
mkg-41075	76	4	in	in	ADP
mkg-41075	76	5	the	the	DET
mkg-41075	76	6	field	field	NOUN
mkg-41075	76	7	turns	turn	VERB
mkg-41075	76	8	into	into	ADP
mkg-41075	76	9	a	a	DET
mkg-41075	76	10	cancer	cancer	NOUN
mkg-41075	76	11	cell	cell	NOUN
mkg-41075	76	12	after	after	ADP
mkg-41075	76	13	another	another	DET
mkg-41075	76	14	series	series	NOUN
mkg-41075	76	15	of	of	ADP
mkg-41075	76	16	carcinogenic	carcinogenic	ADJ
mkg-41075	76	17	exposures	exposure	NOUN
mkg-41075	76	18	.	.	PUNCT
mkg-41075	77	1	h.	h.	PROPN
mkg-41075	77	2	carcinoma	carcinoma	PROPN
mkg-41075	77	3	develops	develop	VERB
mkg-41075	77	4	in	in	ADP
mkg-41075	77	5	the	the	DET
mkg-41075	77	6	same	same	ADJ
mkg-41075	77	7	field	field	NOUN
mkg-41075	77	8	:	:	PUNCT
mkg-41075	77	9	a	a	DET
mkg-41075	77	10	second	second	ADJ
mkg-41075	77	11	-	-	PUNCT
mkg-41075	77	12	field	field	NOUN
mkg-41075	77	13	tumor.1	tumor.1	NOUN
mkg-41075	77	14	copyright	copyright	NOUN
mkg-41075	77	15	©	©	ADP
mkg-41075	77	16	2023	2023	NUM
mkg-41075	77	17	dental	dental	ADJ
mkg-41075	77	18	journal	journal	NOUN
mkg-41075	77	19	(	(	PUNCT
mkg-41075	77	20	majalah	majalah	PROPN
mkg-41075	77	21	kedokteran	kedokteran	PROPN
mkg-41075	77	22	gigi	gigi	PROPN
mkg-41075	77	23	)	)	PUNCT
mkg-41075	78	1	p	p	X
mkg-41075	78	2	-	-	PUNCT
mkg-41075	78	3	issn	issn	NOUN
mkg-41075	78	4	:	:	PUNCT
mkg-41075	78	5	1978	1978	NUM
mkg-41075	78	6	-	-	SYM
mkg-41075	78	7	3728	3728	NUM
mkg-41075	78	8	;	;	PUNCT
mkg-41075	78	9	e	e	X
mkg-41075	78	10	-	-	PUNCT
mkg-41075	78	11	issn	issn	ADJ
mkg-41075	78	12	:	:	PUNCT
mkg-41075	78	13	2442	2442	NUM
mkg-41075	78	14	-	-	SYM
mkg-41075	78	15	9740	9740	NUM
mkg-41075	78	16	.	.	PUNCT
mkg-41075	79	1	accredited	accredit	VERB
mkg-41075	79	2	no	no	INTJ
mkg-41075	79	3	.	.	PROPN
mkg-41075	80	1	158	158	NUM
mkg-41075	80	2	/	/	SYM
mkg-41075	80	3	e	e	NOUN
mkg-41075	80	4	/	/	SYM
mkg-41075	80	5	kpt/2021	kpt/2021	NOUN
mkg-41075	80	6	.	.	PUNCT
mkg-41075	81	1	open	open	ADJ
mkg-41075	81	2	access	access	NOUN
mkg-41075	81	3	under	under	ADP
mkg-41075	81	4	cc	cc	NOUN
mkg-41075	81	5	-	-	PUNCT
mkg-41075	81	6	by	by	ADP
mkg-41075	81	7	-	-	PUNCT
mkg-41075	81	8	sa	sa	NOUN
mkg-41075	81	9	license	license	NOUN
mkg-41075	81	10	.	.	PUNCT
mkg-41075	82	1	available	available	ADJ
mkg-41075	82	2	at	at	ADP
mkg-41075	82	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-41075	82	4	doi	doi	NOUN
mkg-41075	82	5	:	:	PUNCT
mkg-41075	82	6	10.20473	10.20473	NUM
mkg-41075	82	7	/	/	SYM
mkg-41075	82	8	j.djmkg.v56.i3.p189–196	j.djmkg.v56.i3.p189–196	PROPN
mkg-41075	82	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	PROPN
mkg-41075	82	10	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	PROPN
mkg-41075	82	11	192	192	NUM
mkg-41075	82	12	puspasari	puspasari	PROPN
mkg-41075	82	13	et	et	PROPN
mkg-41075	82	14	al	al	PROPN
mkg-41075	82	15	.	.	PROPN
mkg-41075	82	16	dent	dent	PROPN
mkg-41075	82	17	.	.	PUNCT
mkg-41075	83	1	j.	j.	PROPN
mkg-41075	83	2	(	(	PUNCT
mkg-41075	83	3	majalah	majalah	PROPN
mkg-41075	83	4	kedokteran	kedokteran	PROPN
mkg-41075	83	5	gigi	gigi	PROPN
mkg-41075	83	6	)	)	PUNCT
mkg-41075	83	7	2023	2023	NUM
mkg-41075	83	8	september	september	PROPN
mkg-41075	83	9	;	;	PUNCT
mkg-41075	83	10	56(3	56(3	NUM
mkg-41075	83	11	):	):	PUNCT
mkg-41075	83	12	189–196	189–196	NUM
mkg-41075	83	13	unique	unique	ADJ
mkg-41075	83	14	alteration	alteration	NOUN
mkg-41075	83	15	pattern	pattern	NOUN
mkg-41075	83	16	,	,	PUNCT
mkg-41075	83	17	information	information	NOUN
mkg-41075	83	18	about	about	ADP
mkg-41075	83	19	these	these	DET
mkg-41075	83	20	markers	marker	NOUN
mkg-41075	83	21	can	can	AUX
mkg-41075	83	22	be	be	AUX
mkg-41075	83	23	used	use	VERB
mkg-41075	83	24	to	to	PART
mkg-41075	83	25	measure	measure	VERB
mkg-41075	83	26	the	the	DET
mkg-41075	83	27	clonal	clonal	ADJ
mkg-41075	83	28	correlation	correlation	NOUN
mkg-41075	83	29	between	between	ADP
mkg-41075	83	30	lesions	lesion	NOUN
mkg-41075	83	31	in	in	ADP
mkg-41075	83	32	a	a	DET
mkg-41075	83	33	single	single	ADJ
mkg-41075	83	34	patient	patient	NOUN
mkg-41075	83	35	.	.	PUNCT
mkg-41075	84	1	the	the	DET
mkg-41075	84	2	presence	presence	NOUN
mkg-41075	84	3	of	of	ADP
mkg-41075	84	4	a	a	DET
mkg-41075	84	5	field	field	NOUN
mkg-41075	84	6	with	with	ADP
mkg-41075	84	7	genetically	genetically	ADV
mkg-41075	84	8	altered	alter	VERB
mkg-41075	84	9	cells	cell	NOUN
mkg-41075	84	10	is	be	AUX
mkg-41075	84	11	a	a	DET
mkg-41075	84	12	risk	risk	NOUN
mkg-41075	84	13	factor	factor	NOUN
mkg-41075	84	14	for	for	ADP
mkg-41075	84	15	cancer	cancer	NOUN
mkg-41075	84	16	.	.	PUNCT
mkg-41075	85	1	many	many	ADJ
mkg-41075	85	2	pre	pre	ADJ
mkg-41075	85	3	-	-	ADJ
mkg-41075	85	4	cancerization	cancerization	ADJ
mkg-41075	85	5	cells	cell	NOUN
mkg-41075	85	6	within	within	ADP
mkg-41075	85	7	the	the	DET
mkg-41075	85	8	proliferating	proliferate	VERB
mkg-41075	85	9	area	area	NOUN
mkg-41075	85	10	may	may	AUX
mkg-41075	85	11	increase	increase	VERB
mkg-41075	85	12	cancer	cancer	NOUN
mkg-41075	85	13	risk	risk	NOUN
mkg-41075	85	14	significantly	significantly	ADV
mkg-41075	85	15	.	.	PUNCT
mkg-41075	86	1	the	the	DET
mkg-41075	86	2	early	early	ADJ
mkg-41075	86	3	genetic	genetic	ADJ
mkg-41075	86	4	event	event	NOUN
mkg-41075	86	5	can	can	AUX
mkg-41075	86	6	lead	lead	VERB
mkg-41075	86	7	to	to	ADP
mkg-41075	86	8	clonal	clonal	ADJ
mkg-41075	86	9	expansion	expansion	NOUN
mkg-41075	86	10	from	from	ADP
mkg-41075	86	11	pre	pre	ADJ
mkg-41075	86	12	-	-	ADJ
mkg-41075	86	13	malignant	malignant	ADJ
mkg-41075	86	14	daughter	daughter	NOUN
mkg-41075	86	15	cells	cell	NOUN
mkg-41075	86	16	in	in	ADP
mkg-41075	86	17	specific	specific	ADJ
mkg-41075	86	18	tumor	tumor	NOUN
mkg-41075	86	19	fields	field	NOUN
mkg-41075	86	20	.	.	PUNCT
mkg-41075	87	1	subsequent	subsequent	ADJ
mkg-41075	87	2	genomic	genomic	ADJ
mkg-41075	87	3	alteration	alteration	NOUN
mkg-41075	87	4	in	in	ADP
mkg-41075	87	5	a	a	DET
mkg-41075	87	6	few	few	ADJ
mkg-41075	87	7	cells	cell	NOUN
mkg-41075	87	8	can	can	AUX
mkg-41075	87	9	induce	induce	VERB
mkg-41075	87	10	a	a	DET
mkg-41075	87	11	malignant	malignant	ADJ
mkg-41075	87	12	phenotype.1	phenotype.1	NOUN
mkg-41075	87	13	biomarkers	biomarker	NOUN
mkg-41075	87	14	can	can	AUX
mkg-41075	87	15	be	be	AUX
mkg-41075	87	16	used	use	VERB
mkg-41075	87	17	to	to	PART
mkg-41075	87	18	monitor	monitor	VERB
mkg-41075	87	19	tumor	tumor	NOUN
mkg-41075	87	20	progression	progression	NOUN
mkg-41075	87	21	,	,	PUNCT
mkg-41075	87	22	thus	thus	ADV
mkg-41075	87	23	preventing	prevent	VERB
mkg-41075	87	24	invasive	invasive	ADJ
mkg-41075	87	25	cancer	cancer	NOUN
mkg-41075	87	26	transformation	transformation	NOUN
mkg-41075	87	27	in	in	ADP
mkg-41075	87	28	precancerous	precancerous	ADJ
mkg-41075	87	29	lesions	lesion	NOUN
mkg-41075	87	30	.	.	PUNCT
mkg-41075	88	1	the	the	DET
mkg-41075	88	2	standard	standard	ADJ
mkg-41075	88	3	markers	marker	NOUN
mkg-41075	88	4	for	for	ADP
mkg-41075	88	5	identifying	identify	VERB
mkg-41075	88	6	field	field	NOUN
mkg-41075	88	7	cancerization	cancerization	NOUN
mkg-41075	88	8	are	be	AUX
mkg-41075	88	9	loss	loss	NOUN
mkg-41075	88	10	of	of	ADP
mkg-41075	88	11	heterozygosity	heterozygosity	NOUN
mkg-41075	88	12	,	,	PUNCT
mkg-41075	88	13	microsatellite	microsatellite	ADJ
mkg-41075	88	14	alterations	alteration	NOUN
mkg-41075	88	15	,	,	PUNCT
mkg-41075	88	16	chromosomal	chromosomal	ADJ
mkg-41075	88	17	instability	instability	NOUN
mkg-41075	88	18	,	,	PUNCT
mkg-41075	88	19	and	and	CCONJ
mkg-41075	88	20	p53	p53	NOUN
mkg-41075	88	21	gene	gene	NOUN
mkg-41075	88	22	mutations	mutation	NOUN
mkg-41075	88	23	,	,	PUNCT
mkg-41075	88	24	generally	generally	ADV
mkg-41075	88	25	detected	detect	VERB
mkg-41075	88	26	by	by	ADP
mkg-41075	88	27	polymerase	polymerase	NOUN
mkg-41075	88	28	chain	chain	NOUN
mkg-41075	88	29	reaction	reaction	NOUN
mkg-41075	88	30	,	,	PUNCT
mkg-41075	88	31	immunohistochemistry	immunohistochemistry	NOUN
mkg-41075	88	32	,	,	PUNCT
mkg-41075	88	33	and	and	CCONJ
mkg-41075	88	34	in	in	ADP
mkg-41075	88	35	situ	situ	PROPN
mkg-41075	88	36	hybridization.9	hybridization.9	PROPN
mkg-41075	88	37	more	more	ADV
mkg-41075	88	38	specifically	specifically	ADV
mkg-41075	88	39	,	,	PUNCT
mkg-41075	88	40	some	some	DET
mkg-41075	88	41	alteration	alteration	NOUN
mkg-41075	88	42	or	or	CCONJ
mkg-41075	88	43	modification	modification	NOUN
mkg-41075	88	44	can	can	AUX
mkg-41075	88	45	detect	detect	VERB
mkg-41075	88	46	both	both	DET
mkg-41075	88	47	pre	pre	NOUN
mkg-41075	88	48	-	-	NOUN
mkg-41075	88	49	cancerization	cancerization	NOUN
mkg-41075	88	50	and	and	CCONJ
mkg-41075	88	51	cancerization	cancerization	NOUN
mkg-41075	88	52	.	.	PUNCT
mkg-41075	89	1	in	in	ADP
mkg-41075	89	2	some	some	DET
mkg-41075	89	3	instances	instance	NOUN
mkg-41075	89	4	of	of	ADP
mkg-41075	89	5	pre	pre	ADJ
mkg-41075	89	6	-	-	NOUN
mkg-41075	89	7	cancerization	cancerization	NOUN
mkg-41075	89	8	,	,	PUNCT
mkg-41075	89	9	known	know	VERB
mkg-41075	89	10	as	as	ADP
mkg-41075	89	11	opmds	opmds	NOUN
mkg-41075	89	12	,	,	PUNCT
mkg-41075	89	13	biomolecular	biomolecular	ADJ
mkg-41075	89	14	markers	marker	NOUN
mkg-41075	89	15	have	have	VERB
mkg-41075	89	16	a	a	DET
mkg-41075	89	17	significant	significant	ADJ
mkg-41075	89	18	role	role	NOUN
mkg-41075	89	19	in	in	ADP
mkg-41075	89	20	detecting	detect	VERB
mkg-41075	89	21	transformation	transformation	NOUN
mkg-41075	89	22	to	to	ADP
mkg-41075	89	23	oral	oral	ADJ
mkg-41075	89	24	cancers	cancer	NOUN
mkg-41075	89	25	.	.	PUNCT
mkg-41075	90	1	available	available	ADJ
mkg-41075	90	2	data	data	PROPN
mkg-41075	90	3	state	state	NOUN
mkg-41075	90	4	that	that	SCONJ
mkg-41075	90	5	the	the	DET
mkg-41075	90	6	intratumoral	intratumoral	ADJ
mkg-41075	90	7	heterogeneity,25	heterogeneity,25	PROPN
mkg-41075	90	8	proteome	proteome	PROPN
mkg-41075	90	9	and	and	CCONJ
mkg-41075	90	10	lipidome	lipidome	VERB
mkg-41075	90	11	profile,26	profile,26	NOUN
mkg-41075	90	12	myofibroblasts,27	myofibroblasts,27	ADJ
mkg-41075	90	13	and	and	CCONJ
mkg-41075	90	14	cytokeratin	cytokeratin	NOUN
mkg-41075	90	15	markers	marker	NOUN
mkg-41075	90	16	like	like	ADP
mkg-41075	90	17	tissue	tissue	NOUN
mkg-41075	90	18	polypeptide	polypeptide	ADP
mkg-41075	90	19	antigen	antigen	NOUN
mkg-41075	90	20	(	(	PUNCT
mkg-41075	90	21	tpa	tpa	NOUN
mkg-41075	90	22	)	)	PUNCT
mkg-41075	90	23	and	and	CCONJ
mkg-41075	90	24	tissue	tissue	NOUN
mkg-41075	90	25	polypeptide	polypeptide	ADJ
mkg-41075	90	26	specific	specific	ADJ
mkg-41075	90	27	antigen	antigen	NOUN
mkg-41075	90	28	(	(	PUNCT
mkg-41075	90	29	tps),28	tps),28	PROPN
mkg-41075	90	30	are	be	AUX
mkg-41075	90	31	the	the	DET
mkg-41075	90	32	current	current	ADJ
mkg-41075	90	33	biomarkers	biomarker	NOUN
mkg-41075	90	34	of	of	ADP
mkg-41075	90	35	pre	pre	ADJ
mkg-41075	90	36	-	-	ADJ
mkg-41075	90	37	cancerization	cancerization	NOUN
mkg-41075	90	38	lesions	lesion	NOUN
mkg-41075	90	39	.	.	PUNCT
mkg-41075	91	1	further	far	ADV
mkg-41075	91	2	,	,	PUNCT
mkg-41075	91	3	extensive	extensive	ADJ
mkg-41075	91	4	analysis	analysis	NOUN
mkg-41075	91	5	at	at	ADP
mkg-41075	91	6	the	the	DET
mkg-41075	91	7	tissue	tissue	NOUN
mkg-41075	91	8	and	and	CCONJ
mkg-41075	91	9	dna	dna	NOUN
mkg-41075	91	10	level	level	NOUN
mkg-41075	91	11	has	have	AUX
mkg-41075	91	12	been	be	AUX
mkg-41075	91	13	developed	develop	VERB
mkg-41075	91	14	.	.	PUNCT
mkg-41075	92	1	dna	dna	PROPN
mkg-41075	92	2	aneuploidy	aneuploidy	VERB
mkg-41075	92	3	29	29	NUM
mkg-41075	92	4	and	and	CCONJ
mkg-41075	92	5	chromosome	chromosome	NOUN
mkg-41075	92	6	aberrations30	aberrations30	NOUN
mkg-41075	92	7	are	be	AUX
mkg-41075	92	8	commonly	commonly	ADV
mkg-41075	92	9	used	use	VERB
mkg-41075	92	10	to	to	PART
mkg-41075	92	11	detect	detect	VERB
mkg-41075	92	12	field	field	NOUN
mkg-41075	92	13	cancerization	cancerization	NOUN
mkg-41075	92	14	at	at	ADP
mkg-41075	92	15	the	the	DET
mkg-41075	92	16	dna	dna	PROPN
mkg-41075	92	17	level	level	NOUN
mkg-41075	92	18	.	.	PUNCT
mkg-41075	93	1	several	several	ADJ
mkg-41075	93	2	markers	marker	NOUN
mkg-41075	93	3	(	(	PUNCT
mkg-41075	93	4	p53	p53	NOUN
mkg-41075	93	5	,	,	PUNCT
mkg-41075	93	6	ki-67,31	ki-67,31	PUNCT
mkg-41075	93	7	cytokeratin	cytokeratin	NOUN
mkg-41075	93	8	fragments	fragment	VERB
mkg-41075	93	9	21‐1,28	21‐1,28	NUM
mkg-41075	93	10	variations	variation	NOUN
mkg-41075	93	11	in	in	ADP
mkg-41075	93	12	nucleolar	nucleolar	ADJ
mkg-41075	93	13	organizer	organizer	NOUN
mkg-41075	93	14	regions,32	regions,32	VERB
mkg-41075	93	15	phosphatases	phosphatase	NOUN
mkg-41075	93	16	and	and	CCONJ
mkg-41075	93	17	tensin	tensin	PROPN
mkg-41075	93	18	homolog	homolog	PROPN
mkg-41075	93	19	deleted	delete	VERB
mkg-41075	93	20	on	on	ADP
mkg-41075	93	21	chromosome	chromosome	NOUN
mkg-41075	93	22	10	10	NUM
mkg-41075	93	23	allelic	allelic	PROPN
mkg-41075	93	24	loss,33	loss,33	PROPN
mkg-41075	93	25	dek	dek	PROPN
mkg-41075	93	26	overexpression,34	overexpression,34	PROPN
mkg-41075	93	27	micro	micro	PROPN
mkg-41075	93	28	rna	rna	PROPN
mkg-41075	93	29	[	[	X
mkg-41075	93	30	hsa	hsa	PROPN
mkg-41075	93	31	-	-	PUNCT
mkg-41075	93	32	mir-221	mir-221	NOUN
mkg-41075	93	33	,	,	PUNCT
mkg-41075	93	34	hsa	hsa	PROPN
mkg-41075	93	35	-	-	PUNCT
mkg-41075	93	36	mir-21	mir-21	PROPN
mkg-41075	93	37	,	,	PUNCT
mkg-41075	93	38	hsa	hsa	NOUN
mkg-41075	93	39	-	-	PUNCT
mkg-41075	93	40	mir-135b	mir-135b	PROPN
mkg-41075	93	41	,	,	PUNCT
mkg-41075	93	42	and	and	CCONJ
mkg-41075	93	43	hsa	hsa	PROPN
mkg-41075	93	44	-	-	PUNCT
mkg-41075	93	45	mir-29c	mir-29c	NUM
mkg-41075	93	46	]	]	PUNCT
mkg-41075	93	47	detection,35	detection,35	PROPN
mkg-41075	93	48	atp	atp	NOUN
mkg-41075	93	49	-	-	PUNCT
mkg-41075	93	50	binding	bind	VERB
mkg-41075	93	51	cassette	cassette	NOUN
mkg-41075	93	52	subfamily	subfamily	ADV
mkg-41075	93	53	g	g	PROPN
mkg-41075	93	54	member	member	NOUN
mkg-41075	93	55	2,36	2,36	NUM
mkg-41075	93	56	mutl	mutl	NOUN
mkg-41075	93	57	protein	protein	NOUN
mkg-41075	93	58	homolog	homolog	NOUN
mkg-41075	93	59	1	1	NUM
mkg-41075	93	60	,	,	PUNCT
mkg-41075	93	61	methylguanine	methylguanine	NOUN
mkg-41075	93	62	-	-	PUNCT
mkg-41075	93	63	methyltransferase	methyltransferase	NOUN
mkg-41075	93	64	methylation,37	methylation,37	NOUN
mkg-41075	93	65	interferonstimulated	interferonstimulate	VERB
mkg-41075	93	66	gene	gene	NOUN
mkg-41075	93	67	15,38	15,38	NUM
mkg-41075	93	68	aldehyde	aldehyde	NOUN
mkg-41075	93	69	dehydrogenase	dehydrogenase	NOUN
mkg-41075	93	70	,	,	PUNCT
mkg-41075	93	71	notch1,39	notch1,39	NOUN
mkg-41075	93	72	and	and	CCONJ
mkg-41075	93	73	bmi140	bmi140	PROPN
mkg-41075	93	74	)	)	PUNCT
mkg-41075	93	75	have	have	AUX
mkg-41075	93	76	been	be	AUX
mkg-41075	93	77	identified	identify	VERB
mkg-41075	93	78	in	in	ADP
mkg-41075	93	79	pre	pre	ADJ
mkg-41075	93	80	-	-	NOUN
mkg-41075	93	81	cancerization	cancerization	NOUN
mkg-41075	93	82	transformation	transformation	NOUN
mkg-41075	93	83	into	into	ADP
mkg-41075	93	84	oral	oral	ADJ
mkg-41075	93	85	cancer	cancer	NOUN
mkg-41075	93	86	,	,	PUNCT
mkg-41075	93	87	stimulating	stimulate	VERB
mkg-41075	93	88	the	the	DET
mkg-41075	93	89	cell	cell	NOUN
mkg-41075	93	90	cycle	cycle	NOUN
mkg-41075	93	91	and	and	CCONJ
mkg-41075	93	92	promoting	promote	VERB
mkg-41075	93	93	dna	dna	NOUN
mkg-41075	93	94	replication	replication	NOUN
mkg-41075	93	95	(	(	PUNCT
mkg-41075	93	96	figure	figure	NOUN
mkg-41075	93	97	3	3	NUM
mkg-41075	93	98	)	)	PUNCT
mkg-41075	93	99	.	.	PUNCT
mkg-41075	94	1	various	various	ADJ
mkg-41075	94	2	protein	protein	NOUN
mkg-41075	94	3	expressions	expression	NOUN
mkg-41075	94	4	or	or	CCONJ
mkg-41075	94	5	markers	marker	NOUN
mkg-41075	94	6	have	have	AUX
mkg-41075	94	7	been	be	AUX
mkg-41075	94	8	revealed	reveal	VERB
mkg-41075	94	9	at	at	ADP
mkg-41075	94	10	the	the	DET
mkg-41075	94	11	tissue	tissue	NOUN
mkg-41075	94	12	level	level	NOUN
mkg-41075	94	13	and	and	CCONJ
mkg-41075	94	14	may	may	AUX
mkg-41075	94	15	be	be	AUX
mkg-41075	94	16	easier	easy	ADJ
mkg-41075	94	17	to	to	PART
mkg-41075	94	18	replicate	replicate	VERB
mkg-41075	94	19	in	in	ADP
mkg-41075	94	20	clinical	clinical	ADJ
mkg-41075	94	21	settings	setting	NOUN
mkg-41075	94	22	than	than	ADP
mkg-41075	94	23	dna	dna	PROPN
mkg-41075	94	24	analysis	analysis	NOUN
mkg-41075	94	25	.	.	PUNCT
mkg-41075	95	1	these	these	PRON
mkg-41075	95	2	include	include	VERB
mkg-41075	95	3	the	the	DET
mkg-41075	95	4	expression	expression	NOUN
mkg-41075	95	5	of	of	ADP
mkg-41075	95	6	ki-67,38	ki-67,38	NOUN
mkg-41075	95	7	kaiso	kaiso	NOUN
mkg-41075	95	8	,	,	PUNCT
mkg-41075	95	9	e	e	NOUN
mkg-41075	95	10	-	-	NOUN
mkg-41075	95	11	cadherin,41	cadherin,41	ADJ
mkg-41075	95	12	stathmin,42	stathmin,42	NOUN
mkg-41075	95	13	oct4	oct4	PROPN
mkg-41075	95	14	+	+	ADJ
mkg-41075	95	15	,	,	PUNCT
mkg-41075	95	16	sox2+,43	sox2+,43	ADJ
mkg-41075	95	17	glut-3	glut-3	NOUN
mkg-41075	95	18	,	,	PUNCT
mkg-41075	95	19	glut	glut	VERB
mkg-41075	95	20	4,44	4,44	DET
mkg-41075	95	21	substance	substance	NOUN
mkg-41075	95	22	p	p	NOUN
mkg-41075	95	23	,	,	PUNCT
mkg-41075	95	24	nk1r,45	nk1r,45	ADP
mkg-41075	95	25	podoplanin,36	podoplanin,36	PRON
mkg-41075	95	26	matrix	matrix	VERB
mkg-41075	95	27	metalloproteinase	metalloproteinase	NOUN
mkg-41075	95	28	9	9	NUM
mkg-41075	95	29	(	(	PUNCT
mkg-41075	95	30	mmp-9	mmp-9	NUM
mkg-41075	95	31	)	)	PUNCT
mkg-41075	95	32	,	,	PUNCT
mkg-41075	95	33	tissue	tissue	NOUN
mkg-41075	95	34	inhibitor	inhibitor	NOUN
mkg-41075	95	35	of	of	ADP
mkg-41075	95	36	metalloproteinase	metalloproteinase	PROPN
mkg-41075	95	37	1	1	NUM
mkg-41075	95	38	(	(	PUNCT
mkg-41075	95	39	timp-1	timp-1	NUM
mkg-41075	95	40	)	)	PUNCT
mkg-41075	95	41	,	,	PUNCT
mkg-41075	95	42	vimentin	vimentin	NOUN
mkg-41075	95	43	(	(	PUNCT
mkg-41075	95	44	vim),46	vim),46	NOUN
mkg-41075	95	45	cornulin,38	cornulin,38	NOUN
mkg-41075	95	46	transforming	transform	VERB
mkg-41075	95	47	growth	growth	NOUN
mkg-41075	95	48	factor	factor	NOUN
mkg-41075	95	49	(	(	PUNCT
mkg-41075	95	50	tgfβ1	tgfβ1	PROPN
mkg-41075	95	51	)	)	PUNCT
mkg-41075	95	52	and	and	CCONJ
mkg-41075	95	53	interleukin	interleukin	NOUN
mkg-41075	95	54	17	17	NUM
mkg-41075	95	55	-	-	SYM
mkg-41075	95	56	a	a	PRON
mkg-41075	95	57	(	(	PUNCT
mkg-41075	95	58	il-17a).47	il-17a).47	NOUN
mkg-41075	95	59	these	these	DET
mkg-41075	95	60	markers	marker	NOUN
mkg-41075	95	61	are	be	AUX
mkg-41075	95	62	essential	essential	ADJ
mkg-41075	95	63	in	in	ADP
mkg-41075	95	64	detecting	detect	VERB
mkg-41075	95	65	oral	oral	ADJ
mkg-41075	95	66	cancer	cancer	NOUN
mkg-41075	95	67	,	,	PUNCT
mkg-41075	95	68	especially	especially	ADV
mkg-41075	95	69	oscc	oscc	ADJ
mkg-41075	95	70	.	.	PUNCT
mkg-41075	96	1	all	all	DET
mkg-41075	96	2	these	these	DET
mkg-41075	96	3	markers	marker	NOUN
mkg-41075	96	4	have	have	AUX
mkg-41075	96	5	demonstrated	demonstrate	VERB
mkg-41075	96	6	strong	strong	ADJ
mkg-41075	96	7	reactivity	reactivity	NOUN
mkg-41075	96	8	,	,	PUNCT
mkg-41075	96	9	and	and	CCONJ
mkg-41075	96	10	detecting	detect	VERB
mkg-41075	96	11	these	these	DET
mkg-41075	96	12	markers	marker	NOUN
mkg-41075	96	13	increased	increase	VERB
mkg-41075	96	14	the	the	DET
mkg-41075	96	15	survival	survival	NOUN
mkg-41075	96	16	rate	rate	NOUN
mkg-41075	96	17	(	(	PUNCT
mkg-41075	96	18	figure	figure	NOUN
mkg-41075	96	19	3	3	NUM
mkg-41075	96	20	)	)	PUNCT
mkg-41075	96	21	.	.	PUNCT
mkg-41075	97	1	the	the	DET
mkg-41075	97	2	specific	specific	ADJ
mkg-41075	97	3	techniques	technique	NOUN
mkg-41075	97	4	to	to	PART
mkg-41075	97	5	obtain	obtain	VERB
mkg-41075	97	6	satisfactory	satisfactory	ADJ
mkg-41075	97	7	results	result	NOUN
mkg-41075	97	8	are	be	AUX
mkg-41075	97	9	whole	whole	ADJ
mkg-41075	97	10	-	-	PUNCT
mkg-41075	97	11	exome	exome	NOUN
mkg-41075	97	12	sequencing	sequencing	NOUN
mkg-41075	97	13	and	and	CCONJ
mkg-41075	97	14	targeted	target	VERB
mkg-41075	97	15	ultra	ultra	ADJ
mkg-41075	97	16	-	-	ADJ
mkg-41075	97	17	deep	deep	ADJ
mkg-41075	97	18	sequencing,48	sequencing,48	NOUN
mkg-41075	97	19	dna	dna	NOUN
mkg-41075	97	20	high	high	ADJ
mkg-41075	97	21	-	-	PUNCT
mkg-41075	97	22	resolution	resolution	NOUN
mkg-41075	97	23	flow	flow	NOUN
mkg-41075	97	24	cytometry	cytometry	NOUN
mkg-41075	97	25	,	,	PUNCT
mkg-41075	97	26	arraycomparative	arraycomparative	ADJ
mkg-41075	97	27	genomic	genomic	PROPN
mkg-41075	97	28	hybridization,30	hybridization,30	PROPN
mkg-41075	97	29	mass	mass	PROPN
mkg-41075	97	30	spectrometry	spectrometry	NOUN
mkg-41075	97	31	imaging	imaging	NOUN
mkg-41075	97	32	based	base	VERB
mkg-41075	97	33	on	on	ADP
mkg-41075	97	34	matrix	matrix	NOUN
mkg-41075	97	35	-	-	PUNCT
mkg-41075	97	36	assisted	assist	VERB
mkg-41075	97	37	desorption	desorption	NOUN
mkg-41075	97	38	-	-	PUNCT
mkg-41075	97	39	ionization,26	ionization,26	NOUN
mkg-41075	97	40	and	and	CCONJ
mkg-41075	97	41	liquid	liquid	ADJ
mkg-41075	97	42	biopsy.49	biopsy.49	ADJ
mkg-41075	97	43	discussion	discussion	NOUN
mkg-41075	97	44	the	the	DET
mkg-41075	97	45	world	world	PROPN
mkg-41075	97	46	health	health	NOUN
mkg-41075	97	47	organization	organization	NOUN
mkg-41075	97	48	has	have	AUX
mkg-41075	97	49	proposed	propose	VERB
mkg-41075	97	50	the	the	DET
mkg-41075	97	51	term	term	NOUN
mkg-41075	97	52	opmd	opmd	ADV
mkg-41075	97	53	for	for	ADP
mkg-41075	97	54	classifying	classify	VERB
mkg-41075	97	55	fifteen	fifteen	NUM
mkg-41075	97	56	conditions	condition	NOUN
mkg-41075	97	57	,	,	PUNCT
mkg-41075	97	58	including	include	VERB
mkg-41075	97	59	leukoplakia	leukoplakia	NOUN
mkg-41075	97	60	,	,	PUNCT
mkg-41075	97	61	erythroplakia	erythroplakia	NOUN
mkg-41075	97	62	,	,	PUNCT
mkg-41075	97	63	proliferative	proliferative	ADJ
mkg-41075	97	64	verrucous	verrucous	ADJ
mkg-41075	97	65	leukoplakia	leukoplakia	NOUN
mkg-41075	97	66	,	,	PUNCT
mkg-41075	97	67	oral	oral	ADJ
mkg-41075	97	68	submucous	submucous	ADJ
mkg-41075	97	69	fibrosis	fibrosis	NOUN
mkg-41075	97	70	,	,	PUNCT
mkg-41075	97	71	and	and	CCONJ
mkg-41075	97	72	oral	oral	ADJ
mkg-41075	97	73	lichen	lichen	NOUN
mkg-41075	97	74	figure	figure	NOUN
mkg-41075	97	75	3	3	NUM
mkg-41075	97	76	.	.	PUNCT
mkg-41075	98	1	the	the	DET
mkg-41075	98	2	markers	marker	NOUN
mkg-41075	98	3	of	of	ADP
mkg-41075	98	4	oscc	oscc	ADJ
mkg-41075	98	5	,	,	PUNCT
mkg-41075	98	6	including	include	VERB
mkg-41075	98	7	dna	dna	PROPN
mkg-41075	98	8	analysis	analysis	NOUN
mkg-41075	98	9	and	and	CCONJ
mkg-41075	98	10	tissue	tissue	NOUN
mkg-41075	98	11	expression	expression	NOUN
mkg-41075	98	12	,	,	PUNCT
mkg-41075	98	13	are	be	AUX
mkg-41075	98	14	purposed	purpose	VERB
mkg-41075	98	15	for	for	ADP
mkg-41075	98	16	field	field	NOUN
mkg-41075	98	17	cancerization	cancerization	NOUN
mkg-41075	98	18	to	to	PART
mkg-41075	98	19	prevent	prevent	VERB
mkg-41075	98	20	malignant	malignant	ADJ
mkg-41075	98	21	transformation	transformation	NOUN
mkg-41075	98	22	or	or	CCONJ
mkg-41075	98	23	recurrence	recurrence	NOUN
mkg-41075	98	24	.	.	PUNCT
mkg-41075	99	1	copyright	copyright	NOUN
mkg-41075	99	2	©	©	ADP
mkg-41075	99	3	2023	2023	NUM
mkg-41075	99	4	dental	dental	ADJ
mkg-41075	99	5	journal	journal	NOUN
mkg-41075	99	6	(	(	PUNCT
mkg-41075	99	7	majalah	majalah	PROPN
mkg-41075	99	8	kedokteran	kedokteran	PROPN
mkg-41075	99	9	gigi	gigi	PROPN
mkg-41075	99	10	)	)	PUNCT
mkg-41075	100	1	p	p	X
mkg-41075	100	2	-	-	PUNCT
mkg-41075	100	3	issn	issn	NOUN
mkg-41075	100	4	:	:	PUNCT
mkg-41075	100	5	1978	1978	NUM
mkg-41075	100	6	-	-	SYM
mkg-41075	100	7	3728	3728	NUM
mkg-41075	100	8	;	;	PUNCT
mkg-41075	100	9	e	e	X
mkg-41075	100	10	-	-	PUNCT
mkg-41075	100	11	issn	issn	ADJ
mkg-41075	100	12	:	:	PUNCT
mkg-41075	100	13	2442	2442	NUM
mkg-41075	100	14	-	-	SYM
mkg-41075	100	15	9740	9740	NUM
mkg-41075	100	16	.	.	PUNCT
mkg-41075	101	1	accredited	accredit	VERB
mkg-41075	101	2	no	no	INTJ
mkg-41075	101	3	.	.	PROPN
mkg-41075	102	1	158	158	NUM
mkg-41075	102	2	/	/	SYM
mkg-41075	102	3	e	e	NOUN
mkg-41075	102	4	/	/	SYM
mkg-41075	102	5	kpt/2021	kpt/2021	NOUN
mkg-41075	102	6	.	.	PUNCT
mkg-41075	103	1	open	open	ADJ
mkg-41075	103	2	access	access	NOUN
mkg-41075	103	3	under	under	ADP
mkg-41075	103	4	cc	cc	NOUN
mkg-41075	103	5	-	-	PUNCT
mkg-41075	103	6	by	by	ADP
mkg-41075	103	7	-	-	PUNCT
mkg-41075	103	8	sa	sa	NOUN
mkg-41075	103	9	license	license	NOUN
mkg-41075	103	10	.	.	PUNCT
mkg-41075	104	1	available	available	ADJ
mkg-41075	104	2	at	at	ADP
mkg-41075	104	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-41075	104	4	doi	doi	NOUN
mkg-41075	104	5	:	:	PUNCT
mkg-41075	104	6	10.20473	10.20473	NUM
mkg-41075	104	7	/	/	SYM
mkg-41075	104	8	j.djmkg.v56.i3.p189–196	j.djmkg.v56.i3.p189–196	ADJ
mkg-41075	104	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	PROPN
mkg-41075	104	10	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	PROPN
mkg-41075	105	1	193puspasari	193puspasari	PROPN
mkg-41075	105	2	et	et	PROPN
mkg-41075	105	3	al	al	PROPN
mkg-41075	105	4	.	.	PROPN
mkg-41075	105	5	dent	dent	PROPN
mkg-41075	105	6	.	.	PUNCT
mkg-41075	106	1	j.	j.	PROPN
mkg-41075	106	2	(	(	PUNCT
mkg-41075	106	3	majalah	majalah	PROPN
mkg-41075	106	4	kedokteran	kedokteran	PROPN
mkg-41075	106	5	gigi	gigi	PROPN
mkg-41075	106	6	)	)	PUNCT
mkg-41075	106	7	2023	2023	NUM
mkg-41075	106	8	september	september	PROPN
mkg-41075	106	9	;	;	PUNCT
mkg-41075	106	10	56(3	56(3	NUM
mkg-41075	106	11	):	):	PUNCT
mkg-41075	106	12	189–196	189–196	NUM
mkg-41075	106	13	planus.5	planus.5	NOUN
mkg-41075	106	14	opmds	opmds	NOUN
mkg-41075	106	15	are	be	AUX
mkg-41075	106	16	determined	determine	VERB
mkg-41075	106	17	to	to	PART
mkg-41075	106	18	be	be	AUX
mkg-41075	106	19	pre	pre	ADJ
mkg-41075	106	20	-	-	ADJ
mkg-41075	106	21	cancerization	cancerization	NOUN
mkg-41075	106	22	lesions	lesion	NOUN
mkg-41075	106	23	because	because	SCONJ
mkg-41075	106	24	some	some	PRON
mkg-41075	106	25	of	of	ADP
mkg-41075	106	26	the	the	DET
mkg-41075	106	27	cells	cell	NOUN
mkg-41075	106	28	carry	carry	VERB
mkg-41075	106	29	cancer	cancer	NOUN
mkg-41075	106	30	-	-	PUNCT
mkg-41075	106	31	associated	associate	VERB
mkg-41075	106	32	genetic	genetic	ADJ
mkg-41075	106	33	or	or	CCONJ
mkg-41075	106	34	epigenetic	epigenetic	ADJ
mkg-41075	106	35	alterations	alteration	NOUN
mkg-41075	106	36	.	.	PUNCT
mkg-41075	107	1	some	some	DET
mkg-41075	107	2	oral	oral	ADJ
mkg-41075	107	3	cancer	cancer	NOUN
mkg-41075	107	4	specimens	specimen	NOUN
mkg-41075	107	5	from	from	ADP
mkg-41075	107	6	the	the	DET
mkg-41075	107	7	border	border	NOUN
mkg-41075	107	8	of	of	ADP
mkg-41075	107	9	malignant	malignant	ADJ
mkg-41075	107	10	lesions	lesion	NOUN
mkg-41075	107	11	,	,	PUNCT
mkg-41075	107	12	showing	show	VERB
mkg-41075	107	13	a	a	DET
mkg-41075	107	14	histologically	histologically	ADV
mkg-41075	107	15	normal	normal	ADJ
mkg-41075	107	16	appearance	appearance	NOUN
mkg-41075	107	17	,	,	PUNCT
mkg-41075	107	18	have	have	VERB
mkg-41075	107	19	a	a	DET
mkg-41075	107	20	genetic	genetic	ADJ
mkg-41075	107	21	alteration	alteration	NOUN
mkg-41075	107	22	,	,	PUNCT
mkg-41075	107	23	indicating	indicate	VERB
mkg-41075	107	24	that	that	SCONJ
mkg-41075	107	25	not	not	PART
mkg-41075	107	26	all	all	DET
mkg-41075	107	27	pre	pre	ADJ
mkg-41075	107	28	-	-	ADJ
mkg-41075	107	29	cancerous	cancerous	ADJ
mkg-41075	107	30	fields	field	NOUN
mkg-41075	107	31	can	can	AUX
mkg-41075	107	32	be	be	AUX
mkg-41075	107	33	identified	identify	VERB
mkg-41075	107	34	histologically.50	histologically.50	NOUN
mkg-41075	107	35	genetic	genetic	ADJ
mkg-41075	107	36	markers	marker	NOUN
mkg-41075	107	37	must	must	AUX
mkg-41075	107	38	be	be	AUX
mkg-41075	107	39	used	use	VERB
mkg-41075	107	40	to	to	PART
mkg-41075	107	41	identify	identify	VERB
mkg-41075	107	42	all	all	DET
mkg-41075	107	43	potentially	potentially	ADV
mkg-41075	107	44	malignant	malignant	ADJ
mkg-41075	107	45	areas.5	areas.5	NOUN
mkg-41075	107	46	alteration	alteration	NOUN
mkg-41075	107	47	can	can	AUX
mkg-41075	107	48	happen	happen	VERB
mkg-41075	107	49	within	within	ADP
mkg-41075	107	50	the	the	DET
mkg-41075	107	51	epithelium	epithelium	NOUN
mkg-41075	107	52	and/or	and/or	CCONJ
mkg-41075	107	53	the	the	DET
mkg-41075	107	54	stroma.1	stroma.1	PROPN
mkg-41075	107	55	in	in	ADP
mkg-41075	107	56	the	the	DET
mkg-41075	107	57	oral	oral	ADJ
mkg-41075	107	58	cavity	cavity	NOUN
mkg-41075	107	59	,	,	PUNCT
mkg-41075	107	60	tobacco	tobacco	NOUN
mkg-41075	107	61	and	and	CCONJ
mkg-41075	107	62	alcohol	alcohol	NOUN
mkg-41075	107	63	work	work	NOUN
mkg-41075	107	64	synergistically	synergistically	ADV
mkg-41075	107	65	as	as	ADP
mkg-41075	107	66	primary	primary	ADJ
mkg-41075	107	67	carcinogens	carcinogen	NOUN
mkg-41075	107	68	in	in	ADP
mkg-41075	107	69	developing	develop	VERB
mkg-41075	107	70	osccs	osccs	NOUN
mkg-41075	107	71	.	.	PUNCT
mkg-41075	108	1	environmental	environmental	ADJ
mkg-41075	108	2	carcinogens	carcinogen	NOUN
mkg-41075	108	3	reach	reach	VERB
mkg-41075	108	4	a	a	DET
mkg-41075	108	5	broader	broad	ADJ
mkg-41075	108	6	area	area	NOUN
mkg-41075	108	7	simultaneously	simultaneously	ADV
mkg-41075	108	8	,	,	PUNCT
mkg-41075	108	9	destroy	destroy	VERB
mkg-41075	108	10	in	in	ADP
mkg-41075	108	11	more	more	ADV
mkg-41075	108	12	significant	significant	ADJ
mkg-41075	108	13	proportions	proportion	NOUN
mkg-41075	108	14	and	and	CCONJ
mkg-41075	108	15	contribute	contribute	VERB
mkg-41075	108	16	to	to	ADP
mkg-41075	108	17	premalignant	premalignant	ADJ
mkg-41075	108	18	conditions	condition	NOUN
mkg-41075	108	19	within	within	ADP
mkg-41075	108	20	the	the	DET
mkg-41075	108	21	exposed	expose	VERB
mkg-41075	108	22	area	area	NOUN
mkg-41075	108	23	and	and	CCONJ
mkg-41075	108	24	can	can	AUX
mkg-41075	108	25	manifest	manifest	VERB
mkg-41075	108	26	as	as	ADP
mkg-41075	108	27	micro	micro	NOUN
mkg-41075	108	28	-	-	ADJ
mkg-41075	108	29	metastatic	metastatic	ADJ
mkg-41075	108	30	deposits.51	deposits.51	NOUN
mkg-41075	108	31	a	a	DET
mkg-41075	108	32	pre	pre	ADJ
mkg-41075	108	33	-	-	ADJ
mkg-41075	108	34	malignant	malignant	ADJ
mkg-41075	108	35	field	field	NOUN
mkg-41075	108	36	often	often	ADV
mkg-41075	108	37	needs	need	VERB
mkg-41075	108	38	a	a	DET
mkg-41075	108	39	long	long	ADJ
mkg-41075	108	40	time	time	NOUN
mkg-41075	108	41	,	,	PUNCT
mkg-41075	108	42	about	about	ADP
mkg-41075	108	43	67–96	67–96	NUM
mkg-41075	108	44	months	month	NOUN
mkg-41075	108	45	,	,	PUNCT
mkg-41075	108	46	to	to	PART
mkg-41075	108	47	develop	develop	VERB
mkg-41075	108	48	and	and	CCONJ
mkg-41075	108	49	become	become	VERB
mkg-41075	108	50	invasive	invasive	ADJ
mkg-41075	108	51	carcinoma	carcinoma	NOUN
mkg-41075	108	52	.	.	PUNCT
mkg-41075	109	1	an	an	DET
mkg-41075	109	2	analysis	analysis	NOUN
mkg-41075	109	3	of	of	ADP
mkg-41075	109	4	783	783	NUM
mkg-41075	109	5	patients	patient	NOUN
mkg-41075	109	6	by	by	ADP
mkg-41075	109	7	slaughter	slaughter	NOUN
mkg-41075	109	8	suggested	suggest	VERB
mkg-41075	109	9	that	that	SCONJ
mkg-41075	109	10	exposure	exposure	NOUN
mkg-41075	109	11	to	to	ADP
mkg-41075	109	12	carcinogen	carcinogen	NOUN
mkg-41075	109	13	-	-	PUNCT
mkg-41075	109	14	induced	induce	VERB
mkg-41075	109	15	mucosal	mucosal	NOUN
mkg-41075	109	16	changes	change	NOUN
mkg-41075	109	17	causes	cause	VERB
mkg-41075	109	18	vulnerability	vulnerability	NOUN
mkg-41075	109	19	of	of	ADP
mkg-41075	109	20	the	the	DET
mkg-41075	109	21	surrounding	surround	VERB
mkg-41075	109	22	area	area	NOUN
mkg-41075	109	23	to	to	ADP
mkg-41075	109	24	multiple	multiple	ADJ
mkg-41075	109	25	malignant	malignant	ADJ
mkg-41075	109	26	foci.52	foci.52	ADJ
mkg-41075	109	27	oral	oral	ADJ
mkg-41075	109	28	field	field	NOUN
mkg-41075	109	29	cancerization	cancerization	NOUN
mkg-41075	109	30	is	be	AUX
mkg-41075	109	31	caused	cause	VERB
mkg-41075	109	32	by	by	ADP
mkg-41075	109	33	either	either	DET
mkg-41075	109	34	cell	cell	NOUN
mkg-41075	109	35	migration	migration	NOUN
mkg-41075	109	36	or	or	CCONJ
mkg-41075	109	37	from	from	ADP
mkg-41075	109	38	an	an	DET
mkg-41075	109	39	independent	independent	ADJ
mkg-41075	109	40	cell	cell	NOUN
mkg-41075	109	41	.	.	PUNCT
mkg-41075	110	1	multiple	multiple	ADJ
mkg-41075	110	2	tumors	tumor	NOUN
mkg-41075	110	3	from	from	ADP
mkg-41075	110	4	the	the	DET
mkg-41075	110	5	original	original	ADJ
mkg-41075	110	6	primary	primary	ADJ
mkg-41075	110	7	cells	cell	NOUN
mkg-41075	110	8	and	and	CCONJ
mkg-41075	110	9	genetically	genetically	ADV
mkg-41075	110	10	altered	alter	VERB
mkg-41075	110	11	cells	cell	NOUN
mkg-41075	110	12	from	from	ADP
mkg-41075	110	13	the	the	DET
mkg-41075	110	14	primary	primary	ADJ
mkg-41075	110	15	cell	cell	NOUN
mkg-41075	110	16	are	be	AUX
mkg-41075	110	17	brought	bring	VERB
mkg-41075	110	18	to	to	ADP
mkg-41075	110	19	their	their	PRON
mkg-41075	110	20	progenitor	progenitor	NOUN
mkg-41075	110	21	cells	cell	NOUN
mkg-41075	110	22	.	.	PUNCT
mkg-41075	111	1	investigating	investigate	VERB
mkg-41075	111	2	the	the	DET
mkg-41075	111	3	development	development	NOUN
mkg-41075	111	4	of	of	ADP
mkg-41075	111	5	primary	primary	ADJ
mkg-41075	111	6	lesions	lesion	NOUN
mkg-41075	111	7	and	and	CCONJ
mkg-41075	111	8	their	their	PRON
mkg-41075	111	9	progression	progression	NOUN
mkg-41075	111	10	through	through	ADP
mkg-41075	111	11	cell	cell	NOUN
mkg-41075	111	12	expansion	expansion	NOUN
mkg-41075	111	13	is	be	AUX
mkg-41075	111	14	crucial	crucial	ADJ
mkg-41075	111	15	for	for	ADP
mkg-41075	111	16	measuring	measure	VERB
mkg-41075	111	17	clonal	clonal	ADJ
mkg-41075	111	18	markers	marker	NOUN
mkg-41075	111	19	based	base	VERB
mkg-41075	111	20	on	on	ADP
mkg-41075	111	21	the	the	DET
mkg-41075	111	22	early	early	ADJ
mkg-41075	111	23	identification	identification	NOUN
mkg-41075	111	24	of	of	ADP
mkg-41075	111	25	genetic	genetic	ADJ
mkg-41075	111	26	events.18	events.18	NOUN
mkg-41075	111	27	clinically	clinically	ADV
mkg-41075	111	28	,	,	PUNCT
mkg-41075	111	29	oral	oral	ADJ
mkg-41075	111	30	cancer	cancer	NOUN
mkg-41075	111	31	lesions	lesion	NOUN
mkg-41075	111	32	may	may	AUX
mkg-41075	111	33	appear	appear	VERB
mkg-41075	111	34	as	as	ADP
mkg-41075	111	35	white	white	ADJ
mkg-41075	111	36	plaques	plaque	NOUN
mkg-41075	111	37	,	,	PUNCT
mkg-41075	111	38	red	red	ADJ
mkg-41075	111	39	plaques	plaque	NOUN
mkg-41075	111	40	,	,	PUNCT
mkg-41075	111	41	ulcers	ulcer	NOUN
mkg-41075	111	42	,	,	PUNCT
mkg-41075	111	43	or	or	CCONJ
mkg-41075	111	44	verrucous	verrucous	ADJ
mkg-41075	111	45	forms	form	NOUN
mkg-41075	111	46	,	,	PUNCT
mkg-41075	111	47	with	with	ADP
mkg-41075	111	48	a	a	DET
mkg-41075	111	49	low	low	ADJ
mkg-41075	111	50	degree	degree	NOUN
mkg-41075	111	51	of	of	ADP
mkg-41075	111	52	hyperplasia	hyperplasia	NOUN
mkg-41075	111	53	.	.	PUNCT
mkg-41075	112	1	however	however	ADV
mkg-41075	112	2	,	,	PUNCT
mkg-41075	112	3	the	the	DET
mkg-41075	112	4	surrounding	surround	VERB
mkg-41075	112	5	tissue	tissue	NOUN
mkg-41075	112	6	may	may	AUX
mkg-41075	112	7	have	have	VERB
mkg-41075	112	8	a	a	DET
mkg-41075	112	9	well	well	ADV
mkg-41075	112	10	-	-	PUNCT
mkg-41075	112	11	differentiated	differentiate	VERB
mkg-41075	112	12	,	,	PUNCT
mkg-41075	112	13	verrucous	verrucous	ADJ
mkg-41075	112	14	hyperplasia	hyperplasia	NOUN
mkg-41075	112	15	,	,	PUNCT
mkg-41075	112	16	severe	severe	ADJ
mkg-41075	112	17	dysplasia	dysplasia	NOUN
mkg-41075	112	18	,	,	PUNCT
mkg-41075	112	19	and	and	CCONJ
mkg-41075	112	20	even	even	ADV
mkg-41075	112	21	a	a	DET
mkg-41075	112	22	carcinoma	carcinoma	NOUN
mkg-41075	112	23	in	in	ADP
mkg-41075	112	24	situ.53	situ.53	NOUN
mkg-41075	112	25	why	why	SCONJ
mkg-41075	112	26	the	the	DET
mkg-41075	112	27	surrounding	surround	VERB
mkg-41075	112	28	tissues	tissue	NOUN
mkg-41075	112	29	transform	transform	VERB
mkg-41075	112	30	into	into	ADP
mkg-41075	112	31	cancer	cancer	NOUN
mkg-41075	112	32	is	be	AUX
mkg-41075	112	33	still	still	ADV
mkg-41075	112	34	not	not	PART
mkg-41075	112	35	fully	fully	ADV
mkg-41075	112	36	understood	understand	VERB
mkg-41075	112	37	.	.	PUNCT
mkg-41075	113	1	the	the	DET
mkg-41075	113	2	possible	possible	ADJ
mkg-41075	113	3	mechanism	mechanism	NOUN
mkg-41075	113	4	is	be	AUX
mkg-41075	113	5	that	that	SCONJ
mkg-41075	113	6	the	the	DET
mkg-41075	113	7	adjacent	adjacent	ADJ
mkg-41075	113	8	tumor	tumor	NOUN
mkg-41075	113	9	microenvironment	microenvironment	NOUN
mkg-41075	113	10	and	and	CCONJ
mkg-41075	113	11	cancer	cancer	NOUN
mkg-41075	113	12	occur	occur	VERB
mkg-41075	113	13	through	through	ADP
mkg-41075	113	14	dynamic	dynamic	ADJ
mkg-41075	113	15	interactions	interaction	NOUN
mkg-41075	113	16	by	by	ADP
mkg-41075	113	17	direct	direct	ADJ
mkg-41075	113	18	cell	cell	NOUN
mkg-41075	113	19	-	-	PUNCT
mkg-41075	113	20	to	to	ADP
mkg-41075	113	21	-	-	PUNCT
mkg-41075	113	22	cell	cell	NOUN
mkg-41075	113	23	communication	communication	NOUN
mkg-41075	113	24	or	or	CCONJ
mkg-41075	113	25	extracellular	extracellular	ADJ
mkg-41075	113	26	and	and	CCONJ
mkg-41075	113	27	intracellular	intracellular	ADJ
mkg-41075	113	28	agents	agent	NOUN
mkg-41075	113	29	.	.	PUNCT
mkg-41075	114	1	some	some	DET
mkg-41075	114	2	hypotheses	hypothesis	NOUN
mkg-41075	114	3	for	for	ADP
mkg-41075	114	4	cancer	cancer	NOUN
mkg-41075	114	5	transformation	transformation	NOUN
mkg-41075	114	6	are	be	AUX
mkg-41075	114	7	cell	cell	NOUN
mkg-41075	114	8	fusion	fusion	NOUN
mkg-41075	114	9	,	,	PUNCT
mkg-41075	114	10	horizontal	horizontal	ADJ
mkg-41075	114	11	gene	gene	NOUN
mkg-41075	114	12	transfer	transfer	NOUN
mkg-41075	114	13	,	,	PUNCT
mkg-41075	114	14	genetic	genetic	ADJ
mkg-41075	114	15	instability	instability	NOUN
mkg-41075	114	16	,	,	PUNCT
mkg-41075	114	17	and	and	CCONJ
mkg-41075	114	18	microenvironment	microenvironment	ADJ
mkg-41075	114	19	involvement.54	involvement.54	NOUN
mkg-41075	114	20	noncoding	noncoding	NOUN
mkg-41075	114	21	and	and	CCONJ
mkg-41075	114	22	micrornas	microrna	NOUN
mkg-41075	114	23	represent	represent	VERB
mkg-41075	114	24	the	the	DET
mkg-41075	114	25	dynamic	dynamic	ADJ
mkg-41075	114	26	interaction	interaction	NOUN
mkg-41075	114	27	between	between	ADP
mkg-41075	114	28	tumor	tumor	NOUN
mkg-41075	114	29	and	and	CCONJ
mkg-41075	114	30	nontumor	nontumor	PROPN
mkg-41075	114	31	cells.55	cells.55	PROPN
mkg-41075	114	32	this	this	DET
mkg-41075	114	33	process	process	NOUN
mkg-41075	114	34	may	may	AUX
mkg-41075	114	35	induce	induce	VERB
mkg-41075	114	36	cancer	cancer	NOUN
mkg-41075	114	37	-	-	PUNCT
mkg-41075	114	38	associated	associate	VERB
mkg-41075	114	39	fibroblasts	fibroblast	NOUN
mkg-41075	114	40	,	,	PUNCT
mkg-41075	114	41	the	the	DET
mkg-41075	114	42	dominant	dominant	ADJ
mkg-41075	114	43	cell	cell	NOUN
mkg-41075	114	44	type	type	NOUN
mkg-41075	114	45	within	within	ADP
mkg-41075	114	46	the	the	DET
mkg-41075	114	47	reactive	reactive	ADJ
mkg-41075	114	48	stroma	stroma	NOUN
mkg-41075	114	49	of	of	ADP
mkg-41075	114	50	many	many	ADJ
mkg-41075	114	51	tumor	tumor	NOUN
mkg-41075	114	52	types.56	types.56	VERB
mkg-41075	114	53	other	other	ADJ
mkg-41075	114	54	causal	causal	ADJ
mkg-41075	114	55	factors	factor	NOUN
mkg-41075	114	56	include	include	VERB
mkg-41075	114	57	cytokine	cytokine	ADJ
mkg-41075	114	58	involvement	involvement	NOUN
mkg-41075	114	59	,	,	PUNCT
mkg-41075	114	60	growth	growth	NOUN
mkg-41075	114	61	factors	factor	NOUN
mkg-41075	114	62	,	,	PUNCT
mkg-41075	114	63	and	and	CCONJ
mkg-41075	114	64	reactive	reactive	ADJ
mkg-41075	114	65	oxygen	oxygen	NOUN
mkg-41075	114	66	species	specie	NOUN
mkg-41075	114	67	(	(	PUNCT
mkg-41075	114	68	ros	ros	PROPN
mkg-41075	114	69	)	)	PUNCT
mkg-41075	114	70	as	as	SCONJ
mkg-41075	114	71	cell	cell	NOUN
mkg-41075	114	72	signaling	signal	VERB
mkg-41075	114	73	molecules	molecule	NOUN
mkg-41075	114	74	that	that	PRON
mkg-41075	114	75	aid	aid	VERB
mkg-41075	114	76	cell	cell	NOUN
mkg-41075	114	77	-	-	PUNCT
mkg-41075	114	78	to	to	ADP
mkg-41075	114	79	-	-	PUNCT
mkg-41075	114	80	cell	cell	NOUN
mkg-41075	114	81	communication.57	communication.57	PROPN
mkg-41075	114	82	field	field	NOUN
mkg-41075	114	83	cancerization	cancerization	NOUN
mkg-41075	114	84	replaces	replace	VERB
mkg-41075	114	85	the	the	DET
mkg-41075	114	86	normal	normal	ADJ
mkg-41075	114	87	cell	cell	NOUN
mkg-41075	114	88	population	population	NOUN
mkg-41075	114	89	with	with	ADP
mkg-41075	114	90	a	a	DET
mkg-41075	114	91	histologically	histologically	ADV
mkg-41075	114	92	nondysplastic	nondysplastic	ADJ
mkg-41075	114	93	but	but	CCONJ
mkg-41075	114	94	pro	pro	ADJ
mkg-41075	114	95	-	-	ADJ
mkg-41075	114	96	tumorigenic	tumorigenic	ADJ
mkg-41075	114	97	mutant	mutant	ADJ
mkg-41075	114	98	cell	cell	NOUN
mkg-41075	114	99	clone.58	clone.58	VERB
mkg-41075	114	100	this	this	DET
mkg-41075	114	101	mechanism	mechanism	NOUN
mkg-41075	114	102	is	be	AUX
mkg-41075	114	103	demonstrated	demonstrate	VERB
mkg-41075	114	104	in	in	ADP
mkg-41075	114	105	figure	figure	NOUN
mkg-41075	114	106	2e	2e	NOUN
mkg-41075	114	107	;	;	PUNCT
mkg-41075	114	108	after	after	ADP
mkg-41075	114	109	surgical	surgical	ADJ
mkg-41075	114	110	treatment	treatment	NOUN
mkg-41075	114	111	,	,	PUNCT
mkg-41075	114	112	the	the	DET
mkg-41075	114	113	surrounding	surround	VERB
mkg-41075	114	114	tissue	tissue	NOUN
mkg-41075	114	115	can	can	AUX
mkg-41075	114	116	progress	progress	VERB
mkg-41075	114	117	to	to	ADP
mkg-41075	114	118	oral	oral	ADJ
mkg-41075	114	119	cancer	cancer	NOUN
mkg-41075	114	120	because	because	SCONJ
mkg-41075	114	121	a	a	DET
mkg-41075	114	122	single	single	ADJ
mkg-41075	114	123	cell	cell	NOUN
mkg-41075	114	124	with	with	ADP
mkg-41075	114	125	cancer	cancer	NOUN
mkg-41075	114	126	-	-	PUNCT
mkg-41075	114	127	associated	associate	VERB
mkg-41075	114	128	genetic	genetic	ADJ
mkg-41075	114	129	or	or	CCONJ
mkg-41075	114	130	epigenetic	epigenetic	ADJ
mkg-41075	114	131	alterations	alteration	NOUN
mkg-41075	114	132	can	can	AUX
mkg-41075	114	133	induce	induce	VERB
mkg-41075	114	134	a	a	DET
mkg-41075	114	135	neighboring	neighboring	NOUN
mkg-41075	114	136	cell	cell	NOUN
mkg-41075	114	137	to	to	PART
mkg-41075	114	138	transform	transform	VERB
mkg-41075	114	139	(	(	PUNCT
mkg-41075	114	140	figure	figure	NOUN
mkg-41075	114	141	4	4	NUM
mkg-41075	114	142	)	)	PUNCT
mkg-41075	114	143	.	.	PUNCT
mkg-41075	115	1	during	during	ADP
mkg-41075	115	2	the	the	DET
mkg-41075	115	3	biopsy	biopsy	NOUN
mkg-41075	115	4	,	,	PUNCT
mkg-41075	115	5	it	it	PRON
mkg-41075	115	6	suggested	suggest	VERB
mkg-41075	115	7	that	that	SCONJ
mkg-41075	115	8	the	the	DET
mkg-41075	115	9	sample	sample	NOUN
mkg-41075	115	10	should	should	AUX
mkg-41075	115	11	be	be	AUX
mkg-41075	115	12	larger	large	ADJ
mkg-41075	115	13	than	than	ADP
mkg-41075	115	14	a	a	DET
mkg-41075	115	15	single	single	ADJ
mkg-41075	115	16	clonal	clonal	ADJ
mkg-41075	115	17	unit	unit	NOUN
mkg-41075	115	18	,	,	PUNCT
mkg-41075	115	19	i.e.	i.e.	X
mkg-41075	115	20	,	,	PUNCT
mkg-41075	115	21	containing	contain	VERB
mkg-41075	115	22	at	at	ADV
mkg-41075	115	23	least	least	ADV
mkg-41075	115	24	200	200	NUM
mkg-41075	115	25	cells	cell	NOUN
mkg-41075	115	26	in	in	ADP
mkg-41075	115	27	width	width	NOUN
mkg-41075	115	28	and	and	CCONJ
mkg-41075	115	29	reaching	reach	VERB
mkg-41075	115	30	10	10	NUM
mkg-41075	115	31	cm	cm	NOUN
mkg-41075	115	32	in	in	ADP
mkg-41075	115	33	diameter.19	diameter.19	NOUN
mkg-41075	115	34	this	this	PRON
mkg-41075	115	35	could	could	AUX
mkg-41075	115	36	identify	identify	VERB
mkg-41075	115	37	pre	pre	ADJ
mkg-41075	115	38	-	-	NOUN
mkg-41075	115	39	cancerization	cancerization	NOUN
mkg-41075	115	40	at	at	ADP
mkg-41075	115	41	the	the	DET
mkg-41075	115	42	periphery	periphery	NOUN
mkg-41075	115	43	of	of	ADP
mkg-41075	115	44	the	the	DET
mkg-41075	115	45	incision	incision	NOUN
mkg-41075	115	46	,	,	PUNCT
mkg-41075	115	47	making	make	VERB
mkg-41075	115	48	the	the	DET
mkg-41075	115	49	examination	examination	NOUN
mkg-41075	115	50	of	of	ADP
mkg-41075	115	51	possible	possible	ADJ
mkg-41075	115	52	areas	area	NOUN
mkg-41075	115	53	of	of	ADP
mkg-41075	115	54	field	field	NOUN
mkg-41075	115	55	cancerization	cancerization	NOUN
mkg-41075	115	56	more	more	ADV
mkg-41075	115	57	precise	precise	ADJ
mkg-41075	115	58	and	and	CCONJ
mkg-41075	115	59	adequate	adequate	ADJ
mkg-41075	115	60	.	.	PUNCT
mkg-41075	116	1	however	however	ADV
mkg-41075	116	2	,	,	PUNCT
mkg-41075	116	3	it	it	PRON
mkg-41075	116	4	should	should	AUX
mkg-41075	116	5	be	be	AUX
mkg-41075	116	6	noted	note	VERB
mkg-41075	116	7	that	that	SCONJ
mkg-41075	116	8	some	some	DET
mkg-41075	116	9	lesions	lesion	NOUN
mkg-41075	116	10	and	and	CCONJ
mkg-41075	116	11	anatomical	anatomical	ADJ
mkg-41075	116	12	locations	location	NOUN
mkg-41075	116	13	are	be	AUX
mkg-41075	116	14	a	a	DET
mkg-41075	116	15	barrier	barrier	NOUN
mkg-41075	116	16	to	to	ADP
mkg-41075	116	17	carrying	carry	VERB
mkg-41075	116	18	out	out	ADP
mkg-41075	116	19	comprehensive	comprehensive	ADJ
mkg-41075	116	20	biopsies	biopsy	NOUN
mkg-41075	116	21	.	.	PUNCT
mkg-41075	117	1	comprehensive	comprehensive	ADJ
mkg-41075	117	2	biopsies	biopsy	NOUN
mkg-41075	117	3	aid	aid	VERB
mkg-41075	117	4	in	in	ADP
mkg-41075	117	5	the	the	DET
mkg-41075	117	6	adequate	adequate	ADJ
mkg-41075	117	7	detection	detection	NOUN
mkg-41075	117	8	of	of	ADP
mkg-41075	117	9	field	field	NOUN
mkg-41075	117	10	cancerization	cancerization	NOUN
mkg-41075	117	11	.	.	PUNCT
mkg-41075	118	1	clinical	clinical	ADJ
mkg-41075	118	2	symptoms	symptom	NOUN
mkg-41075	118	3	do	do	AUX
mkg-41075	118	4	not	not	PART
mkg-41075	118	5	correlate	correlate	VERB
mkg-41075	118	6	with	with	ADP
mkg-41075	118	7	the	the	DET
mkg-41075	118	8	pathogenesis	pathogenesis	NOUN
mkg-41075	118	9	and	and	CCONJ
mkg-41075	118	10	development	development	NOUN
mkg-41075	118	11	of	of	ADP
mkg-41075	118	12	oral	oral	ADJ
mkg-41075	118	13	cancer	cancer	NOUN
mkg-41075	118	14	in	in	ADP
mkg-41075	118	15	the	the	DET
mkg-41075	118	16	early	early	ADJ
mkg-41075	118	17	stages	stage	NOUN
mkg-41075	118	18	.	.	PUNCT
mkg-41075	119	1	thus	thus	ADV
mkg-41075	119	2	,	,	PUNCT
mkg-41075	119	3	diagnostic	diagnostic	ADJ
mkg-41075	119	4	biomarkers	biomarker	NOUN
mkg-41075	119	5	are	be	AUX
mkg-41075	119	6	crucial	crucial	ADJ
mkg-41075	119	7	for	for	ADP
mkg-41075	119	8	determining	determine	VERB
mkg-41075	119	9	histopathology	histopathology	NOUN
mkg-41075	119	10	grading	grading	NOUN
mkg-41075	119	11	and	and	CCONJ
mkg-41075	119	12	prognosis	prognosis	NOUN
mkg-41075	119	13	.	.	PUNCT
mkg-41075	120	1	when	when	SCONJ
mkg-41075	120	2	cancer	cancer	NOUN
mkg-41075	120	3	has	have	AUX
mkg-41075	120	4	invaded	invade	VERB
mkg-41075	120	5	,	,	PUNCT
mkg-41075	120	6	there	there	PRON
mkg-41075	120	7	are	be	VERB
mkg-41075	120	8	increased	increase	VERB
mkg-41075	120	9	clinical	clinical	ADJ
mkg-41075	120	10	symptoms	symptom	NOUN
mkg-41075	120	11	,	,	PUNCT
mkg-41075	120	12	and	and	CCONJ
mkg-41075	120	13	the	the	DET
mkg-41075	120	14	need	need	NOUN
mkg-41075	120	15	for	for	ADP
mkg-41075	120	16	biomarker	biomarker	NOUN
mkg-41075	120	17	diagnostics	diagnostic	NOUN
mkg-41075	120	18	is	be	AUX
mkg-41075	120	19	decreased	decrease	VERB
mkg-41075	120	20	.	.	PUNCT
mkg-41075	121	1	since	since	SCONJ
mkg-41075	121	2	figure	figure	NOUN
mkg-41075	121	3	4	4	NUM
mkg-41075	121	4	.	.	PUNCT
mkg-41075	121	5	mechanism	mechanism	NOUN
mkg-41075	121	6	of	of	ADP
mkg-41075	121	7	field	field	NOUN
mkg-41075	121	8	cancerization	cancerization	NOUN
mkg-41075	121	9	and	and	CCONJ
mkg-41075	121	10	cell	cell	NOUN
mkg-41075	121	11	transformation	transformation	NOUN
mkg-41075	121	12	through	through	ADP
mkg-41075	121	13	noncoding	noncoding	ADJ
mkg-41075	121	14	rna	rna	PROPN
mkg-41075	121	15	,	,	PUNCT
mkg-41075	121	16	microrna	microrna	PROPN
mkg-41075	121	17	,	,	PUNCT
mkg-41075	121	18	cytokines	cytokine	NOUN
mkg-41075	121	19	,	,	PUNCT
mkg-41075	121	20	growth	growth	NOUN
mkg-41075	121	21	factors	factor	NOUN
mkg-41075	121	22	,	,	PUNCT
mkg-41075	121	23	and	and	CCONJ
mkg-41075	121	24	reactive	reactive	ADJ
mkg-41075	121	25	oxygen	oxygen	NOUN
mkg-41075	121	26	species	specie	NOUN
mkg-41075	121	27	.	.	PUNCT
mkg-41075	122	1	copyright	copyright	NOUN
mkg-41075	122	2	©	©	ADP
mkg-41075	122	3	2023	2023	NUM
mkg-41075	122	4	dental	dental	ADJ
mkg-41075	122	5	journal	journal	NOUN
mkg-41075	122	6	(	(	PUNCT
mkg-41075	122	7	majalah	majalah	PROPN
mkg-41075	122	8	kedokteran	kedokteran	PROPN
mkg-41075	122	9	gigi	gigi	PROPN
mkg-41075	122	10	)	)	PUNCT
mkg-41075	123	1	p	p	X
mkg-41075	123	2	-	-	PUNCT
mkg-41075	123	3	issn	issn	NOUN
mkg-41075	123	4	:	:	PUNCT
mkg-41075	123	5	1978	1978	NUM
mkg-41075	123	6	-	-	SYM
mkg-41075	123	7	3728	3728	NUM
mkg-41075	123	8	;	;	PUNCT
mkg-41075	123	9	e	e	X
mkg-41075	123	10	-	-	PUNCT
mkg-41075	123	11	issn	issn	ADJ
mkg-41075	123	12	:	:	PUNCT
mkg-41075	123	13	2442	2442	NUM
mkg-41075	123	14	-	-	SYM
mkg-41075	123	15	9740	9740	NUM
mkg-41075	123	16	.	.	PUNCT
mkg-41075	124	1	accredited	accredit	VERB
mkg-41075	124	2	no	no	INTJ
mkg-41075	124	3	.	.	PROPN
mkg-41075	125	1	158	158	NUM
mkg-41075	125	2	/	/	SYM
mkg-41075	125	3	e	e	NOUN
mkg-41075	125	4	/	/	SYM
mkg-41075	125	5	kpt/2021	kpt/2021	NOUN
mkg-41075	125	6	.	.	PUNCT
mkg-41075	126	1	open	open	ADJ
mkg-41075	126	2	access	access	NOUN
mkg-41075	126	3	under	under	ADP
mkg-41075	126	4	cc	cc	NOUN
mkg-41075	126	5	-	-	PUNCT
mkg-41075	126	6	by	by	ADP
mkg-41075	126	7	-	-	PUNCT
mkg-41075	126	8	sa	sa	NOUN
mkg-41075	126	9	license	license	NOUN
mkg-41075	126	10	.	.	PUNCT
mkg-41075	127	1	available	available	ADJ
mkg-41075	127	2	at	at	ADP
mkg-41075	127	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-41075	127	4	doi	doi	NOUN
mkg-41075	127	5	:	:	PUNCT
mkg-41075	127	6	10.20473	10.20473	NUM
mkg-41075	127	7	/	/	SYM
mkg-41075	127	8	j.djmkg.v56.i3.p189–196	j.djmkg.v56.i3.p189–196	PROPN
mkg-41075	127	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	PROPN
mkg-41075	127	10	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	PROPN
mkg-41075	127	11	194	194	NUM
mkg-41075	127	12	puspasari	puspasari	PROPN
mkg-41075	127	13	et	et	PROPN
mkg-41075	127	14	al	al	PROPN
mkg-41075	127	15	.	.	PROPN
mkg-41075	127	16	dent	dent	PROPN
mkg-41075	127	17	.	.	PUNCT
mkg-41075	128	1	j.	j.	PROPN
mkg-41075	128	2	(	(	PUNCT
mkg-41075	128	3	majalah	majalah	PROPN
mkg-41075	128	4	kedokteran	kedokteran	PROPN
mkg-41075	128	5	gigi	gigi	PROPN
mkg-41075	128	6	)	)	PUNCT
mkg-41075	128	7	2023	2023	NUM
mkg-41075	128	8	september	september	PROPN
mkg-41075	128	9	;	;	PUNCT
mkg-41075	128	10	56(3	56(3	NUM
mkg-41075	128	11	):	):	PUNCT
mkg-41075	128	12	189–196	189–196	NUM
mkg-41075	128	13	the	the	DET
mkg-41075	128	14	cancer	cancer	NOUN
mkg-41075	128	15	is	be	AUX
mkg-41075	128	16	already	already	ADV
mkg-41075	128	17	in	in	ADP
mkg-41075	128	18	the	the	DET
mkg-41075	128	19	final	final	ADJ
mkg-41075	128	20	stage	stage	NOUN
mkg-41075	128	21	,	,	PUNCT
mkg-41075	128	22	the	the	DET
mkg-41075	128	23	clinician	clinician	NOUN
mkg-41075	128	24	focuses	focus	VERB
mkg-41075	128	25	on	on	ADP
mkg-41075	128	26	the	the	DET
mkg-41075	128	27	diagnosis	diagnosis	NOUN
mkg-41075	128	28	and	and	CCONJ
mkg-41075	128	29	treatment	treatment	NOUN
mkg-41075	128	30	plan	plan	NOUN
mkg-41075	128	31	with	with	ADP
mkg-41075	128	32	the	the	DET
mkg-41075	128	33	possibility	possibility	NOUN
mkg-41075	128	34	of	of	ADP
mkg-41075	128	35	a	a	DET
mkg-41075	128	36	poor	poor	ADJ
mkg-41075	128	37	prognosis	prognosis	NOUN
mkg-41075	128	38	(	(	PUNCT
mkg-41075	128	39	figure	figure	NOUN
mkg-41075	128	40	5	5	NUM
mkg-41075	128	41	)	)	PUNCT
mkg-41075	128	42	.	.	PUNCT
mkg-41075	129	1	management	management	NOUN
mkg-41075	129	2	strategies	strategy	NOUN
mkg-41075	129	3	for	for	ADP
mkg-41075	129	4	opmd	opmd	ADJ
mkg-41075	129	5	or	or	CCONJ
mkg-41075	129	6	pre	pre	ADJ
mkg-41075	129	7	-	-	ADJ
mkg-41075	129	8	cancerization	cancerization	NOUN
mkg-41075	129	9	lesions	lesion	NOUN
mkg-41075	129	10	should	should	AUX
mkg-41075	129	11	follow	follow	VERB
mkg-41075	129	12	a	a	DET
mkg-41075	129	13	strict	strict	ADJ
mkg-41075	129	14	protocol	protocol	NOUN
mkg-41075	129	15	,	,	PUNCT
mkg-41075	129	16	including	include	VERB
mkg-41075	129	17	counseling	counseling	NOUN
mkg-41075	129	18	emphasizing	emphasize	VERB
mkg-41075	129	19	the	the	DET
mkg-41075	129	20	patient	patient	NOUN
mkg-41075	129	21	’s	’s	PART
mkg-41075	129	22	commitment	commitment	NOUN
mkg-41075	129	23	to	to	ADP
mkg-41075	129	24	discontinuing	discontinue	VERB
mkg-41075	129	25	their	their	PRON
mkg-41075	129	26	bad	bad	ADJ
mkg-41075	129	27	habits	habit	NOUN
mkg-41075	129	28	.	.	PUNCT
mkg-41075	130	1	the	the	DET
mkg-41075	130	2	clinician	clinician	NOUN
mkg-41075	130	3	must	must	AUX
mkg-41075	130	4	provide	provide	VERB
mkg-41075	130	5	a	a	DET
mkg-41075	130	6	long	long	ADJ
mkg-41075	130	7	-	-	PUNCT
mkg-41075	130	8	term	term	NOUN
mkg-41075	130	9	follow	follow	NOUN
mkg-41075	130	10	-	-	PUNCT
mkg-41075	130	11	up	up	NOUN
mkg-41075	130	12	and	and	CCONJ
mkg-41075	130	13	patient	patient	ADJ
mkg-41075	130	14	monitoring	monitoring	NOUN
mkg-41075	130	15	with	with	ADP
mkg-41075	130	16	an	an	DET
mkg-41075	130	17	estimation	estimation	NOUN
mkg-41075	130	18	of	of	ADP
mkg-41075	130	19	67	67	NUM
mkg-41075	130	20	–	–	SYM
mkg-41075	130	21	96	96	NUM
mkg-41075	130	22	months	month	NOUN
mkg-41075	130	23	to	to	PART
mkg-41075	130	24	detect	detect	VERB
mkg-41075	130	25	invasive	invasive	ADJ
mkg-41075	130	26	carcinoma	carcinoma	NOUN
mkg-41075	130	27	transformation	transformation	NOUN
mkg-41075	130	28	.	.	PUNCT
mkg-41075	131	1	based	base	VERB
mkg-41075	131	2	on	on	ADP
mkg-41075	131	3	the	the	DET
mkg-41075	131	4	clinical	clinical	ADJ
mkg-41075	131	5	characteristics	characteristic	NOUN
mkg-41075	131	6	,	,	PUNCT
mkg-41075	131	7	it	it	PRON
mkg-41075	131	8	is	be	AUX
mkg-41075	131	9	essential	essential	ADJ
mkg-41075	131	10	to	to	PART
mkg-41075	131	11	examine	examine	VERB
mkg-41075	131	12	and	and	CCONJ
mkg-41075	131	13	observe	observe	VERB
mkg-41075	131	14	the	the	DET
mkg-41075	131	15	entire	entire	ADJ
mkg-41075	131	16	oral	oral	ADJ
mkg-41075	131	17	area	area	NOUN
mkg-41075	131	18	and	and	CCONJ
mkg-41075	131	19	not	not	PART
mkg-41075	131	20	just	just	ADV
mkg-41075	131	21	the	the	DET
mkg-41075	131	22	area	area	NOUN
mkg-41075	131	23	with	with	ADP
mkg-41075	131	24	lesions	lesion	NOUN
mkg-41075	131	25	.	.	PUNCT
mkg-41075	132	1	specific	specific	ADJ
mkg-41075	132	2	biomarkers	biomarker	NOUN
mkg-41075	132	3	must	must	AUX
mkg-41075	132	4	be	be	AUX
mkg-41075	132	5	used	use	VERB
mkg-41075	132	6	appropriately.17	appropriately.17	PROPN
mkg-41075	132	7	these	these	DET
mkg-41075	132	8	steps	step	NOUN
mkg-41075	132	9	should	should	AUX
mkg-41075	132	10	contribute	contribute	VERB
mkg-41075	132	11	to	to	ADP
mkg-41075	132	12	improving	improve	VERB
mkg-41075	132	13	prognosis.17	prognosis.17	NOUN
mkg-41075	132	14	identifying	identify	VERB
mkg-41075	132	15	molecular	molecular	ADJ
mkg-41075	132	16	markers	marker	NOUN
mkg-41075	132	17	is	be	AUX
mkg-41075	132	18	essential	essential	ADJ
mkg-41075	132	19	in	in	ADP
mkg-41075	132	20	genetically	genetically	ADV
mkg-41075	132	21	transformed	transform	VERB
mkg-41075	132	22	cells	cell	NOUN
mkg-41075	132	23	with	with	ADP
mkg-41075	132	24	normal	normal	ADJ
mkg-41075	132	25	histological	histological	ADJ
mkg-41075	132	26	appearance.59	appearance.59	NOUN
mkg-41075	132	27	thus	thus	ADV
mkg-41075	132	28	,	,	PUNCT
mkg-41075	132	29	tumor	tumor	NOUN
mkg-41075	132	30	-	-	PUNCT
mkg-41075	132	31	specific	specific	ADJ
mkg-41075	132	32	biomarker	biomarker	NOUN
mkg-41075	132	33	identification	identification	NOUN
mkg-41075	132	34	has	have	VERB
mkg-41075	132	35	an	an	DET
mkg-41075	132	36	excellent	excellent	ADJ
mkg-41075	132	37	role	role	NOUN
mkg-41075	132	38	in	in	ADP
mkg-41075	132	39	monitoring	monitor	VERB
mkg-41075	132	40	tumor	tumor	NOUN
mkg-41075	132	41	progression	progression	NOUN
mkg-41075	132	42	and	and	CCONJ
mkg-41075	132	43	,	,	PUNCT
mkg-41075	132	44	if	if	SCONJ
mkg-41075	132	45	possible	possible	ADJ
mkg-41075	132	46	,	,	PUNCT
mkg-41075	132	47	preventing	prevent	VERB
mkg-41075	132	48	invasive	invasive	ADJ
mkg-41075	132	49	cancer	cancer	NOUN
mkg-41075	132	50	transformation	transformation	NOUN
mkg-41075	132	51	.	.	PUNCT
mkg-41075	133	1	early	early	ADJ
mkg-41075	133	2	identification	identification	NOUN
mkg-41075	133	3	and	and	CCONJ
mkg-41075	133	4	management	management	NOUN
mkg-41075	133	5	of	of	ADP
mkg-41075	133	6	field	field	NOUN
mkg-41075	133	7	cancerization	cancerization	NOUN
mkg-41075	133	8	are	be	AUX
mkg-41075	133	9	critical	critical	ADJ
mkg-41075	133	10	for	for	ADP
mkg-41075	133	11	cancer	cancer	NOUN
mkg-41075	133	12	mortality	mortality	NOUN
mkg-41075	133	13	and	and	CCONJ
mkg-41075	133	14	morbidity	morbidity	NOUN
mkg-41075	133	15	prevention	prevention	NOUN
mkg-41075	133	16	.	.	PUNCT
mkg-41075	134	1	in	in	ADP
mkg-41075	134	2	the	the	DET
mkg-41075	134	3	clinical	clinical	ADJ
mkg-41075	134	4	setting	setting	NOUN
mkg-41075	134	5	,	,	PUNCT
mkg-41075	134	6	oral	oral	ADJ
mkg-41075	134	7	field	field	NOUN
mkg-41075	134	8	cancerization	cancerization	NOUN
mkg-41075	134	9	should	should	AUX
mkg-41075	134	10	prompt	prompt	VERB
mkg-41075	134	11	healthcare	healthcare	NOUN
mkg-41075	134	12	professionals	professional	NOUN
mkg-41075	134	13	to	to	PART
mkg-41075	134	14	remind	remind	VERB
mkg-41075	134	15	patients	patient	NOUN
mkg-41075	134	16	that	that	SCONJ
mkg-41075	134	17	frequent	frequent	ADJ
mkg-41075	134	18	oral	oral	ADJ
mkg-41075	134	19	examination	examination	NOUN
mkg-41075	134	20	with	with	ADP
mkg-41075	134	21	histological	histological	ADJ
mkg-41075	134	22	studies	study	NOUN
mkg-41075	134	23	and	and	CCONJ
mkg-41075	134	24	molecular	molecular	ADJ
mkg-41075	134	25	testing	testing	NOUN
mkg-41075	134	26	is	be	AUX
mkg-41075	134	27	mandatory	mandatory	ADJ
mkg-41075	134	28	for	for	ADP
mkg-41075	134	29	those	those	PRON
mkg-41075	134	30	at	at	ADP
mkg-41075	134	31	high	high	ADJ
mkg-41075	134	32	risk	risk	NOUN
mkg-41075	134	33	of	of	ADP
mkg-41075	134	34	developing	develop	VERB
mkg-41075	134	35	malignancies	malignancy	NOUN
mkg-41075	134	36	.	.	PUNCT
mkg-41075	135	1	references	reference	NOUN
mkg-41075	135	2	1	1	NUM
mkg-41075	135	3	.	.	PUNCT
mkg-41075	136	1	mallegowda	mallegowda	PROPN
mkg-41075	136	2	h	h	PROPN
mkg-41075	136	3	,	,	PUNCT
mkg-41075	136	4	theresa	theresa	PROPN
mkg-41075	136	5	r	r	PROPN
mkg-41075	136	6	,	,	PUNCT
mkg-41075	136	7	amberkar	amberkar	NOUN
mkg-41075	136	8	v.	v.	ADP
mkg-41075	136	9	oral	oral	ADJ
mkg-41075	136	10	field	field	NOUN
mkg-41075	136	11	cancerization	cancerization	NOUN
mkg-41075	136	12	:	:	PUNCT
mkg-41075	136	13	tracking	track	VERB
mkg-41075	136	14	the	the	DET
mkg-41075	136	15	invisible	invisible	ADJ
mkg-41075	136	16	.	.	PUNCT
mkg-41075	137	1	int	int	PROPN
mkg-41075	137	2	j	j	PROPN
mkg-41075	137	3	oral	oral	ADJ
mkg-41075	137	4	heal	heal	PROPN
mkg-41075	137	5	sci	sci	PROPN
mkg-41075	137	6	.	.	PROPN
mkg-41075	137	7	2019	2019	NUM
mkg-41075	137	8	;	;	PUNCT
mkg-41075	137	9	9(1	9(1	NUM
mkg-41075	137	10	):	):	PUNCT
mkg-41075	137	11	28–35	28–35	NUM
mkg-41075	137	12	.	.	NOUN
mkg-41075	138	1	2	2	NUM
mkg-41075	138	2	.	.	X
mkg-41075	138	3	hecht	hecht	PROPN
mkg-41075	138	4	ss	ss	PROPN
mkg-41075	138	5	,	,	PUNCT
mkg-41075	138	6	hatsukami	hatsukami	ADJ
mkg-41075	138	7	dk	dk	PROPN
mkg-41075	138	8	.	.	PROPN
mkg-41075	138	9	smokeless	smokeless	NOUN
mkg-41075	138	10	tobacco	tobacco	NOUN
mkg-41075	138	11	and	and	CCONJ
mkg-41075	138	12	cigarette	cigarette	NOUN
mkg-41075	138	13	smoking	smoking	NOUN
mkg-41075	138	14	:	:	PUNCT
mkg-41075	138	15	chemical	chemical	NOUN
mkg-41075	138	16	mechanisms	mechanism	NOUN
mkg-41075	138	17	and	and	CCONJ
mkg-41075	138	18	cancer	cancer	NOUN
mkg-41075	138	19	prevention	prevention	NOUN
mkg-41075	138	20	.	.	PUNCT
mkg-41075	139	1	nat	nat	PROPN
mkg-41075	139	2	rev	rev	PROPN
mkg-41075	139	3	cancer	cancer	NOUN
mkg-41075	139	4	.	.	PUNCT
mkg-41075	140	1	2022	2022	NUM
mkg-41075	140	2	;	;	PUNCT
mkg-41075	140	3	22(3	22(3	NUM
mkg-41075	140	4	):	):	PUNCT
mkg-41075	140	5	143–55	143–55	NUM
mkg-41075	140	6	.	.	PUNCT
mkg-41075	141	1	3	3	X
mkg-41075	141	2	.	.	X
mkg-41075	141	3	bhandari	bhandari	PROPN
mkg-41075	141	4	a	a	PROPN
mkg-41075	141	5	,	,	PUNCT
mkg-41075	141	6	bhatta	bhatta	PROPN
mkg-41075	141	7	n.	n.	NOUN
mkg-41075	141	8	tobacco	tobacco	NOUN
mkg-41075	141	9	and	and	CCONJ
mkg-41075	141	10	its	its	PRON
mkg-41075	141	11	relationship	relationship	NOUN
mkg-41075	141	12	with	with	ADP
mkg-41075	141	13	oral	oral	ADJ
mkg-41075	141	14	health	health	NOUN
mkg-41075	141	15	.	.	PUNCT
mkg-41075	142	1	j	j	PROPN
mkg-41075	142	2	nepal	nepal	PROPN
mkg-41075	142	3	med	med	PROPN
mkg-41075	142	4	assoc	assoc	PROPN
mkg-41075	142	5	.	.	PUNCT
mkg-41075	142	6	2021	2021	NUM
mkg-41075	142	7	;	;	PUNCT
mkg-41075	142	8	59(243	59(243	NUM
mkg-41075	142	9	):	):	PUNCT
mkg-41075	142	10	1204–6	1204–6	PROPN
mkg-41075	142	11	.	.	PUNCT
mkg-41075	143	1	4	4	NUM
mkg-41075	143	2	.	.	X
mkg-41075	143	3	vassoler	vassoler	PROPN
mkg-41075	143	4	t	t	PROPN
mkg-41075	143	5	,	,	PUNCT
mkg-41075	143	6	dogenski	dogenski	PROPN
mkg-41075	143	7	lc	lc	PROPN
mkg-41075	143	8	,	,	PUNCT
mkg-41075	143	9	sartori	sartori	NOUN
mkg-41075	143	10	vk	vk	PROPN
mkg-41075	143	11	,	,	PUNCT
mkg-41075	143	12	presotto	presotto	PROPN
mkg-41075	143	13	js	js	PROPN
mkg-41075	143	14	,	,	PUNCT
mkg-41075	143	15	cardoso	cardoso	PROPN
mkg-41075	143	16	mz	mz	PROPN
mkg-41075	143	17	,	,	PUNCT
mkg-41075	143	18	zandoná	zandoná	PROPN
mkg-41075	143	19	j	j	PROPN
mkg-41075	143	20	,	,	PUNCT
mkg-41075	143	21	trentin	trentin	PROPN
mkg-41075	143	22	ms	ms	PROPN
mkg-41075	143	23	,	,	PUNCT
mkg-41075	143	24	linden	linden	PROPN
mkg-41075	143	25	ms	ms	PROPN
mkg-41075	143	26	,	,	PUNCT
mkg-41075	143	27	palhano	palhano	PROPN
mkg-41075	143	28	hs	hs	PROPN
mkg-41075	143	29	,	,	PUNCT
mkg-41075	143	30	vargas	vargas	PROPN
mkg-41075	143	31	je	je	PROPN
mkg-41075	143	32	,	,	PUNCT
mkg-41075	143	33	de	de	PROPN
mkg-41075	143	34	carli	carli	PROPN
mkg-41075	143	35	jp	jp	PROPN
mkg-41075	143	36	.	.	PUNCT
mkg-41075	144	1	evaluation	evaluation	NOUN
mkg-41075	144	2	of	of	ADP
mkg-41075	144	3	the	the	DET
mkg-41075	144	4	genotoxicity	genotoxicity	NOUN
mkg-41075	144	5	of	of	ADP
mkg-41075	144	6	tobacco	tobacco	NOUN
mkg-41075	144	7	and	and	CCONJ
mkg-41075	144	8	alcohol	alcohol	NOUN
mkg-41075	144	9	in	in	ADP
mkg-41075	144	10	oral	oral	ADJ
mkg-41075	144	11	mucosa	mucosa	NOUN
mkg-41075	144	12	cells	cell	NOUN
mkg-41075	144	13	:	:	PUNCT
mkg-41075	144	14	a	a	DET
mkg-41075	144	15	pilot	pilot	NOUN
mkg-41075	144	16	study	study	NOUN
mkg-41075	144	17	.	.	PUNCT
mkg-41075	145	1	j	j	PROPN
mkg-41075	145	2	contemp	contemp	PROPN
mkg-41075	145	3	dent	dent	NOUN
mkg-41075	145	4	pract	pract	NOUN
mkg-41075	145	5	.	.	PUNCT
mkg-41075	146	1	2021	2021	NUM
mkg-41075	146	2	;	;	PUNCT
mkg-41075	146	3	22(7	22(7	NUM
mkg-41075	146	4	):	):	PUNCT
mkg-41075	146	5	745–50	745–50	NOUN
mkg-41075	146	6	.	.	PUNCT
mkg-41075	147	1	5	5	NUM
mkg-41075	147	2	.	.	X
mkg-41075	147	3	bouaoud	bouaoud	PROPN
mkg-41075	147	4	j	j	PROPN
mkg-41075	147	5	,	,	PUNCT
mkg-41075	147	6	bossi	bossi	PROPN
mkg-41075	147	7	p	p	PROPN
mkg-41075	147	8	,	,	PUNCT
mkg-41075	147	9	elkabets	elkabet	NOUN
mkg-41075	147	10	m	m	PROPN
mkg-41075	147	11	,	,	PUNCT
mkg-41075	147	12	schmitz	schmitz	PROPN
mkg-41075	147	13	s	s	PROPN
mkg-41075	147	14	,	,	PUNCT
mkg-41075	147	15	van	van	PROPN
mkg-41075	147	16	kempen	kempen	PROPN
mkg-41075	147	17	lc	lc	PROPN
mkg-41075	147	18	,	,	PUNCT
mkg-41075	147	19	martinez	martinez	PROPN
mkg-41075	147	20	p	p	PROPN
mkg-41075	147	21	,	,	PUNCT
mkg-41075	147	22	jagadeeshan	jagadeeshan	PROPN
mkg-41075	147	23	s	s	PROPN
mkg-41075	147	24	,	,	PUNCT
mkg-41075	147	25	breuskin	breuskin	X
mkg-41075	147	26	i	i	PRON
mkg-41075	147	27	,	,	PUNCT
mkg-41075	147	28	puppels	puppels	PROPN
mkg-41075	147	29	gj	gj	PROPN
mkg-41075	147	30	,	,	PUNCT
mkg-41075	147	31	hoffmann	hoffmann	PROPN
mkg-41075	147	32	c	c	PROPN
mkg-41075	147	33	,	,	PUNCT
mkg-41075	147	34	hunter	hunter	NOUN
mkg-41075	147	35	kd	kd	PROPN
mkg-41075	147	36	,	,	PUNCT
mkg-41075	147	37	simon	simon	PROPN
mkg-41075	147	38	c	c	PROPN
mkg-41075	147	39	,	,	PUNCT
mkg-41075	147	40	machiels	machiels	PROPN
mkg-41075	147	41	j	j	PROPN
mkg-41075	147	42	-	-	PUNCT
mkg-41075	147	43	p	p	PROPN
mkg-41075	147	44	,	,	PUNCT
mkg-41075	147	45	grégoire	grégoire	NOUN
mkg-41075	147	46	v	v	NOUN
mkg-41075	147	47	,	,	PUNCT
mkg-41075	147	48	bertolus	bertolus	PROPN
mkg-41075	147	49	c	c	NOUN
mkg-41075	147	50	,	,	PUNCT
mkg-41075	147	51	brakenhoff	brakenhoff	PROPN
mkg-41075	147	52	rh	rh	PROPN
mkg-41075	147	53	,	,	PUNCT
mkg-41075	147	54	koljenović	koljenović	NOUN
mkg-41075	147	55	s	s	PROPN
mkg-41075	147	56	,	,	PUNCT
mkg-41075	147	57	saintigny	saintigny	PROPN
mkg-41075	147	58	p.	p.	PROPN
mkg-41075	147	59	unmet	unmet	NOUN
mkg-41075	147	60	needs	need	NOUN
mkg-41075	147	61	and	and	CCONJ
mkg-41075	147	62	perspectives	perspective	NOUN
mkg-41075	147	63	in	in	ADP
mkg-41075	147	64	oral	oral	ADJ
mkg-41075	147	65	cancer	cancer	NOUN
mkg-41075	147	66	prevention	prevention	NOUN
mkg-41075	147	67	.	.	PUNCT
mkg-41075	148	1	cancers	cancer	NOUN
mkg-41075	148	2	(	(	PUNCT
mkg-41075	148	3	basel	basel	PROPN
mkg-41075	148	4	)	)	PUNCT
mkg-41075	148	5	.	.	PUNCT
mkg-41075	149	1	2022	2022	NUM
mkg-41075	149	2	;	;	PUNCT
mkg-41075	149	3	14(7	14(7	NUM
mkg-41075	149	4	):	):	PUNCT
mkg-41075	149	5	1815	1815	NUM
mkg-41075	149	6	.	.	PUNCT
mkg-41075	150	1	6	6	NUM
mkg-41075	150	2	.	.	X
mkg-41075	150	3	abati	abati	PROPN
mkg-41075	150	4	s	s	PROPN
mkg-41075	150	5	,	,	PUNCT
mkg-41075	150	6	bramati	bramati	PROPN
mkg-41075	150	7	c	c	PROPN
mkg-41075	150	8	,	,	PUNCT
mkg-41075	150	9	bondi	bondi	PROPN
mkg-41075	150	10	s	s	PROPN
mkg-41075	150	11	,	,	PUNCT
mkg-41075	150	12	lissoni	lissoni	ADJ
mkg-41075	150	13	a	a	DET
mkg-41075	150	14	,	,	PUNCT
mkg-41075	150	15	trimarchi	trimarchi	ADJ
mkg-41075	150	16	m.	m.	NOUN
mkg-41075	150	17	oral	oral	ADJ
mkg-41075	150	18	cancer	cancer	NOUN
mkg-41075	150	19	and	and	CCONJ
mkg-41075	150	20	precancer	precancer	NOUN
mkg-41075	150	21	:	:	PUNCT
mkg-41075	150	22	a	a	DET
mkg-41075	150	23	narrative	narrative	ADJ
mkg-41075	150	24	review	review	NOUN
mkg-41075	150	25	on	on	ADP
mkg-41075	150	26	the	the	DET
mkg-41075	150	27	relevance	relevance	NOUN
mkg-41075	150	28	of	of	ADP
mkg-41075	150	29	early	early	ADJ
mkg-41075	150	30	diagnosis	diagnosis	NOUN
mkg-41075	150	31	.	.	PUNCT
mkg-41075	151	1	int	int	PROPN
mkg-41075	152	1	j	j	PROPN
mkg-41075	152	2	environ	environ	PROPN
mkg-41075	152	3	res	re	VERB
mkg-41075	152	4	public	public	ADJ
mkg-41075	152	5	health	health	NOUN
mkg-41075	152	6	.	.	PUNCT
mkg-41075	153	1	2020	2020	NUM
mkg-41075	153	2	;	;	PUNCT
mkg-41075	153	3	17(24	17(24	NUM
mkg-41075	153	4	):	):	PUNCT
mkg-41075	153	5	9160	9160	NUM
mkg-41075	153	6	.	.	PUNCT
mkg-41075	154	1	7	7	X
mkg-41075	154	2	.	.	X
mkg-41075	154	3	patil	patil	PROPN
mkg-41075	154	4	vm	vm	PROPN
mkg-41075	154	5	,	,	PUNCT
mkg-41075	154	6	noronha	noronha	VERB
mkg-41075	154	7	v	v	PROPN
mkg-41075	154	8	,	,	PUNCT
mkg-41075	154	9	joshi	joshi	PROPN
mkg-41075	154	10	a	a	X
mkg-41075	154	11	,	,	PUNCT
mkg-41075	154	12	abhyankar	abhyankar	ADJ
mkg-41075	154	13	a	a	X
mkg-41075	154	14	,	,	PUNCT
mkg-41075	154	15	menon	menon	PROPN
mkg-41075	154	16	n	n	CCONJ
mkg-41075	154	17	,	,	PUNCT
mkg-41075	154	18	dhumal	dhumal	ADJ
mkg-41075	154	19	s	s	NOUN
mkg-41075	154	20	,	,	PUNCT
mkg-41075	154	21	prabhash	prabhash	PROPN
mkg-41075	154	22	k.	k.	PROPN
mkg-41075	154	23	beyond	beyond	ADP
mkg-41075	154	24	conventional	conventional	ADJ
mkg-41075	154	25	chemotherapy	chemotherapy	NOUN
mkg-41075	154	26	,	,	PUNCT
mkg-41075	154	27	targeted	target	VERB
mkg-41075	154	28	therapy	therapy	NOUN
mkg-41075	154	29	and	and	CCONJ
mkg-41075	154	30	immunotherapy	immunotherapy	NOUN
mkg-41075	154	31	in	in	ADP
mkg-41075	154	32	squamous	squamous	ADJ
mkg-41075	154	33	cell	cell	NOUN
mkg-41075	154	34	cancer	cancer	NOUN
mkg-41075	154	35	of	of	ADP
mkg-41075	154	36	the	the	DET
mkg-41075	154	37	oral	oral	ADJ
mkg-41075	154	38	cavity	cavity	NOUN
mkg-41075	154	39	.	.	PUNCT
mkg-41075	155	1	oral	oral	ADJ
mkg-41075	155	2	oncol	oncol	ADJ
mkg-41075	155	3	.	.	PUNCT
mkg-41075	156	1	2020	2020	NUM
mkg-41075	156	2	;	;	PUNCT
mkg-41075	156	3	105	105	NUM
mkg-41075	156	4	:	:	SYM
mkg-41075	156	5	104673	104673	NUM
mkg-41075	156	6	.	.	PUNCT
mkg-41075	157	1	8	8	X
mkg-41075	157	2	.	.	PUNCT
mkg-41075	158	1	desai	desai	PROPN
mkg-41075	158	2	rs	rs	PROPN
mkg-41075	158	3	,	,	PUNCT
mkg-41075	158	4	shirsat	shirsat	ADJ
mkg-41075	158	5	pm	pm	NOUN
mkg-41075	158	6	,	,	PUNCT
mkg-41075	158	7	bansal	bansal	NOUN
mkg-41075	158	8	s	s	PROPN
mkg-41075	158	9	,	,	PUNCT
mkg-41075	158	10	prasad	prasad	PROPN
mkg-41075	158	11	p	p	PROPN
mkg-41075	158	12	,	,	PUNCT
mkg-41075	158	13	satish	satish	ADJ
mkg-41075	158	14	arvandekar	arvandekar	PROPN
mkg-41075	158	15	a.	a.	PROPN
mkg-41075	158	16	oral	oral	PROPN
mkg-41075	158	17	field	field	NOUN
mkg-41075	158	18	cancerization	cancerization	NOUN
mkg-41075	158	19	:	:	PUNCT
mkg-41075	158	20	a	a	DET
mkg-41075	158	21	critical	critical	ADJ
mkg-41075	158	22	appraisal	appraisal	NOUN
mkg-41075	158	23	.	.	PUNCT
mkg-41075	159	1	oral	oral	ADJ
mkg-41075	159	2	oncol	oncol	ADJ
mkg-41075	159	3	.	.	PUNCT
mkg-41075	160	1	2021	2021	NUM
mkg-41075	160	2	;	;	PUNCT
mkg-41075	160	3	118	118	NUM
mkg-41075	160	4	:	:	SYM
mkg-41075	160	5	105304	105304	NUM
mkg-41075	160	6	.	.	PUNCT
mkg-41075	161	1	9	9	X
mkg-41075	161	2	.	.	X
mkg-41075	161	3	poh	poh	PROPN
mkg-41075	161	4	cf	cf	PROPN
mkg-41075	161	5	,	,	PUNCT
mkg-41075	161	6	zhang	zhang	PROPN
mkg-41075	161	7	l	l	PROPN
mkg-41075	161	8	,	,	PUNCT
mkg-41075	161	9	anderson	anderson	PROPN
mkg-41075	161	10	dw	dw	PROPN
mkg-41075	161	11	,	,	PUNCT
mkg-41075	161	12	durham	durham	PROPN
mkg-41075	161	13	js	js	PROPN
mkg-41075	161	14	,	,	PUNCT
mkg-41075	161	15	williams	williams	PROPN
mkg-41075	161	16	pm	pm	PROPN
mkg-41075	161	17	,	,	PUNCT
mkg-41075	161	18	priddy	priddy	PROPN
mkg-41075	161	19	rw	rw	PROPN
mkg-41075	161	20	,	,	PUNCT
mkg-41075	161	21	berean	berean	PROPN
mkg-41075	161	22	kw	kw	PROPN
mkg-41075	161	23	,	,	PUNCT
mkg-41075	161	24	ng	ng	PROPN
mkg-41075	161	25	s	s	PROPN
mkg-41075	161	26	,	,	PUNCT
mkg-41075	161	27	tseng	tseng	PROPN
mkg-41075	161	28	ol	ol	PROPN
mkg-41075	161	29	,	,	PUNCT
mkg-41075	161	30	macaulay	macaulay	NOUN
mkg-41075	161	31	c	c	PROPN
mkg-41075	161	32	,	,	PUNCT
mkg-41075	161	33	rosin	rosin	NOUN
mkg-41075	161	34	mp	mp	PROPN
mkg-41075	161	35	.	.	PROPN
mkg-41075	161	36	fluorescence	fluorescence	PROPN
mkg-41075	161	37	visualization	visualization	NOUN
mkg-41075	161	38	detection	detection	NOUN
mkg-41075	161	39	of	of	ADP
mkg-41075	161	40	field	field	NOUN
mkg-41075	161	41	alterations	alteration	NOUN
mkg-41075	161	42	in	in	ADP
mkg-41075	161	43	tumor	tumor	NOUN
mkg-41075	161	44	margins	margin	NOUN
mkg-41075	161	45	of	of	ADP
mkg-41075	161	46	oral	oral	ADJ
mkg-41075	161	47	cancer	cancer	NOUN
mkg-41075	161	48	patients	patient	NOUN
mkg-41075	161	49	.	.	PUNCT
mkg-41075	162	1	clin	clin	PROPN
mkg-41075	162	2	cancer	cancer	NOUN
mkg-41075	162	3	res	re	NOUN
mkg-41075	162	4	.	.	PUNCT
mkg-41075	163	1	2006	2006	NUM
mkg-41075	163	2	;	;	PUNCT
mkg-41075	164	1	12(22	12(22	NUM
mkg-41075	164	2	):	):	PUNCT
mkg-41075	164	3	6716–22	6716–22	NOUN
mkg-41075	164	4	.	.	PUNCT
mkg-41075	165	1	10	10	NUM
mkg-41075	165	2	.	.	PUNCT
mkg-41075	166	1	warnakulasuriya	warnakulasuriya	PROPN
mkg-41075	166	2	s	s	PROPN
mkg-41075	166	3	,	,	PUNCT
mkg-41075	166	4	ariyawardana	ariyawardana	ADJ
mkg-41075	166	5	a.	a.	NOUN
mkg-41075	166	6	malignant	malignant	ADJ
mkg-41075	166	7	transformation	transformation	NOUN
mkg-41075	166	8	of	of	ADP
mkg-41075	166	9	oral	oral	ADJ
mkg-41075	166	10	leukoplakia	leukoplakia	NOUN
mkg-41075	166	11	:	:	PUNCT
mkg-41075	166	12	a	a	DET
mkg-41075	166	13	systematic	systematic	ADJ
mkg-41075	166	14	review	review	NOUN
mkg-41075	166	15	of	of	ADP
mkg-41075	166	16	observational	observational	ADJ
mkg-41075	166	17	studies	study	NOUN
mkg-41075	166	18	.	.	PUNCT
mkg-41075	167	1	j	j	PROPN
mkg-41075	167	2	oral	oral	ADJ
mkg-41075	167	3	pathol	pathol	NOUN
mkg-41075	167	4	med	me	VERB
mkg-41075	167	5	.	.	PROPN
mkg-41075	167	6	2016	2016	NUM
mkg-41075	167	7	;	;	PUNCT
mkg-41075	167	8	45(3	45(3	NUM
mkg-41075	167	9	):	):	PUNCT
mkg-41075	167	10	155–66	155–66	NUM
mkg-41075	167	11	.	.	PROPN
mkg-41075	168	1	11	11	NUM
mkg-41075	168	2	.	.	PUNCT
mkg-41075	168	3	aguirre‐urizar	aguirre‐urizar	PROPN
mkg-41075	168	4	jm	jm	PROPN
mkg-41075	168	5	,	,	PUNCT
mkg-41075	168	6	lafuente‐ibáñez	lafuente‐ibáñez	PROPN
mkg-41075	168	7	de	de	PROPN
mkg-41075	168	8	mendoza	mendoza	PROPN
mkg-41075	168	9	i	i	PROPN
mkg-41075	168	10	,	,	PUNCT
mkg-41075	168	11	warnakulasuriya	warnakulasuriya	PROPN
mkg-41075	168	12	s.	s.	PROPN
mkg-41075	168	13	malignant	malignant	ADJ
mkg-41075	168	14	transformation	transformation	NOUN
mkg-41075	168	15	of	of	ADP
mkg-41075	168	16	oral	oral	ADJ
mkg-41075	168	17	leukoplakia	leukoplakia	NOUN
mkg-41075	168	18	:	:	PUNCT
mkg-41075	168	19	systematic	systematic	ADJ
mkg-41075	168	20	review	review	NOUN
mkg-41075	168	21	and	and	CCONJ
mkg-41075	168	22	meta‐analysis	meta‐analysis	NOUN
mkg-41075	168	23	of	of	ADP
mkg-41075	168	24	the	the	DET
mkg-41075	168	25	last	last	ADJ
mkg-41075	168	26	5	5	NUM
mkg-41075	168	27	years	year	NOUN
mkg-41075	168	28	.	.	PUNCT
mkg-41075	169	1	oral	oral	ADJ
mkg-41075	169	2	dis	dis	PROPN
mkg-41075	169	3	.	.	PUNCT
mkg-41075	169	4	2021	2021	NUM
mkg-41075	169	5	;	;	PUNCT
mkg-41075	169	6	27(8	27(8	NUM
mkg-41075	169	7	):	):	PUNCT
mkg-41075	169	8	1881–95	1881–95	NUM
mkg-41075	169	9	.	.	PUNCT
mkg-41075	170	1	12	12	NUM
mkg-41075	170	2	.	.	PUNCT
mkg-41075	171	1	pinto	pinto	NOUN
mkg-41075	171	2	ac	ac	PROPN
mkg-41075	171	3	,	,	PUNCT
mkg-41075	171	4	caramês	caramês	PROPN
mkg-41075	171	5	j	j	PROPN
mkg-41075	171	6	,	,	PUNCT
mkg-41075	171	7	francisco	francisco	PROPN
mkg-41075	171	8	h	h	PROPN
mkg-41075	171	9	,	,	PUNCT
mkg-41075	171	10	chen	chen	PROPN
mkg-41075	171	11	a	a	PRON
mkg-41075	171	12	,	,	PUNCT
mkg-41075	171	13	azul	azul	ADJ
mkg-41075	171	14	am	am	NOUN
mkg-41075	171	15	,	,	PUNCT
mkg-41075	171	16	marques	marques	PROPN
mkg-41075	171	17	d.	d.	PROPN
mkg-41075	171	18	malignant	malignant	ADJ
mkg-41075	171	19	transformation	transformation	NOUN
mkg-41075	171	20	rate	rate	NOUN
mkg-41075	171	21	of	of	ADP
mkg-41075	171	22	oral	oral	ADJ
mkg-41075	171	23	leukoplakia	leukoplakia	NOUN
mkg-41075	171	24	—	—	PUNCT
mkg-41075	171	25	systematic	systematic	ADJ
mkg-41075	171	26	review	review	NOUN
mkg-41075	171	27	.	.	PUNCT
mkg-41075	172	1	oral	oral	ADJ
mkg-41075	172	2	surg	surg	NOUN
mkg-41075	172	3	oral	oral	ADJ
mkg-41075	172	4	med	med	ADJ
mkg-41075	172	5	oral	oral	ADJ
mkg-41075	172	6	pathol	pathol	NOUN
mkg-41075	172	7	oral	oral	ADJ
mkg-41075	172	8	radiol	radiol	NOUN
mkg-41075	172	9	.	.	PUNCT
mkg-41075	173	1	2020	2020	NUM
mkg-41075	173	2	;	;	PUNCT
mkg-41075	173	3	129(6	129(6	NUM
mkg-41075	173	4	):	):	PUNCT
mkg-41075	173	5	600	600	NUM
mkg-41075	173	6	-	-	NUM
mkg-41075	173	7	611.e2	611.e2	NUM
mkg-41075	173	8	.	.	PUNCT
mkg-41075	174	1	13	13	NUM
mkg-41075	174	2	.	.	PUNCT
mkg-41075	175	1	brignardello	brignardello	PROPN
mkg-41075	175	2	-	-	PUNCT
mkg-41075	175	3	petersen	petersen	PROPN
mkg-41075	175	4	r.	r.	PROPN
mkg-41075	175	5	proliferative	proliferative	PROPN
mkg-41075	175	6	verrucous	verrucous	ADJ
mkg-41075	175	7	leukoplakia	leukoplakia	NOUN
mkg-41075	175	8	and	and	CCONJ
mkg-41075	175	9	erythroplakia	erythroplakia	NOUN
mkg-41075	175	10	are	be	AUX
mkg-41075	175	11	probably	probably	ADV
mkg-41075	175	12	the	the	DET
mkg-41075	175	13	disorders	disorder	NOUN
mkg-41075	175	14	with	with	ADP
mkg-41075	175	15	the	the	DET
mkg-41075	175	16	highest	high	ADJ
mkg-41075	175	17	rate	rate	NOUN
mkg-41075	175	18	of	of	ADP
mkg-41075	175	19	malignant	malignant	ADJ
mkg-41075	175	20	transformation	transformation	NOUN
mkg-41075	175	21	.	.	PUNCT
mkg-41075	176	1	j	j	PROPN
mkg-41075	176	2	am	be	AUX
mkg-41075	176	3	dent	dent	ADJ
mkg-41075	176	4	assoc	assoc	NOUN
mkg-41075	176	5	.	.	PUNCT
mkg-41075	177	1	2020	2020	NUM
mkg-41075	177	2	;	;	PUNCT
mkg-41075	177	3	151(8	151(8	NUM
mkg-41075	177	4	):	):	PUNCT
mkg-41075	177	5	e62	e62	NOUN
mkg-41075	177	6	.	.	PUNCT
mkg-41075	178	1	figure	figure	NOUN
mkg-41075	178	2	5	5	NUM
mkg-41075	178	3	.	.	NOUN
mkg-41075	178	4	carcinogenesis	carcinogenesis	NOUN
mkg-41075	178	5	model	model	NOUN
mkg-41075	178	6	and	and	CCONJ
mkg-41075	178	7	clinical	clinical	ADJ
mkg-41075	178	8	need	need	NOUN
mkg-41075	178	9	for	for	ADP
mkg-41075	178	10	diagnostic	diagnostic	ADJ
mkg-41075	178	11	biomarkers	biomarker	NOUN
mkg-41075	178	12	.	.	PUNCT
mkg-41075	179	1	copyright	copyright	NOUN
mkg-41075	179	2	©	©	ADP
mkg-41075	179	3	2023	2023	NUM
mkg-41075	179	4	dental	dental	ADJ
mkg-41075	179	5	journal	journal	NOUN
mkg-41075	179	6	(	(	PUNCT
mkg-41075	179	7	majalah	majalah	PROPN
mkg-41075	179	8	kedokteran	kedokteran	PROPN
mkg-41075	179	9	gigi	gigi	PROPN
mkg-41075	179	10	)	)	PUNCT
mkg-41075	180	1	p	p	X
mkg-41075	180	2	-	-	PUNCT
mkg-41075	180	3	issn	issn	NOUN
mkg-41075	180	4	:	:	PUNCT
mkg-41075	180	5	1978	1978	NUM
mkg-41075	180	6	-	-	SYM
mkg-41075	180	7	3728	3728	NUM
mkg-41075	180	8	;	;	PUNCT
mkg-41075	180	9	e	e	X
mkg-41075	180	10	-	-	PUNCT
mkg-41075	180	11	issn	issn	ADJ
mkg-41075	180	12	:	:	PUNCT
mkg-41075	180	13	2442	2442	NUM
mkg-41075	180	14	-	-	SYM
mkg-41075	180	15	9740	9740	NUM
mkg-41075	180	16	.	.	PUNCT
mkg-41075	181	1	accredited	accredit	VERB
mkg-41075	181	2	no	no	INTJ
mkg-41075	181	3	.	.	PROPN
mkg-41075	182	1	158	158	NUM
mkg-41075	182	2	/	/	SYM
mkg-41075	182	3	e	e	NOUN
mkg-41075	182	4	/	/	SYM
mkg-41075	182	5	kpt/2021	kpt/2021	NOUN
mkg-41075	182	6	.	.	PUNCT
mkg-41075	183	1	open	open	ADJ
mkg-41075	183	2	access	access	NOUN
mkg-41075	183	3	under	under	ADP
mkg-41075	183	4	cc	cc	NOUN
mkg-41075	183	5	-	-	PUNCT
mkg-41075	183	6	by	by	ADP
mkg-41075	183	7	-	-	PUNCT
mkg-41075	183	8	sa	sa	NOUN
mkg-41075	183	9	license	license	NOUN
mkg-41075	183	10	.	.	PUNCT
mkg-41075	184	1	available	available	ADJ
mkg-41075	184	2	at	at	ADP
mkg-41075	184	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-41075	184	4	doi	doi	NOUN
mkg-41075	184	5	:	:	PUNCT
mkg-41075	184	6	10.20473	10.20473	NUM
mkg-41075	184	7	/	/	SYM
mkg-41075	184	8	j.djmkg.v56.i3.p189–196	j.djmkg.v56.i3.p189–196	PROPN
mkg-41075	184	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	PROPN
mkg-41075	184	10	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	PROPN
mkg-41075	185	1	195puspasari	195puspasari	PROPN
mkg-41075	185	2	et	et	PROPN
mkg-41075	185	3	al	al	PROPN
mkg-41075	185	4	.	.	PROPN
mkg-41075	185	5	dent	dent	PROPN
mkg-41075	185	6	.	.	PUNCT
mkg-41075	186	1	j.	j.	PROPN
mkg-41075	186	2	(	(	PUNCT
mkg-41075	186	3	majalah	majalah	PROPN
mkg-41075	186	4	kedokteran	kedokteran	PROPN
mkg-41075	186	5	gigi	gigi	PROPN
mkg-41075	186	6	)	)	PUNCT
mkg-41075	186	7	2023	2023	NUM
mkg-41075	186	8	september	september	PROPN
mkg-41075	186	9	;	;	PUNCT
mkg-41075	186	10	56(3	56(3	NUM
mkg-41075	186	11	):	):	PUNCT
mkg-41075	186	12	189–196	189–196	NUM
mkg-41075	186	13	14	14	NUM
mkg-41075	186	14	.	.	PUNCT
mkg-41075	187	1	aghbari	aghbari	PROPN
mkg-41075	187	2	smh	smh	PROPN
mkg-41075	187	3	,	,	PUNCT
mkg-41075	187	4	abushouk	abushouk	PROPN
mkg-41075	187	5	ai	ai	PROPN
mkg-41075	187	6	,	,	PUNCT
mkg-41075	187	7	attia	attia	PROPN
mkg-41075	187	8	a	a	PROPN
mkg-41075	187	9	,	,	PUNCT
mkg-41075	187	10	elmaraezy	elmaraezy	NOUN
mkg-41075	187	11	a	a	PRON
mkg-41075	187	12	,	,	PUNCT
mkg-41075	187	13	menshawy	menshawy	PROPN
mkg-41075	187	14	a	a	PRON
mkg-41075	187	15	,	,	PUNCT
mkg-41075	187	16	ahmed	ahmed	PROPN
mkg-41075	187	17	ms	ms	PROPN
mkg-41075	187	18	,	,	PUNCT
mkg-41075	187	19	elsaadany	elsaadany	PROPN
mkg-41075	187	20	ba	ba	PROPN
mkg-41075	187	21	,	,	PUNCT
mkg-41075	187	22	ahmed	ahme	VERB
mkg-41075	187	23	em	em	PRON
mkg-41075	187	24	.	.	PUNCT
mkg-41075	188	1	malignant	malignant	ADJ
mkg-41075	188	2	transformation	transformation	NOUN
mkg-41075	188	3	of	of	ADP
mkg-41075	188	4	oral	oral	ADJ
mkg-41075	188	5	lichen	lichen	NOUN
mkg-41075	188	6	planus	planus	NOUN
mkg-41075	188	7	and	and	CCONJ
mkg-41075	188	8	oral	oral	ADJ
mkg-41075	188	9	lichenoid	lichenoid	PROPN
mkg-41075	188	10	lesions	lesion	NOUN
mkg-41075	188	11	:	:	PUNCT
mkg-41075	188	12	a	a	DET
mkg-41075	188	13	meta	meta	ADJ
mkg-41075	188	14	-	-	PUNCT
mkg-41075	188	15	analysis	analysis	NOUN
mkg-41075	188	16	of	of	ADP
mkg-41075	188	17	20095	20095	NUM
mkg-41075	188	18	patient	patient	ADJ
mkg-41075	188	19	data	datum	NOUN
mkg-41075	188	20	.	.	PUNCT
mkg-41075	189	1	oral	oral	ADJ
mkg-41075	189	2	oncol	oncol	ADJ
mkg-41075	189	3	.	.	PUNCT
mkg-41075	190	1	2017	2017	NUM
mkg-41075	190	2	;	;	PUNCT
mkg-41075	190	3	68	68	NUM
mkg-41075	190	4	:	:	PUNCT
mkg-41075	190	5	92–102	92–102	NUM
mkg-41075	190	6	.	.	NOUN
mkg-41075	190	7	15	15	NUM
mkg-41075	190	8	.	.	PUNCT
mkg-41075	190	9	gonzález‐moles	gonzález‐moles	PROPN
mkg-41075	190	10	má	má	PROPN
mkg-41075	190	11	,	,	PUNCT
mkg-41075	190	12	ramos‐garcía	ramos‐garcía	NOUN
mkg-41075	190	13	p	p	X
mkg-41075	190	14	,	,	PUNCT
mkg-41075	190	15	warnakulasuriya	warnakulasuriya	PROPN
mkg-41075	190	16	s.	s.	PROPN
mkg-41075	190	17	an	an	DET
mkg-41075	190	18	appraisal	appraisal	NOUN
mkg-41075	190	19	of	of	ADP
mkg-41075	190	20	highest	high	ADJ
mkg-41075	190	21	quality	quality	NOUN
mkg-41075	190	22	studies	study	NOUN
mkg-41075	190	23	reporting	report	VERB
mkg-41075	190	24	malignant	malignant	ADJ
mkg-41075	190	25	transformation	transformation	NOUN
mkg-41075	190	26	of	of	ADP
mkg-41075	190	27	oral	oral	ADJ
mkg-41075	190	28	lichen	lichen	NOUN
mkg-41075	190	29	planus	planus	NOUN
mkg-41075	190	30	based	base	VERB
mkg-41075	190	31	on	on	ADP
mkg-41075	190	32	a	a	DET
mkg-41075	190	33	systematic	systematic	ADJ
mkg-41075	190	34	review	review	NOUN
mkg-41075	190	35	.	.	PUNCT
mkg-41075	191	1	oral	oral	ADJ
mkg-41075	191	2	dis	dis	PROPN
mkg-41075	191	3	.	.	PUNCT
mkg-41075	191	4	2021	2021	NUM
mkg-41075	191	5	;	;	PUNCT
mkg-41075	191	6	27(8	27(8	NUM
mkg-41075	191	7	):	):	PUNCT
mkg-41075	191	8	1908–18	1908–18	NUM
mkg-41075	191	9	.	.	PUNCT
mkg-41075	192	1	16	16	NUM
mkg-41075	192	2	.	.	PUNCT
mkg-41075	193	1	offen	offen	PROPN
mkg-41075	193	2	e	e	PROPN
mkg-41075	193	3	,	,	PUNCT
mkg-41075	193	4	allison	allison	PROPN
mkg-41075	193	5	jr	jr	PROPN
mkg-41075	193	6	.	.	PUNCT
mkg-41075	194	1	what	what	PRON
mkg-41075	194	2	is	be	AUX
mkg-41075	194	3	the	the	DET
mkg-41075	194	4	malignant	malignant	ADJ
mkg-41075	194	5	transformation	transformation	NOUN
mkg-41075	194	6	potential	potential	NOUN
mkg-41075	194	7	of	of	ADP
mkg-41075	194	8	oral	oral	ADJ
mkg-41075	194	9	lichen	lichen	NOUN
mkg-41075	194	10	planus	planus	NOUN
mkg-41075	194	11	?	?	PUNCT
mkg-41075	195	1	evid	evid	PROPN
mkg-41075	195	2	based	base	VERB
mkg-41075	195	3	dent	dent	NOUN
mkg-41075	195	4	.	.	PUNCT
mkg-41075	196	1	2022	2022	NUM
mkg-41075	196	2	;	;	PUNCT
mkg-41075	196	3	23(1	23(1	NUM
mkg-41075	196	4	):	):	PUNCT
mkg-41075	197	1	36–7	36–7	PROPN
mkg-41075	197	2	.	.	PROPN
mkg-41075	197	3	17	17	NUM
mkg-41075	197	4	.	.	PUNCT
mkg-41075	198	1	sathiasekar	sathiasekar	PROPN
mkg-41075	198	2	a	a	PROPN
mkg-41075	198	3	,	,	PUNCT
mkg-41075	198	4	mathew	mathew	PROPN
mkg-41075	198	5	d	d	PROPN
mkg-41075	198	6	,	,	PUNCT
mkg-41075	198	7	jaish	jaish	PROPN
mkg-41075	198	8	lal	lal	PROPN
mkg-41075	198	9	m	m	PROPN
mkg-41075	198	10	,	,	PUNCT
mkg-41075	198	11	arul	arul	PROPN
mkg-41075	198	12	prakash	prakash	PROPN
mkg-41075	198	13	a	a	PROPN
mkg-41075	198	14	,	,	PUNCT
mkg-41075	198	15	goma	goma	PROPN
mkg-41075	198	16	kumar	kumar	PROPN
mkg-41075	198	17	k.	k.	PROPN
mkg-41075	198	18	oral	oral	PROPN
mkg-41075	198	19	field	field	NOUN
mkg-41075	198	20	cancerization	cancerization	NOUN
mkg-41075	198	21	and	and	CCONJ
mkg-41075	198	22	its	its	PRON
mkg-41075	198	23	clinical	clinical	ADJ
mkg-41075	198	24	implications	implication	NOUN
mkg-41075	198	25	in	in	ADP
mkg-41075	198	26	the	the	DET
mkg-41075	198	27	management	management	NOUN
mkg-41075	198	28	in	in	ADP
mkg-41075	198	29	potentially	potentially	ADV
mkg-41075	198	30	malignant	malignant	ADJ
mkg-41075	198	31	disorders	disorder	NOUN
mkg-41075	198	32	.	.	PUNCT
mkg-41075	199	1	j	j	PROPN
mkg-41075	199	2	pharm	pharm	PROPN
mkg-41075	199	3	bioallied	bioallie	VERB
mkg-41075	199	4	sci	sci	PROPN
mkg-41075	199	5	.	.	PROPN
mkg-41075	199	6	2017	2017	NUM
mkg-41075	199	7	;	;	PUNCT
mkg-41075	199	8	9(5	9(5	NUM
mkg-41075	199	9	):	):	PUNCT
mkg-41075	199	10	23	23	NUM
mkg-41075	199	11	.	.	X
mkg-41075	200	1	18	18	NUM
mkg-41075	200	2	.	.	PUNCT
mkg-41075	201	1	mohan	mohan	PROPN
mkg-41075	201	2	m	m	PROPN
mkg-41075	201	3	,	,	PUNCT
mkg-41075	201	4	jagannathan	jagannathan	PROPN
mkg-41075	201	5	n.	n.	PROPN
mkg-41075	201	6	oral	oral	ADJ
mkg-41075	201	7	field	field	NOUN
mkg-41075	201	8	cancerization	cancerization	NOUN
mkg-41075	201	9	:	:	PUNCT
mkg-41075	201	10	an	an	DET
mkg-41075	201	11	update	update	NOUN
mkg-41075	201	12	on	on	ADP
mkg-41075	201	13	current	current	ADJ
mkg-41075	201	14	concepts	concept	NOUN
mkg-41075	201	15	.	.	PUNCT
mkg-41075	202	1	oncol	oncol	PROPN
mkg-41075	202	2	rev	rev	PROPN
mkg-41075	202	3	.	.	PROPN
mkg-41075	202	4	2014	2014	NUM
mkg-41075	202	5	;	;	PUNCT
mkg-41075	202	6	8(1	8(1	NOUN
mkg-41075	202	7	):	):	PUNCT
mkg-41075	202	8	244	244	NUM
mkg-41075	202	9	.	.	PUNCT
mkg-41075	203	1	19	19	NUM
mkg-41075	203	2	.	.	PUNCT
mkg-41075	203	3	angadi	angadi	NOUN
mkg-41075	203	4	p	p	PROPN
mkg-41075	203	5	v.	v.	PROPN
mkg-41075	203	6	,	,	PUNCT
mkg-41075	203	7	savitha	savitha	PROPN
mkg-41075	203	8	jk	jk	PROPN
mkg-41075	203	9	,	,	PUNCT
mkg-41075	203	10	rao	rao	PROPN
mkg-41075	203	11	ss	ss	PROPN
mkg-41075	203	12	,	,	PUNCT
mkg-41075	203	13	sivaranjini	sivaranjini	PROPN
mkg-41075	203	14	y.	y.	PROPN
mkg-41075	203	15	oral	oral	ADJ
mkg-41075	203	16	field	field	NOUN
mkg-41075	203	17	cancerization	cancerization	NOUN
mkg-41075	203	18	:	:	PUNCT
mkg-41075	203	19	current	current	ADJ
mkg-41075	203	20	evidence	evidence	NOUN
mkg-41075	203	21	and	and	CCONJ
mkg-41075	203	22	future	future	ADJ
mkg-41075	203	23	perspectives	perspective	NOUN
mkg-41075	203	24	.	.	PUNCT
mkg-41075	204	1	oral	oral	ADJ
mkg-41075	204	2	maxillofac	maxillofac	NOUN
mkg-41075	204	3	surg	surg	NOUN
mkg-41075	204	4	.	.	PUNCT
mkg-41075	205	1	2012	2012	NUM
mkg-41075	205	2	;	;	PUNCT
mkg-41075	205	3	16(2	16(2	NUM
mkg-41075	205	4	):	):	PUNCT
mkg-41075	205	5	171–80	171–80	NUM
mkg-41075	205	6	.	.	X
mkg-41075	206	1	20	20	NUM
mkg-41075	206	2	.	.	PUNCT
mkg-41075	207	1	ha	ha	INTJ
mkg-41075	207	2	pk	pk	PROPN
mkg-41075	207	3	,	,	PUNCT
mkg-41075	207	4	califano	califano	PROPN
mkg-41075	207	5	ja	ja	PROPN
mkg-41075	207	6	.	.	PUNCT
mkg-41075	208	1	the	the	DET
mkg-41075	208	2	molecular	molecular	ADJ
mkg-41075	208	3	biology	biology	NOUN
mkg-41075	208	4	of	of	ADP
mkg-41075	208	5	mucosal	mucosal	ADJ
mkg-41075	208	6	field	field	NOUN
mkg-41075	208	7	cancerization	cancerization	NOUN
mkg-41075	208	8	of	of	ADP
mkg-41075	208	9	the	the	DET
mkg-41075	208	10	head	head	NOUN
mkg-41075	208	11	and	and	CCONJ
mkg-41075	208	12	neck	neck	NOUN
mkg-41075	208	13	.	.	PUNCT
mkg-41075	209	1	crit	crit	PROPN
mkg-41075	209	2	rev	rev	PROPN
mkg-41075	209	3	oral	oral	PROPN
mkg-41075	209	4	biol	biol	PROPN
mkg-41075	209	5	med	me	VERB
mkg-41075	209	6	.	.	PUNCT
mkg-41075	209	7	2003	2003	NUM
mkg-41075	209	8	;	;	PUNCT
mkg-41075	210	1	14(5	14(5	NUM
mkg-41075	210	2	):	):	PUNCT
mkg-41075	210	3	363–9	363–9	NUM
mkg-41075	210	4	.	.	PROPN
mkg-41075	211	1	21	21	NUM
mkg-41075	211	2	.	.	PUNCT
mkg-41075	212	1	curtius	curtius	PROPN
mkg-41075	212	2	k	k	PROPN
mkg-41075	212	3	,	,	PUNCT
mkg-41075	212	4	wright	wright	PROPN
mkg-41075	212	5	na	na	PROPN
mkg-41075	212	6	,	,	PUNCT
mkg-41075	212	7	graham	graham	PROPN
mkg-41075	212	8	ta	ta	PROPN
mkg-41075	212	9	.	.	PUNCT
mkg-41075	213	1	an	an	DET
mkg-41075	213	2	evolutionary	evolutionary	ADJ
mkg-41075	213	3	perspective	perspective	NOUN
mkg-41075	213	4	on	on	ADP
mkg-41075	213	5	field	field	NOUN
mkg-41075	213	6	cancerization	cancerization	NOUN
mkg-41075	213	7	.	.	PUNCT
mkg-41075	214	1	nat	nat	PROPN
mkg-41075	214	2	rev	rev	PROPN
mkg-41075	214	3	cancer	cancer	NOUN
mkg-41075	214	4	.	.	PUNCT
mkg-41075	215	1	2018	2018	NUM
mkg-41075	215	2	;	;	PUNCT
mkg-41075	215	3	18(1	18(1	NUM
mkg-41075	215	4	):	):	PUNCT
mkg-41075	215	5	19–32	19–32	NUM
mkg-41075	215	6	.	.	PUNCT
mkg-41075	216	1	22	22	NUM
mkg-41075	216	2	.	.	PUNCT
mkg-41075	217	1	simple	simple	ADJ
mkg-41075	217	2	m	m	PROPN
mkg-41075	217	3	,	,	PUNCT
mkg-41075	217	4	suresh	suresh	PROPN
mkg-41075	217	5	a	a	PROPN
mkg-41075	217	6	,	,	PUNCT
mkg-41075	217	7	das	das	PROPN
mkg-41075	217	8	d	d	PROPN
mkg-41075	217	9	,	,	PUNCT
mkg-41075	217	10	kuriakose	kuriakose	PROPN
mkg-41075	217	11	ma	ma	PROPN
mkg-41075	217	12	.	.	PROPN
mkg-41075	217	13	cancer	cancer	NOUN
mkg-41075	217	14	stem	stem	NOUN
mkg-41075	217	15	cells	cell	NOUN
mkg-41075	217	16	and	and	CCONJ
mkg-41075	217	17	field	field	NOUN
mkg-41075	217	18	cancerization	cancerization	NOUN
mkg-41075	217	19	of	of	ADP
mkg-41075	217	20	oral	oral	ADJ
mkg-41075	217	21	squamous	squamous	ADJ
mkg-41075	217	22	cell	cell	NOUN
mkg-41075	217	23	carcinoma	carcinoma	NOUN
mkg-41075	217	24	.	.	PUNCT
mkg-41075	218	1	oral	oral	ADJ
mkg-41075	218	2	oncol	oncol	ADJ
mkg-41075	218	3	.	.	PUNCT
mkg-41075	219	1	2015	2015	NUM
mkg-41075	219	2	;	;	PUNCT
mkg-41075	219	3	51(7	51(7	NUM
mkg-41075	219	4	):	):	PUNCT
mkg-41075	219	5	643–51	643–51	NOUN
mkg-41075	219	6	.	.	PUNCT
mkg-41075	220	1	23	23	NUM
mkg-41075	220	2	.	.	PUNCT
mkg-41075	220	3	braakhuis	braakhuis	PROPN
mkg-41075	220	4	bjm	bjm	PROPN
mkg-41075	220	5	,	,	PUNCT
mkg-41075	220	6	tabor	tabor	PROPN
mkg-41075	220	7	mp	mp	PROPN
mkg-41075	220	8	,	,	PUNCT
mkg-41075	220	9	rené	rené	PROPN
mkg-41075	220	10	leemans	leemans	PROPN
mkg-41075	220	11	c	c	PROPN
mkg-41075	220	12	,	,	PUNCT
mkg-41075	220	13	van	van	PROPN
mkg-41075	220	14	der	der	PROPN
mkg-41075	220	15	waal	waal	PROPN
mkg-41075	220	16	i	i	PROPN
mkg-41075	220	17	,	,	PUNCT
mkg-41075	220	18	snow	snow	PROPN
mkg-41075	220	19	gb	gb	PROPN
mkg-41075	220	20	,	,	PUNCT
mkg-41075	220	21	brakenhoff	brakenhoff	PROPN
mkg-41075	220	22	rh	rh	PROPN
mkg-41075	220	23	.	.	PROPN
mkg-41075	220	24	second	second	ADJ
mkg-41075	220	25	primary	primary	ADJ
mkg-41075	220	26	tumors	tumor	NOUN
mkg-41075	220	27	and	and	CCONJ
mkg-41075	220	28	field	field	NOUN
mkg-41075	220	29	cancerization	cancerization	NOUN
mkg-41075	220	30	in	in	ADP
mkg-41075	220	31	oral	oral	ADJ
mkg-41075	220	32	and	and	CCONJ
mkg-41075	220	33	oropharyngeal	oropharyngeal	ADJ
mkg-41075	220	34	cancer	cancer	NOUN
mkg-41075	220	35	:	:	PUNCT
mkg-41075	220	36	molecular	molecular	ADJ
mkg-41075	220	37	techniques	technique	NOUN
mkg-41075	220	38	provide	provide	VERB
mkg-41075	220	39	new	new	ADJ
mkg-41075	220	40	insights	insight	NOUN
mkg-41075	220	41	and	and	CCONJ
mkg-41075	220	42	definitions	definition	NOUN
mkg-41075	220	43	.	.	PUNCT
mkg-41075	221	1	head	head	NOUN
mkg-41075	221	2	neck	neck	NOUN
mkg-41075	221	3	.	.	PUNCT
mkg-41075	222	1	2002	2002	NUM
mkg-41075	222	2	;	;	PUNCT
mkg-41075	223	1	24(2	24(2	NUM
mkg-41075	223	2	):	):	PUNCT
mkg-41075	223	3	198–206	198–206	NUM
mkg-41075	223	4	.	.	PUNCT
mkg-41075	224	1	24	24	NUM
mkg-41075	224	2	.	.	PUNCT
mkg-41075	225	1	escher	escher	PROPN
mkg-41075	225	2	a	a	PROPN
mkg-41075	225	3	,	,	PUNCT
mkg-41075	225	4	piotet	piotet	NOUN
mkg-41075	225	5	e	e	NOUN
mkg-41075	225	6	,	,	PUNCT
mkg-41075	225	7	waridel	waridel	PROPN
mkg-41075	225	8	f	f	PROPN
mkg-41075	225	9	,	,	PUNCT
mkg-41075	225	10	iggo	iggo	ADJ
mkg-41075	225	11	r	r	NOUN
mkg-41075	225	12	,	,	PUNCT
mkg-41075	225	13	monnier	monnier	NOUN
mkg-41075	225	14	p.	p.	NOUN
mkg-41075	225	15	p53	p53	NOUN
mkg-41075	225	16	mutation	mutation	NOUN
mkg-41075	225	17	in	in	ADP
mkg-41075	225	18	histologically	histologically	ADV
mkg-41075	225	19	normal	normal	ADJ
mkg-41075	225	20	mucosa	mucosa	NOUN
mkg-41075	225	21	of	of	ADP
mkg-41075	225	22	the	the	DET
mkg-41075	225	23	aero	aero	ADJ
mkg-41075	225	24	-	-	PUNCT
mkg-41075	225	25	digestive	digestive	ADJ
mkg-41075	225	26	tract	tract	NOUN
mkg-41075	225	27	is	be	AUX
mkg-41075	225	28	not	not	PART
mkg-41075	225	29	a	a	DET
mkg-41075	225	30	marker	marker	NOUN
mkg-41075	225	31	of	of	ADP
mkg-41075	225	32	increased	increase	VERB
mkg-41075	225	33	risk	risk	NOUN
mkg-41075	225	34	for	for	ADP
mkg-41075	225	35	second	second	ADJ
mkg-41075	225	36	primary	primary	ADJ
mkg-41075	225	37	carcinoma	carcinoma	NOUN
mkg-41075	225	38	in	in	ADP
mkg-41075	225	39	head	head	NOUN
mkg-41075	225	40	and	and	CCONJ
mkg-41075	225	41	neck	neck	NOUN
mkg-41075	225	42	cancer	cancer	NOUN
mkg-41075	225	43	patients	patient	NOUN
mkg-41075	225	44	.	.	PUNCT
mkg-41075	226	1	eur	eur	PROPN
mkg-41075	226	2	arch	arch	PROPN
mkg-41075	226	3	oto	oto	PROPN
mkg-41075	226	4	-	-	PUNCT
mkg-41075	226	5	rhino	rhino	NOUN
mkg-41075	226	6	-	-	NOUN
mkg-41075	226	7	laryngology	laryngology	NOUN
mkg-41075	226	8	.	.	PUNCT
mkg-41075	226	9	2009	2009	NUM
mkg-41075	226	10	;	;	PUNCT
mkg-41075	226	11	266(4	266(4	NUM
mkg-41075	226	12	):	):	PUNCT
mkg-41075	226	13	547–51	547–51	NUM
mkg-41075	226	14	.	.	PUNCT
mkg-41075	227	1	25	25	NUM
mkg-41075	227	2	.	.	PUNCT
mkg-41075	227	3	gabusi	gabusi	PROPN
mkg-41075	227	4	a	a	PRON
mkg-41075	227	5	,	,	PUNCT
mkg-41075	227	6	gissi	gissi	PROPN
mkg-41075	227	7	db	db	PROPN
mkg-41075	227	8	,	,	PUNCT
mkg-41075	227	9	montebugnoli	montebugnoli	PROPN
mkg-41075	227	10	l	l	PROPN
mkg-41075	227	11	,	,	PUNCT
mkg-41075	227	12	asioli	asioli	PROPN
mkg-41075	227	13	s	s	PROPN
mkg-41075	227	14	,	,	PUNCT
mkg-41075	227	15	tarsitano	tarsitano	PROPN
mkg-41075	227	16	a	a	X
mkg-41075	227	17	,	,	PUNCT
mkg-41075	227	18	marchetti	marchetti	PROPN
mkg-41075	227	19	c	c	PROPN
mkg-41075	227	20	,	,	PUNCT
mkg-41075	227	21	balbi	balbi	PROPN
mkg-41075	227	22	t	t	PROPN
mkg-41075	227	23	,	,	PUNCT
mkg-41075	227	24	helliwell	helliwell	NOUN
mkg-41075	227	25	tr	tr	VERB
mkg-41075	227	26	,	,	PUNCT
mkg-41075	227	27	foschini	foschini	PROPN
mkg-41075	227	28	mp	mp	PROPN
mkg-41075	227	29	,	,	PUNCT
mkg-41075	227	30	morandi	morandi	PROPN
mkg-41075	227	31	l.	l.	PROPN
mkg-41075	227	32	prognostic	prognostic	PROPN
mkg-41075	227	33	impact	impact	NOUN
mkg-41075	227	34	of	of	ADP
mkg-41075	227	35	intra	intra	ADJ
mkg-41075	227	36	-	-	ADJ
mkg-41075	227	37	field	field	ADJ
mkg-41075	227	38	heterogeneity	heterogeneity	NOUN
mkg-41075	227	39	in	in	ADP
mkg-41075	227	40	oral	oral	ADJ
mkg-41075	227	41	squamous	squamous	ADJ
mkg-41075	227	42	cell	cell	NOUN
mkg-41075	227	43	carcinoma	carcinoma	NOUN
mkg-41075	227	44	.	.	PUNCT
mkg-41075	228	1	virchows	virchow	NOUN
mkg-41075	228	2	arch	arch	VERB
mkg-41075	228	3	.	.	PUNCT
mkg-41075	229	1	2020	2020	NUM
mkg-41075	229	2	;	;	PUNCT
mkg-41075	229	3	476(4	476(4	NUM
mkg-41075	229	4	):	):	PUNCT
mkg-41075	229	5	585–95	585–95	NUM
mkg-41075	229	6	.	.	PUNCT
mkg-41075	230	1	26	26	NUM
mkg-41075	230	2	.	.	PUNCT
mkg-41075	231	1	bednarczyk	bednarczyk	PROPN
mkg-41075	231	2	k	k	PROPN
mkg-41075	231	3	,	,	PUNCT
mkg-41075	231	4	gawin	gawin	PROPN
mkg-41075	231	5	m	m	PROPN
mkg-41075	231	6	,	,	PUNCT
mkg-41075	231	7	chekan	chekan	PROPN
mkg-41075	231	8	m	m	PROPN
mkg-41075	231	9	,	,	PUNCT
mkg-41075	231	10	kurczyk	kurczyk	VERB
mkg-41075	231	11	a	a	DET
mkg-41075	231	12	,	,	PUNCT
mkg-41075	231	13	mrukwa	mrukwa	NOUN
mkg-41075	231	14	g	g	NOUN
mkg-41075	231	15	,	,	PUNCT
mkg-41075	231	16	pietrowska	pietrowska	PROPN
mkg-41075	231	17	m	m	PROPN
mkg-41075	231	18	,	,	PUNCT
mkg-41075	231	19	polanska	polanska	PROPN
mkg-41075	231	20	j	j	PROPN
mkg-41075	231	21	,	,	PUNCT
mkg-41075	231	22	widlak	widlak	NOUN
mkg-41075	231	23	p.	p.	NOUN
mkg-41075	231	24	discrimination	discrimination	NOUN
mkg-41075	231	25	of	of	ADP
mkg-41075	231	26	normal	normal	ADJ
mkg-41075	231	27	oral	oral	ADJ
mkg-41075	231	28	mucosa	mucosa	NOUN
mkg-41075	231	29	from	from	ADP
mkg-41075	231	30	oral	oral	ADJ
mkg-41075	231	31	cancer	cancer	NOUN
mkg-41075	231	32	by	by	ADP
mkg-41075	231	33	mass	mass	ADJ
mkg-41075	231	34	spectrometry	spectrometry	NOUN
mkg-41075	231	35	imaging	imaging	NOUN
mkg-41075	231	36	of	of	ADP
mkg-41075	231	37	proteins	protein	NOUN
mkg-41075	231	38	and	and	CCONJ
mkg-41075	231	39	lipids	lipid	NOUN
mkg-41075	231	40	.	.	PUNCT
mkg-41075	232	1	j	j	PROPN
mkg-41075	232	2	mol	mol	PROPN
mkg-41075	232	3	histol	histol	NOUN
mkg-41075	232	4	.	.	PUNCT
mkg-41075	233	1	2019	2019	NUM
mkg-41075	233	2	;	;	PUNCT
mkg-41075	233	3	50(1	50(1	NUM
mkg-41075	233	4	):	):	PUNCT
mkg-41075	233	5	1–10	1–10	NOUN
mkg-41075	233	6	.	.	PUNCT
mkg-41075	234	1	27	27	NUM
mkg-41075	234	2	.	.	PUNCT
mkg-41075	235	1	angadi	angadi	NOUN
mkg-41075	235	2	p	p	PROPN
mkg-41075	235	3	v.	v.	PROPN
mkg-41075	235	4	,	,	PUNCT
mkg-41075	235	5	patil	patil	PROPN
mkg-41075	235	6	p	p	PROPN
mkg-41075	235	7	v.	v.	PROPN
mkg-41075	235	8	,	,	PUNCT
mkg-41075	235	9	kale	kale	NOUN
mkg-41075	235	10	ad	ad	NOUN
mkg-41075	235	11	,	,	PUNCT
mkg-41075	235	12	hallikerimath	hallikerimath	PROPN
mkg-41075	235	13	s	s	PROPN
mkg-41075	235	14	,	,	PUNCT
mkg-41075	235	15	babji	babji	PROPN
mkg-41075	235	16	d.	d.	PROPN
mkg-41075	235	17	myofibroblast	myofibroblast	PROPN
mkg-41075	235	18	presence	presence	NOUN
mkg-41075	235	19	in	in	ADP
mkg-41075	235	20	apparently	apparently	ADV
mkg-41075	235	21	normal	normal	ADJ
mkg-41075	235	22	mucosa	mucosa	NOUN
mkg-41075	235	23	adjacent	adjacent	ADJ
mkg-41075	235	24	to	to	PART
mkg-41075	235	25	oral	oral	ADJ
mkg-41075	235	26	squamous	squamous	ADJ
mkg-41075	235	27	cell	cell	NOUN
mkg-41075	235	28	carcinoma	carcinoma	NOUN
mkg-41075	235	29	associated	associate	VERB
mkg-41075	235	30	with	with	ADP
mkg-41075	235	31	chronic	chronic	ADJ
mkg-41075	235	32	tobacco	tobacco	NOUN
mkg-41075	235	33	/	/	SYM
mkg-41075	235	34	areca	areca	NOUN
mkg-41075	235	35	nut	nut	NOUN
mkg-41075	235	36	use	use	NOUN
mkg-41075	235	37	:	:	PUNCT
mkg-41075	235	38	evidence	evidence	NOUN
mkg-41075	235	39	for	for	ADP
mkg-41075	235	40	field	field	NOUN
mkg-41075	235	41	cancerization	cancerization	NOUN
mkg-41075	235	42	.	.	PUNCT
mkg-41075	236	1	acta	acta	PROPN
mkg-41075	236	2	odontol	odontol	PROPN
mkg-41075	236	3	scand	scand	PROPN
mkg-41075	236	4	.	.	PUNCT
mkg-41075	236	5	2014	2014	NUM
mkg-41075	236	6	;	;	PUNCT
mkg-41075	237	1	72(7	72(7	NUM
mkg-41075	237	2	):	):	PUNCT
mkg-41075	237	3	502–8	502–8	NUM
mkg-41075	237	4	.	.	NOUN
mkg-41075	237	5	28	28	NUM
mkg-41075	237	6	.	.	PUNCT
mkg-41075	238	1	amer	amer	PROPN
mkg-41075	238	2	hw	hw	PROPN
mkg-41075	238	3	,	,	PUNCT
mkg-41075	238	4	waguih	waguih	VERB
mkg-41075	238	5	hm	hm	INTJ
mkg-41075	238	6	,	,	PUNCT
mkg-41075	238	7	el	el	PROPN
mkg-41075	238	8	-	-	PUNCT
mkg-41075	238	9	rouby	rouby	PROPN
mkg-41075	238	10	dh	dh	PROPN
mkg-41075	238	11	.	.	PUNCT
mkg-41075	239	1	development	development	NOUN
mkg-41075	239	2	of	of	ADP
mkg-41075	239	3	field	field	NOUN
mkg-41075	239	4	cancerization	cancerization	NOUN
mkg-41075	239	5	in	in	ADP
mkg-41075	239	6	the	the	DET
mkg-41075	239	7	clinically	clinically	ADV
mkg-41075	239	8	normal	normal	ADJ
mkg-41075	239	9	oral	oral	ADJ
mkg-41075	239	10	mucosa	mucosa	NOUN
mkg-41075	239	11	of	of	ADP
mkg-41075	239	12	shisha	shisha	PROPN
mkg-41075	239	13	smokers	smoker	NOUN
mkg-41075	239	14	.	.	PUNCT
mkg-41075	240	1	int	int	PROPN
mkg-41075	240	2	j	j	PROPN
mkg-41075	240	3	dent	dent	PROPN
mkg-41075	240	4	hyg	hyg	PROPN
mkg-41075	240	5	.	.	PROPN
mkg-41075	240	6	2019	2019	NUM
mkg-41075	240	7	;	;	PUNCT
mkg-41075	240	8	17(1	17(1	NUM
mkg-41075	240	9	):	):	PUNCT
mkg-41075	240	10	39–45	39–45	NUM
mkg-41075	240	11	.	.	NOUN
mkg-41075	240	12	29	29	NUM
mkg-41075	240	13	.	.	PUNCT
mkg-41075	241	1	giaretti	giaretti	PROPN
mkg-41075	241	2	w	w	PROPN
mkg-41075	241	3	,	,	PUNCT
mkg-41075	241	4	pentenero	pentenero	NOUN
mkg-41075	241	5	m	m	PROPN
mkg-41075	241	6	,	,	PUNCT
mkg-41075	241	7	gandolfo	gandolfo	PROPN
mkg-41075	241	8	s	s	PROPN
mkg-41075	241	9	,	,	PUNCT
mkg-41075	241	10	castagnola	castagnola	PROPN
mkg-41075	241	11	p.	p.	PROPN
mkg-41075	241	12	chromosomal	chromosomal	ADJ
mkg-41075	241	13	instability	instability	NOUN
mkg-41075	241	14	,	,	PUNCT
mkg-41075	241	15	aneuploidy	aneuploidy	ADJ
mkg-41075	241	16	and	and	CCONJ
mkg-41075	241	17	routine	routine	ADJ
mkg-41075	241	18	high	high	ADJ
mkg-41075	241	19	-	-	PUNCT
mkg-41075	241	20	resolution	resolution	NOUN
mkg-41075	241	21	dna	dna	NOUN
mkg-41075	241	22	content	content	NOUN
mkg-41075	241	23	analysis	analysis	NOUN
mkg-41075	241	24	in	in	ADP
mkg-41075	241	25	oral	oral	ADJ
mkg-41075	241	26	cancer	cancer	NOUN
mkg-41075	241	27	risk	risk	NOUN
mkg-41075	241	28	evaluation	evaluation	NOUN
mkg-41075	241	29	.	.	PUNCT
mkg-41075	242	1	futur	futur	PROPN
mkg-41075	242	2	oncol	oncol	PROPN
mkg-41075	242	3	.	.	PUNCT
mkg-41075	243	1	2012	2012	NUM
mkg-41075	243	2	;	;	PUNCT
mkg-41075	243	3	8(10	8(10	NUM
mkg-41075	243	4	):	):	PUNCT
mkg-41075	243	5	1257–71	1257–71	NOUN
mkg-41075	243	6	.	.	PUNCT
mkg-41075	244	1	30	30	NUM
mkg-41075	244	2	.	.	PUNCT
mkg-41075	245	1	pentenero	pentenero	PROPN
mkg-41075	245	2	m	m	PROPN
mkg-41075	245	3	,	,	PUNCT
mkg-41075	245	4	donadini	donadini	VERB
mkg-41075	245	5	a	a	DET
mkg-41075	245	6	,	,	PUNCT
mkg-41075	245	7	di	di	PROPN
mkg-41075	245	8	nallo	nallo	PROPN
mkg-41075	245	9	e	e	PROPN
mkg-41075	245	10	,	,	PUNCT
mkg-41075	245	11	maffei	maffei	PROPN
mkg-41075	245	12	m	m	PROPN
mkg-41075	245	13	,	,	PUNCT
mkg-41075	245	14	marino	marino	PROPN
mkg-41075	245	15	r	r	PROPN
mkg-41075	245	16	,	,	PUNCT
mkg-41075	245	17	familiari	familiari	PROPN
mkg-41075	245	18	u	u	PROPN
mkg-41075	245	19	,	,	PUNCT
mkg-41075	245	20	castagnola	castagnola	PROPN
mkg-41075	246	1	p	p	X
mkg-41075	246	2	,	,	PUNCT
mkg-41075	246	3	gandolfo	gandolfo	PROPN
mkg-41075	246	4	s	s	PROPN
mkg-41075	246	5	,	,	PUNCT
mkg-41075	246	6	giaretti	giaretti	PROPN
mkg-41075	246	7	w.	w.	PROPN
mkg-41075	246	8	field	field	PROPN
mkg-41075	246	9	effect	effect	NOUN
mkg-41075	246	10	in	in	ADP
mkg-41075	246	11	oral	oral	ADJ
mkg-41075	246	12	precancer	precancer	NOUN
mkg-41075	246	13	as	as	SCONJ
mkg-41075	246	14	assessed	assess	VERB
mkg-41075	246	15	by	by	ADP
mkg-41075	246	16	dna	dna	PROPN
mkg-41075	246	17	flow	flow	NOUN
mkg-41075	246	18	cytometry	cytometry	NOUN
mkg-41075	246	19	and	and	CCONJ
mkg-41075	246	20	array	array	NOUN
mkg-41075	246	21	-	-	PUNCT
mkg-41075	246	22	cgh	cgh	PROPN
mkg-41075	246	23	.	.	PUNCT
mkg-41075	247	1	j	j	PROPN
mkg-41075	247	2	oral	oral	ADJ
mkg-41075	247	3	pathol	pathol	NOUN
mkg-41075	247	4	med	me	VERB
mkg-41075	247	5	.	.	PUNCT
mkg-41075	247	6	2012	2012	NUM
mkg-41075	247	7	;	;	PUNCT
mkg-41075	247	8	41(2	41(2	NUM
mkg-41075	247	9	):	):	PUNCT
mkg-41075	247	10	119–23	119–23	PROPN
mkg-41075	247	11	.	.	PROPN
mkg-41075	248	1	31	31	NUM
mkg-41075	248	2	.	.	PUNCT
mkg-41075	249	1	peralta	peralta	PROPN
mkg-41075	249	2	-	-	PUNCT
mkg-41075	249	3	mamani	mamani	PROPN
mkg-41075	249	4	m	m	PROPN
mkg-41075	249	5	,	,	PUNCT
mkg-41075	249	6	terrero	terrero	NOUN
mkg-41075	249	7	-	-	PUNCT
mkg-41075	249	8	pérez	pérez	NOUN
mkg-41075	249	9	á	á	PROPN
mkg-41075	249	10	,	,	PUNCT
mkg-41075	249	11	tucunduva	tucunduva	PROPN
mkg-41075	249	12	rma	rma	PROPN
mkg-41075	249	13	,	,	PUNCT
mkg-41075	249	14	rubira	rubira	PROPN
mkg-41075	249	15	cmf	cmf	PROPN
mkg-41075	249	16	,	,	PUNCT
mkg-41075	249	17	santos	santos	PROPN
mkg-41075	249	18	ps	ps	PROPN
mkg-41075	249	19	da	da	PROPN
mkg-41075	249	20	s	s	PROPN
mkg-41075	249	21	,	,	PUNCT
mkg-41075	249	22	honório	honório	NOUN
mkg-41075	249	23	hm	hm	PROPN
mkg-41075	249	24	,	,	PUNCT
mkg-41075	249	25	rubira	rubira	PROPN
mkg-41075	249	26	-	-	PUNCT
mkg-41075	249	27	bullen	bullen	PROPN
mkg-41075	249	28	irf	irf	PROPN
mkg-41075	249	29	.	.	PROPN
mkg-41075	250	1	occurrence	occurrence	NOUN
mkg-41075	250	2	of	of	ADP
mkg-41075	250	3	field	field	NOUN
mkg-41075	250	4	cancerization	cancerization	NOUN
mkg-41075	250	5	in	in	ADP
mkg-41075	250	6	clinically	clinically	ADV
mkg-41075	250	7	normal	normal	ADJ
mkg-41075	250	8	oral	oral	ADJ
mkg-41075	250	9	mucosa	mucosa	NOUN
mkg-41075	250	10	:	:	PUNCT
mkg-41075	250	11	a	a	DET
mkg-41075	250	12	systematic	systematic	ADJ
mkg-41075	250	13	review	review	NOUN
mkg-41075	250	14	and	and	CCONJ
mkg-41075	250	15	meta	meta	ADJ
mkg-41075	250	16	-	-	PUNCT
mkg-41075	250	17	analysis	analysis	NOUN
mkg-41075	250	18	.	.	PUNCT
mkg-41075	251	1	arch	arch	ADJ
mkg-41075	251	2	oral	oral	ADJ
mkg-41075	251	3	biol	biol	NOUN
mkg-41075	251	4	.	.	PUNCT
mkg-41075	252	1	2022	2022	NUM
mkg-41075	252	2	;	;	PUNCT
mkg-41075	252	3	143	143	NUM
mkg-41075	252	4	:	:	SYM
mkg-41075	252	5	105544	105544	NUM
mkg-41075	252	6	.	.	PUNCT
mkg-41075	253	1	32	32	NUM
mkg-41075	253	2	.	.	PUNCT
mkg-41075	254	1	lópez	lópez	NOUN
mkg-41075	254	2	-	-	PUNCT
mkg-41075	254	3	blanc	blanc	PROPN
mkg-41075	254	4	sa	sa	PROPN
mkg-41075	254	5	,	,	PUNCT
mkg-41075	254	6	collet	collet	PROPN
mkg-41075	254	7	am	am	PROPN
mkg-41075	254	8	,	,	PUNCT
mkg-41075	254	9	gandolfo	gandolfo	PROPN
mkg-41075	254	10	ms	ms	PROPN
mkg-41075	254	11	,	,	PUNCT
mkg-41075	254	12	femopase	femopase	PROPN
mkg-41075	254	13	f	f	PROPN
mkg-41075	254	14	,	,	PUNCT
mkg-41075	254	15	hernández	hernández	PROPN
mkg-41075	254	16	sl	sl	PROPN
mkg-41075	254	17	,	,	PUNCT
mkg-41075	254	18	tomasi	tomasi	PROPN
mkg-41075	254	19	vh	vh	PROPN
mkg-41075	254	20	,	,	PUNCT
mkg-41075	254	21	paparella	paparella	PROPN
mkg-41075	254	22	ml	ml	AUX
mkg-41075	254	23	,	,	PUNCT
mkg-41075	254	24	itoiz	itoiz	VERB
mkg-41075	254	25	me	i	PRON
mkg-41075	254	26	.	.	PUNCT
mkg-41075	255	1	nucleolar	nucleolar	ADJ
mkg-41075	255	2	organizer	organizer	NOUN
mkg-41075	255	3	regions	region	NOUN
mkg-41075	255	4	(	(	PUNCT
mkg-41075	255	5	agnor	agnor	NOUN
mkg-41075	255	6	)	)	PUNCT
mkg-41075	255	7	and	and	CCONJ
mkg-41075	255	8	subepithelial	subepithelial	ADJ
mkg-41075	255	9	vascularization	vascularization	NOUN
mkg-41075	255	10	as	as	ADP
mkg-41075	255	11	field	field	NOUN
mkg-41075	255	12	cancerization	cancerization	NOUN
mkg-41075	255	13	markers	marker	NOUN
mkg-41075	255	14	in	in	ADP
mkg-41075	255	15	oral	oral	ADJ
mkg-41075	255	16	mucosa	mucosa	NOUN
mkg-41075	255	17	biopsies	biopsy	NOUN
mkg-41075	255	18	of	of	ADP
mkg-41075	255	19	alcoholic	alcoholic	ADJ
mkg-41075	255	20	and	and	CCONJ
mkg-41075	255	21	smoking	smoking	NOUN
mkg-41075	255	22	patients	patient	NOUN
mkg-41075	255	23	.	.	PUNCT
mkg-41075	256	1	oral	oral	ADJ
mkg-41075	256	2	surgery	surgery	NOUN
mkg-41075	256	3	,	,	PUNCT
mkg-41075	256	4	oral	oral	ADJ
mkg-41075	256	5	med	med	ADJ
mkg-41075	256	6	oral	oral	ADJ
mkg-41075	256	7	pathol	pathol	NOUN
mkg-41075	256	8	oral	oral	ADJ
mkg-41075	256	9	radiol	radiol	NOUN
mkg-41075	256	10	endodontology	endodontology	NOUN
mkg-41075	256	11	.	.	PUNCT
mkg-41075	256	12	2009	2009	NUM
mkg-41075	256	13	;	;	PUNCT
mkg-41075	256	14	108(5	108(5	NUM
mkg-41075	256	15	):	):	PUNCT
mkg-41075	256	16	747–53	747–53	PROPN
mkg-41075	256	17	.	.	PROPN
mkg-41075	257	1	33	33	NUM
mkg-41075	257	2	.	.	PUNCT
mkg-41075	258	1	chaves	chaves	PROPN
mkg-41075	258	2	fn	fn	PROPN
mkg-41075	258	3	,	,	PUNCT
mkg-41075	258	4	bezerra	bezerra	PROPN
mkg-41075	258	5	tmm	tmm	PROPN
mkg-41075	258	6	,	,	PUNCT
mkg-41075	258	7	moraes	moraes	PROPN
mkg-41075	258	8	dc	dc	PROPN
mkg-41075	258	9	,	,	PUNCT
mkg-41075	258	10	costa	costa	PROPN
mkg-41075	258	11	sf	sf	PROPN
mkg-41075	258	12	dos	dos	PROPN
mkg-41075	258	13	s	s	PROPN
mkg-41075	258	14	,	,	PUNCT
mkg-41075	258	15	silva	silva	PROPN
mkg-41075	258	16	pgb	pgb	PROPN
mkg-41075	258	17	,	,	PUNCT
mkg-41075	258	18	alves	alves	PROPN
mkg-41075	258	19	apnn	apnn	PROPN
mkg-41075	258	20	,	,	PUNCT
mkg-41075	258	21	costa	costa	PROPN
mkg-41075	258	22	fwg	fwg	PROPN
mkg-41075	258	23	,	,	PUNCT
mkg-41075	258	24	bernardes	bernardes	PROPN
mkg-41075	258	25	vf	vf	PROPN
mkg-41075	258	26	,	,	PUNCT
mkg-41075	258	27	pereira	pereira	PROPN
mkg-41075	258	28	kma	kma	PROPN
mkg-41075	258	29	.	.	PUNCT
mkg-41075	259	1	loss	loss	NOUN
mkg-41075	259	2	of	of	ADP
mkg-41075	259	3	heterozygosity	heterozygosity	NOUN
mkg-41075	259	4	and	and	CCONJ
mkg-41075	259	5	immunoexpression	immunoexpression	NOUN
mkg-41075	259	6	of	of	ADP
mkg-41075	259	7	pten	pten	NOUN
mkg-41075	259	8	in	in	ADP
mkg-41075	259	9	oral	oral	ADJ
mkg-41075	259	10	epithelial	epithelial	ADJ
mkg-41075	259	11	dysplasia	dysplasia	NOUN
mkg-41075	259	12	and	and	CCONJ
mkg-41075	259	13	squamous	squamous	ADJ
mkg-41075	259	14	cell	cell	NOUN
mkg-41075	259	15	carcinoma	carcinoma	NOUN
mkg-41075	259	16	.	.	PUNCT
mkg-41075	260	1	exp	exp	NOUN
mkg-41075	260	2	mol	mol	ADP
mkg-41075	260	3	pathol	pathol	NOUN
mkg-41075	260	4	.	.	PUNCT
mkg-41075	261	1	2020	2020	NUM
mkg-41075	261	2	;	;	PUNCT
mkg-41075	261	3	112	112	NUM
mkg-41075	261	4	:	:	SYM
mkg-41075	261	5	104341	104341	NUM
mkg-41075	261	6	.	.	PUNCT
mkg-41075	262	1	34	34	NUM
mkg-41075	262	2	.	.	PUNCT
mkg-41075	263	1	nakashima	nakashima	PROPN
mkg-41075	263	2	t	t	PROPN
mkg-41075	263	3	,	,	PUNCT
mkg-41075	263	4	tomita	tomita	PROPN
mkg-41075	263	5	h	h	PROPN
mkg-41075	263	6	,	,	PUNCT
mkg-41075	263	7	hirata	hirata	NOUN
mkg-41075	263	8	a	a	PRON
mkg-41075	263	9	,	,	PUNCT
mkg-41075	263	10	ishida	ishida	PROPN
mkg-41075	263	11	k	k	PROPN
mkg-41075	263	12	,	,	PUNCT
mkg-41075	263	13	hisamatsu	hisamatsu	PROPN
mkg-41075	263	14	k	k	PROPN
mkg-41075	263	15	,	,	PUNCT
mkg-41075	263	16	hatano	hatano	PROPN
mkg-41075	263	17	y	y	PROPN
mkg-41075	263	18	,	,	PUNCT
mkg-41075	263	19	kanayama	kanayama	PROPN
mkg-41075	263	20	t	t	PROPN
mkg-41075	263	21	,	,	PUNCT
mkg-41075	263	22	niwa	niwa	PROPN
mkg-41075	263	23	a	a	PROPN
mkg-41075	263	24	,	,	PUNCT
mkg-41075	263	25	noguchi	noguchi	PROPN
mkg-41075	263	26	k	k	PROPN
mkg-41075	263	27	,	,	PUNCT
mkg-41075	263	28	kato	kato	PROPN
mkg-41075	263	29	k	k	PROPN
mkg-41075	263	30	,	,	PUNCT
mkg-41075	263	31	miyazaki	miyazaki	PROPN
mkg-41075	263	32	t	t	PROPN
mkg-41075	263	33	,	,	PUNCT
mkg-41075	263	34	tanaka	tanaka	PROPN
mkg-41075	263	35	t	t	PROPN
mkg-41075	263	36	,	,	PUNCT
mkg-41075	263	37	shibata	shibata	PROPN
mkg-41075	263	38	t	t	PROPN
mkg-41075	263	39	,	,	PUNCT
mkg-41075	263	40	hara	hara	PROPN
mkg-41075	263	41	a.	a.	NOUN
mkg-41075	263	42	promotion	promotion	NOUN
mkg-41075	263	43	of	of	ADP
mkg-41075	263	44	cell	cell	NOUN
mkg-41075	263	45	proliferation	proliferation	NOUN
mkg-41075	263	46	by	by	ADP
mkg-41075	263	47	the	the	DET
mkg-41075	263	48	protooncogene	protooncogene	NOUN
mkg-41075	263	49	dek	dek	PROPN
mkg-41075	263	50	enhances	enhance	VERB
mkg-41075	263	51	oral	oral	ADJ
mkg-41075	263	52	squamous	squamous	ADJ
mkg-41075	263	53	cell	cell	NOUN
mkg-41075	263	54	carcinogenesis	carcinogenesis	NOUN
mkg-41075	263	55	through	through	ADP
mkg-41075	263	56	field	field	NOUN
mkg-41075	263	57	cancerization	cancerization	NOUN
mkg-41075	263	58	.	.	PUNCT
mkg-41075	264	1	cancer	cancer	NOUN
mkg-41075	264	2	med	med	PROPN
mkg-41075	264	3	.	.	PROPN
mkg-41075	264	4	2017	2017	NUM
mkg-41075	264	5	;	;	PUNCT
mkg-41075	264	6	6(10	6(10	NUM
mkg-41075	264	7	):	):	PUNCT
mkg-41075	264	8	2424–39	2424–39	NUM
mkg-41075	264	9	.	.	PUNCT
mkg-41075	265	1	35	35	NUM
mkg-41075	265	2	.	.	PUNCT
mkg-41075	266	1	lopes	lopes	PROPN
mkg-41075	266	2	cb	cb	PROPN
mkg-41075	266	3	,	,	PUNCT
mkg-41075	266	4	magalhães	magalhães	NOUN
mkg-41075	266	5	ll	ll	NOUN
mkg-41075	266	6	,	,	PUNCT
mkg-41075	266	7	teófilo	teófilo	VERB
mkg-41075	266	8	cr	cr	NUM
mkg-41075	266	9	,	,	PUNCT
mkg-41075	266	10	alves	alves	PROPN
mkg-41075	266	11	apnn	apnn	PROPN
mkg-41075	266	12	,	,	PUNCT
mkg-41075	266	13	montenegro	montenegro	PROPN
mkg-41075	266	14	rc	rc	PROPN
mkg-41075	266	15	,	,	PUNCT
mkg-41075	266	16	negrini	negrini	PROPN
mkg-41075	266	17	m	m	PROPN
mkg-41075	266	18	,	,	PUNCT
mkg-41075	266	19	ribeiro	ribeiro	PROPN
mkg-41075	266	20	-	-	PUNCT
mkg-41075	266	21	dos	dos	PROPN
mkg-41075	266	22	-	-	PUNCT
mkg-41075	266	23	santos	santos	NUM
mkg-41075	266	24	â	â	NOUN
mkg-41075	266	25	.	.	PUNCT
mkg-41075	266	26	differential	differential	ADJ
mkg-41075	266	27	expression	expression	NOUN
mkg-41075	266	28	of	of	ADP
mkg-41075	266	29	hsa	hsa	PROPN
mkg-41075	266	30	-	-	PUNCT
mkg-41075	266	31	mir-221	mir-221	NOUN
mkg-41075	266	32	,	,	PUNCT
mkg-41075	266	33	hsa	hsa	PROPN
mkg-41075	266	34	-	-	PUNCT
mkg-41075	266	35	mir-21	mir-21	PROPN
mkg-41075	266	36	,	,	PUNCT
mkg-41075	266	37	hsa	hsa	NOUN
mkg-41075	266	38	-	-	PUNCT
mkg-41075	266	39	mir-135b	mir-135b	PROPN
mkg-41075	266	40	,	,	PUNCT
mkg-41075	266	41	and	and	CCONJ
mkg-41075	266	42	hsa	hsa	PROPN
mkg-41075	266	43	-	-	PUNCT
mkg-41075	266	44	mir-29c	mir-29c	NOUN
mkg-41075	266	45	suggests	suggest	VERB
mkg-41075	266	46	a	a	DET
mkg-41075	266	47	field	field	NOUN
mkg-41075	266	48	effect	effect	NOUN
mkg-41075	266	49	in	in	ADP
mkg-41075	266	50	oral	oral	ADJ
mkg-41075	266	51	cancer	cancer	NOUN
mkg-41075	266	52	.	.	PUNCT
mkg-41075	267	1	bmc	bmc	NOUN
mkg-41075	267	2	cancer	cancer	NOUN
mkg-41075	267	3	.	.	PUNCT
mkg-41075	268	1	2018	2018	NUM
mkg-41075	268	2	;	;	PUNCT
mkg-41075	268	3	18(1	18(1	NUM
mkg-41075	268	4	):	):	PUNCT
mkg-41075	268	5	721	721	NUM
mkg-41075	268	6	.	.	PUNCT
mkg-41075	269	1	36	36	NUM
mkg-41075	269	2	.	.	PUNCT
mkg-41075	270	1	yang	yang	PROPN
mkg-41075	270	2	x	x	PROPN
mkg-41075	270	3	,	,	PUNCT
mkg-41075	270	4	shi	shi	PROPN
mkg-41075	270	5	l	l	PROPN
mkg-41075	270	6	,	,	PUNCT
mkg-41075	270	7	zhou	zhou	PROPN
mkg-41075	270	8	z	z	PROPN
mkg-41075	270	9	,	,	PUNCT
mkg-41075	270	10	liu	liu	PROPN
mkg-41075	270	11	w.	w.	PROPN
mkg-41075	270	12	podoplanin	podoplanin	PROPN
mkg-41075	270	13	and	and	CCONJ
mkg-41075	270	14	abcg2	abcg2	NOUN
mkg-41075	270	15	expression	expression	NOUN
mkg-41075	270	16	in	in	ADP
mkg-41075	270	17	oral	oral	ADJ
mkg-41075	270	18	erythroplakia	erythroplakia	NOUN
mkg-41075	270	19	revisited	revisit	VERB
mkg-41075	270	20	:	:	PUNCT
mkg-41075	270	21	potential	potential	ADJ
mkg-41075	270	22	evidence	evidence	NOUN
mkg-41075	270	23	for	for	ADP
mkg-41075	270	24	cancer	cancer	NOUN
mkg-41075	270	25	stem	stem	NOUN
mkg-41075	270	26	cells	cell	NOUN
mkg-41075	270	27	driving	drive	VERB
mkg-41075	270	28	the	the	DET
mkg-41075	270	29	process	process	NOUN
mkg-41075	270	30	of	of	ADP
mkg-41075	270	31	field	field	NOUN
mkg-41075	270	32	cancerization	cancerization	NOUN
mkg-41075	270	33	.	.	PUNCT
mkg-41075	271	1	oral	oral	ADJ
mkg-41075	271	2	oncol	oncol	ADJ
mkg-41075	271	3	.	.	PUNCT
mkg-41075	272	1	2020	2020	NUM
mkg-41075	272	2	;	;	PUNCT
mkg-41075	272	3	101	101	NUM
mkg-41075	272	4	:	:	SYM
mkg-41075	272	5	104368	104368	NUM
mkg-41075	272	6	.	.	PUNCT
mkg-41075	273	1	37	37	NUM
mkg-41075	273	2	.	.	PUNCT
mkg-41075	274	1	padin	padin	VERB
mkg-41075	274	2	-	-	NOUN
mkg-41075	274	3	iruegas	iruegas	ADJ
mkg-41075	274	4	e	e	NOUN
mkg-41075	274	5	,	,	PUNCT
mkg-41075	274	6	chamorro	chamorro	ADJ
mkg-41075	274	7	-	-	PUNCT
mkg-41075	274	8	petronacci	petronacci	NOUN
mkg-41075	274	9	cm	cm	NOUN
mkg-41075	274	10	,	,	PUNCT
mkg-41075	274	11	sines	sine	NOUN
mkg-41075	274	12	-	-	PUNCT
mkg-41075	274	13	cajade	cajade	ADJ
mkg-41075	274	14	i	i	PRON
mkg-41075	274	15	,	,	PUNCT
mkg-41075	274	16	lorenzo	lorenzo	PROPN
mkg-41075	274	17	-	-	PUNCT
mkg-41075	274	18	pouso	pouso	NOUN
mkg-41075	274	19	ai	ai	NOUN
mkg-41075	274	20	,	,	PUNCT
mkg-41075	274	21	blanco	blanco	PROPN
mkg-41075	274	22	-	-	PUNCT
mkg-41075	274	23	carrión	carrión	PROPN
mkg-41075	274	24	a	a	PRON
mkg-41075	274	25	,	,	PUNCT
mkg-41075	274	26	pérez	pérez	NOUN
mkg-41075	274	27	-	-	PUNCT
mkg-41075	274	28	jardón	jardón	NOUN
mkg-41075	274	29	a	a	DET
mkg-41075	274	30	,	,	PUNCT
mkg-41075	274	31	gándara	gándara	NOUN
mkg-41075	274	32	-	-	PUNCT
mkg-41075	274	33	vila	vila	NOUN
mkg-41075	274	34	p	p	NOUN
mkg-41075	274	35	,	,	PUNCT
mkg-41075	274	36	pérez	pérez	NOUN
mkg-41075	274	37	-	-	PUNCT
mkg-41075	274	38	sayans	sayan	NOUN
mkg-41075	274	39	m.	m.	NOUN
mkg-41075	274	40	dna	dna	PROPN
mkg-41075	274	41	methylation	methylation	NOUN
mkg-41075	274	42	by	by	ADP
mkg-41075	274	43	bisulfite	bisulfite	NOUN
mkg-41075	274	44	next	next	ADJ
mkg-41075	274	45	-	-	PUNCT
mkg-41075	274	46	generation	generation	NOUN
mkg-41075	274	47	sequencing	sequencing	NOUN
mkg-41075	274	48	for	for	ADP
mkg-41075	274	49	mlh1	mlh1	NOUN
mkg-41075	274	50	and	and	CCONJ
mkg-41075	274	51	mgmt	mgmt	PROPN
mkg-41075	274	52	in	in	ADP
mkg-41075	274	53	oral	oral	ADJ
mkg-41075	274	54	squamous	squamous	ADJ
mkg-41075	274	55	cell	cell	NOUN
mkg-41075	274	56	carcinomas	carcinoma	NOUN
mkg-41075	274	57	and	and	CCONJ
mkg-41075	274	58	potentially	potentially	ADV
mkg-41075	274	59	malignant	malignant	ADJ
mkg-41075	274	60	disorders	disorder	NOUN
mkg-41075	274	61	:	:	PUNCT
mkg-41075	274	62	an	an	DET
mkg-41075	274	63	integrative	integrative	ADJ
mkg-41075	274	64	analysis	analysis	NOUN
mkg-41075	274	65	towards	towards	ADP
mkg-41075	274	66	field	field	NOUN
mkg-41075	274	67	cancerization	cancerization	NOUN
mkg-41075	274	68	.	.	PUNCT
mkg-41075	275	1	medicina	medicina	PROPN
mkg-41075	275	2	(	(	PUNCT
mkg-41075	275	3	b	b	PROPN
mkg-41075	275	4	aires	aire	NOUN
mkg-41075	275	5	)	)	PUNCT
mkg-41075	275	6	.	.	PUNCT
mkg-41075	276	1	2022	2022	NUM
mkg-41075	276	2	;	;	PUNCT
mkg-41075	276	3	58(7	58(7	NUM
mkg-41075	276	4	):	):	PUNCT
mkg-41075	276	5	878	878	NUM
mkg-41075	276	6	.	.	X
mkg-41075	277	1	38	38	NUM
mkg-41075	277	2	.	.	PUNCT
mkg-41075	278	1	govindaraj	govindaraj	PROPN
mkg-41075	278	2	pk	pk	PROPN
mkg-41075	278	3	,	,	PUNCT
mkg-41075	278	4	kallarakkal	kallarakkal	NOUN
mkg-41075	278	5	tg	tg	PROPN
mkg-41075	278	6	,	,	PUNCT
mkg-41075	278	7	mohd	mohd	PROPN
mkg-41075	278	8	zain	zain	PROPN
mkg-41075	278	9	r	r	PROPN
mkg-41075	278	10	,	,	PUNCT
mkg-41075	278	11	tilakaratne	tilakaratne	PROPN
mkg-41075	278	12	wm	wm	PROPN
mkg-41075	278	13	,	,	PUNCT
mkg-41075	278	14	lew	lew	PROPN
mkg-41075	278	15	hl	hl	NOUN
mkg-41075	278	16	.	.	PUNCT
mkg-41075	279	1	expression	expression	NOUN
mkg-41075	279	2	of	of	ADP
mkg-41075	279	3	ki-67	ki-67	PRON
mkg-41075	279	4	,	,	PUNCT
mkg-41075	279	5	cornulin	cornulin	PROPN
mkg-41075	279	6	and	and	CCONJ
mkg-41075	279	7	isg15	isg15	PROPN
mkg-41075	279	8	in	in	ADP
mkg-41075	279	9	non	non	ADJ
mkg-41075	279	10	-	-	ADJ
mkg-41075	279	11	involved	involved	ADJ
mkg-41075	279	12	mucosal	mucosal	ADJ
mkg-41075	279	13	surgical	surgical	ADJ
mkg-41075	279	14	margins	margin	NOUN
mkg-41075	279	15	as	as	ADP
mkg-41075	279	16	predictive	predictive	ADJ
mkg-41075	279	17	markers	marker	NOUN
mkg-41075	279	18	for	for	ADP
mkg-41075	279	19	relapse	relapse	NOUN
mkg-41075	279	20	in	in	ADP
mkg-41075	279	21	oral	oral	ADJ
mkg-41075	279	22	squamous	squamous	ADJ
mkg-41075	279	23	cell	cell	NOUN
mkg-41075	279	24	carcinoma	carcinoma	NOUN
mkg-41075	279	25	(	(	PUNCT
mkg-41075	279	26	oscc	oscc	ADJ
mkg-41075	279	27	)	)	PUNCT
mkg-41075	279	28	.	.	PUNCT
mkg-41075	280	1	ha	ha	INTJ
mkg-41075	281	1	p	p	NOUN
mkg-41075	281	2	,	,	PUNCT
mkg-41075	281	3	editor	editor	NOUN
mkg-41075	281	4	.	.	PUNCT
mkg-41075	282	1	plos	plos	PROPN
mkg-41075	282	2	one	one	NUM
mkg-41075	282	3	.	.	PUNCT
mkg-41075	282	4	2021	2021	NUM
mkg-41075	282	5	;	;	PUNCT
mkg-41075	282	6	16(12	16(12	NUM
mkg-41075	282	7	):	):	PUNCT
mkg-41075	283	1	e0261575	e0261575	PROPN
mkg-41075	283	2	.	.	PROPN
mkg-41075	283	3	39	39	NUM
mkg-41075	283	4	.	.	PUNCT
mkg-41075	284	1	de	de	PROPN
mkg-41075	284	2	freitas	freitas	PROPN
mkg-41075	284	3	filho	filho	PROPN
mkg-41075	284	4	saj	saj	PROPN
mkg-41075	284	5	,	,	PUNCT
mkg-41075	284	6	coutinho	coutinho	PROPN
mkg-41075	284	7	-	-	PUNCT
mkg-41075	284	8	camillo	camillo	PROPN
mkg-41075	284	9	cm	cm	PROPN
mkg-41075	284	10	,	,	PUNCT
mkg-41075	284	11	oliveira	oliveira	PROPN
mkg-41075	284	12	kk	kk	PROPN
mkg-41075	284	13	,	,	PUNCT
mkg-41075	284	14	bettim	bettim	PROPN
mkg-41075	284	15	bb	bb	PROPN
mkg-41075	284	16	,	,	PUNCT
mkg-41075	284	17	pinto	pinto	NOUN
mkg-41075	284	18	cal	cal	PROPN
mkg-41075	284	19	,	,	PUNCT
mkg-41075	284	20	kowalski	kowalski	PROPN
mkg-41075	284	21	lp	lp	PROPN
mkg-41075	284	22	,	,	PUNCT
mkg-41075	284	23	oliveira	oliveira	PROPN
mkg-41075	284	24	dt	dt	PROPN
mkg-41075	284	25	.	.	PUNCT
mkg-41075	285	1	prognostic	prognostic	ADJ
mkg-41075	285	2	implications	implication	NOUN
mkg-41075	285	3	of	of	ADP
mkg-41075	285	4	aldh1	aldh1	NOUN
mkg-41075	285	5	and	and	CCONJ
mkg-41075	285	6	notch1	notch1	NOUN
mkg-41075	285	7	in	in	ADP
mkg-41075	285	8	different	different	ADJ
mkg-41075	285	9	subtypes	subtype	NOUN
mkg-41075	285	10	of	of	ADP
mkg-41075	285	11	oral	oral	ADJ
mkg-41075	285	12	cancer	cancer	NOUN
mkg-41075	285	13	.	.	PUNCT
mkg-41075	286	1	santhekadur	santhekadur	PROPN
mkg-41075	286	2	pk	pk	PROPN
mkg-41075	286	3	,	,	PUNCT
mkg-41075	286	4	editor	editor	NOUN
mkg-41075	286	5	.	.	PUNCT
mkg-41075	287	1	j	j	PROPN
mkg-41075	287	2	oncol	oncol	ADJ
mkg-41075	287	3	.	.	PUNCT
mkg-41075	287	4	2021	2021	NUM
mkg-41075	287	5	;	;	PUNCT
mkg-41075	287	6	:	:	PUNCT
mkg-41075	287	7	6663720	6663720	NUM
mkg-41075	287	8	.	.	PUNCT
mkg-41075	288	1	40	40	NUM
mkg-41075	288	2	.	.	PUNCT
mkg-41075	289	1	feng	feng	PROPN
mkg-41075	289	2	j	j	PROPN
mkg-41075	289	3	,	,	PUNCT
mkg-41075	289	4	zhou	zhou	PROPN
mkg-41075	289	5	z	z	PROPN
mkg-41075	289	6	,	,	PUNCT
mkg-41075	289	7	shi	shi	PROPN
mkg-41075	289	8	l	l	PROPN
mkg-41075	289	9	,	,	PUNCT
mkg-41075	289	10	yang	yang	PROPN
mkg-41075	289	11	x	x	PROPN
mkg-41075	289	12	,	,	PUNCT
mkg-41075	289	13	liu	liu	PROPN
mkg-41075	289	14	w.	w.	PROPN
mkg-41075	289	15	cancer	cancer	PROPN
mkg-41075	289	16	stem	stem	NOUN
mkg-41075	289	17	cell	cell	NOUN
mkg-41075	289	18	markers	marker	NOUN
mkg-41075	289	19	aldh1	aldh1	NOUN
mkg-41075	289	20	and	and	CCONJ
mkg-41075	289	21	bmi1	bmi1	NOUN
mkg-41075	289	22	expression	expression	NOUN
mkg-41075	289	23	in	in	ADP
mkg-41075	289	24	oral	oral	ADJ
mkg-41075	289	25	erythroplakia	erythroplakia	NOUN
mkg-41075	289	26	revisited	revisit	VERB
mkg-41075	289	27	:	:	PUNCT
mkg-41075	289	28	implication	implication	NOUN
mkg-41075	289	29	for	for	ADP
mkg-41075	289	30	driving	drive	VERB
mkg-41075	289	31	the	the	DET
mkg-41075	289	32	process	process	NOUN
mkg-41075	289	33	of	of	ADP
mkg-41075	289	34	field	field	NOUN
mkg-41075	289	35	cancerization	cancerization	NOUN
mkg-41075	289	36	.	.	PUNCT
mkg-41075	290	1	j	j	PROPN
mkg-41075	290	2	oral	oral	ADJ
mkg-41075	290	3	pathol	pathol	NOUN
mkg-41075	290	4	med	me	VERB
mkg-41075	290	5	.	.	PUNCT
mkg-41075	290	6	2020	2020	NUM
mkg-41075	290	7	;	;	PUNCT
mkg-41075	291	1	49(1	49(1	NUM
mkg-41075	291	2	):	):	PUNCT
mkg-41075	291	3	96–9	96–9	NUM
mkg-41075	291	4	.	.	PUNCT
mkg-41075	292	1	41	41	NUM
mkg-41075	292	2	.	.	PUNCT
mkg-41075	293	1	ahmed	ahmed	PROPN
mkg-41075	293	2	s	s	PROPN
mkg-41075	293	3	,	,	PUNCT
mkg-41075	293	4	khan	khan	PROPN
mkg-41075	293	5	s	s	PROPN
mkg-41075	293	6	,	,	PUNCT
mkg-41075	293	7	qureshi	qureshi	PROPN
mkg-41075	293	8	ma	ma	PROPN
mkg-41075	293	9	,	,	PUNCT
mkg-41075	293	10	bukhari	bukhari	PROPN
mkg-41075	293	11	u	u	PROPN
mkg-41075	293	12	,	,	PUNCT
mkg-41075	293	13	anis	anis	PROPN
mkg-41075	293	14	m	m	PROPN
mkg-41075	293	15	,	,	PUNCT
mkg-41075	293	16	mughal	mughal	PROPN
mkg-41075	293	17	mn	mn	PROPN
mkg-41075	293	18	.	.	PROPN
mkg-41075	294	1	expressional	expressional	ADJ
mkg-41075	294	2	variations	variation	NOUN
mkg-41075	294	3	of	of	ADP
mkg-41075	294	4	kaiso	kaiso	NOUN
mkg-41075	294	5	:	:	PUNCT
mkg-41075	294	6	an	an	DET
mkg-41075	294	7	association	association	NOUN
mkg-41075	294	8	with	with	ADP
mkg-41075	294	9	pathological	pathological	ADJ
mkg-41075	294	10	characteristics	characteristic	NOUN
mkg-41075	294	11	and	and	CCONJ
mkg-41075	294	12	field	field	NOUN
mkg-41075	294	13	cancerization	cancerization	NOUN
mkg-41075	294	14	of	of	ADP
mkg-41075	294	15	oscc	oscc	PROPN
mkg-41075	294	16	.	.	PUNCT
mkg-41075	295	1	bmc	bmc	ADJ
mkg-41075	295	2	cancer	cancer	NOUN
mkg-41075	295	3	.	.	PUNCT
mkg-41075	296	1	2022	2022	NUM
mkg-41075	296	2	;	;	PUNCT
mkg-41075	296	3	22(1	22(1	NUM
mkg-41075	296	4	):	):	PUNCT
mkg-41075	296	5	990	990	NUM
mkg-41075	296	6	.	.	PUNCT
mkg-41075	297	1	42	42	NUM
mkg-41075	297	2	.	.	PUNCT
mkg-41075	298	1	vadla	vadla	PROPN
mkg-41075	298	2	p	p	X
mkg-41075	298	3	,	,	PUNCT
mkg-41075	298	4	yeluri	yeluri	PROPN
mkg-41075	298	5	s	s	PROPN
mkg-41075	298	6	,	,	PUNCT
mkg-41075	298	7	deepthi	deepthi	VERB
mkg-41075	298	8	g	g	NOUN
mkg-41075	298	9	,	,	PUNCT
mkg-41075	298	10	guttikonda	guttikonda	NOUN
mkg-41075	298	11	vr	vr	PROPN
mkg-41075	298	12	,	,	PUNCT
mkg-41075	298	13	taneeru	taneeru	NOUN
mkg-41075	298	14	s	s	PROPN
mkg-41075	298	15	,	,	PUNCT
mkg-41075	298	16	naramala	naramala	PROPN
mkg-41075	298	17	s.	s.	PROPN
mkg-41075	298	18	stathmin	stathmin	PROPN
mkg-41075	298	19	!	!	PUNCT
mkg-41075	299	1	an	an	DET
mkg-41075	299	2	immunohistochemical	immunohistochemical	ADJ
mkg-41075	299	3	analysis	analysis	NOUN
mkg-41075	299	4	of	of	ADP
mkg-41075	299	5	the	the	DET
mkg-41075	299	6	novel	novel	ADJ
mkg-41075	299	7	marker	marker	NOUN
mkg-41075	299	8	in	in	ADP
mkg-41075	299	9	oral	oral	ADJ
mkg-41075	299	10	squamous	squamous	ADJ
mkg-41075	299	11	cell	cell	NOUN
mkg-41075	299	12	carcinoma	carcinoma	NOUN
mkg-41075	299	13	and	and	CCONJ
mkg-41075	299	14	oral	oral	ADJ
mkg-41075	299	15	leukoplakia	leukoplakia	NOUN
mkg-41075	299	16	.	.	PUNCT
mkg-41075	300	1	asian	asian	PROPN
mkg-41075	300	2	pacific	pacific	PROPN
mkg-41075	300	3	j	j	PROPN
mkg-41075	300	4	cancer	cancer	NOUN
mkg-41075	300	5	prev	prev	X
mkg-41075	300	6	.	.	PUNCT
mkg-41075	301	1	2020	2020	NUM
mkg-41075	301	2	;	;	PUNCT
mkg-41075	301	3	21(11	21(11	NUM
mkg-41075	301	4	):	):	PUNCT
mkg-41075	301	5	3317–23	3317–23	NUM
mkg-41075	301	6	.	.	PUNCT
mkg-41075	302	1	43	43	NUM
mkg-41075	302	2	.	.	PUNCT
mkg-41075	303	1	qiao	qiao	PROPN
mkg-41075	303	2	b	b	PROPN
mkg-41075	303	3	,	,	PUNCT
mkg-41075	303	4	he	he	PRON
mkg-41075	303	5	b	b	PROPN
mkg-41075	303	6	,	,	PUNCT
mkg-41075	303	7	cai	cai	PROPN
mkg-41075	303	8	j	j	PROPN
mkg-41075	303	9	,	,	PUNCT
mkg-41075	303	10	yang	yang	PROPN
mkg-41075	303	11	w.	w.	PROPN
mkg-41075	304	1	the	the	DET
mkg-41075	304	2	expression	expression	NOUN
mkg-41075	304	3	profile	profile	NOUN
mkg-41075	304	4	of	of	ADP
mkg-41075	304	5	oct4	oct4	NOUN
mkg-41075	304	6	and	and	CCONJ
mkg-41075	304	7	sox2	sox2	NOUN
mkg-41075	304	8	in	in	ADP
mkg-41075	304	9	the	the	DET
mkg-41075	304	10	carcinogenesis	carcinogenesis	NOUN
mkg-41075	304	11	of	of	ADP
mkg-41075	304	12	oral	oral	ADJ
mkg-41075	304	13	mucosa	mucosa	NOUN
mkg-41075	304	14	.	.	PUNCT
mkg-41075	305	1	int	int	PROPN
mkg-41075	306	1	j	j	PROPN
mkg-41075	306	2	clin	clin	PROPN
mkg-41075	306	3	exp	exp	PROPN
mkg-41075	306	4	pathol	pathol	NOUN
mkg-41075	306	5	.	.	PUNCT
mkg-41075	307	1	2014	2014	NUM
mkg-41075	307	2	;	;	PUNCT
mkg-41075	307	3	7(1	7(1	NUM
mkg-41075	307	4	):	):	PUNCT
mkg-41075	307	5	28–37	28–37	NOUN
mkg-41075	307	6	.	.	PUNCT
mkg-41075	308	1	44	44	NUM
mkg-41075	308	2	.	.	PUNCT
mkg-41075	309	1	feitosa	feitosa	PROPN
mkg-41075	309	2	sg	sg	PROPN
mkg-41075	309	3	,	,	PUNCT
mkg-41075	309	4	viana	viana	PROPN
mkg-41075	309	5	kf	kf	PROPN
mkg-41075	309	6	,	,	PUNCT
mkg-41075	309	7	luna	luna	PROPN
mkg-41075	309	8	ecm	ecm	PROPN
mkg-41075	309	9	,	,	PUNCT
mkg-41075	309	10	costa	costa	PROPN
mkg-41075	309	11	fwg	fwg	NOUN
mkg-41075	309	12	,	,	PUNCT
mkg-41075	309	13	cavalcante	cavalcante	NOUN
mkg-41075	309	14	rb	rb	PROPN
mkg-41075	309	15	,	,	PUNCT
mkg-41075	309	16	chaves	chaves	PROPN
mkg-41075	309	17	fn	fn	PROPN
mkg-41075	309	18	,	,	PUNCT
mkg-41075	309	19	chaves	chaves	PROPN
mkg-41075	309	20	hv	hv	PROPN
mkg-41075	309	21	,	,	PUNCT
mkg-41075	309	22	pereira	pereira	PROPN
mkg-41075	309	23	kma	kma	PROPN
mkg-41075	309	24	.	.	PUNCT
mkg-41075	310	1	immunohistochemical	immunohistochemical	ADJ
mkg-41075	310	2	evaluation	evaluation	NOUN
mkg-41075	310	3	of	of	ADP
mkg-41075	310	4	glut-3	glut-3	PROPN
mkg-41075	310	5	and	and	CCONJ
mkg-41075	310	6	glut-4	glut-4	PROPN
mkg-41075	310	7	in	in	ADP
mkg-41075	310	8	oral	oral	ADJ
mkg-41075	310	9	epithelial	epithelial	ADJ
mkg-41075	310	10	dysplasia	dysplasia	NOUN
mkg-41075	310	11	and	and	CCONJ
mkg-41075	310	12	oral	oral	ADJ
mkg-41075	310	13	squamous	squamous	ADJ
mkg-41075	310	14	cell	cell	NOUN
mkg-41075	310	15	carcinoma	carcinoma	NOUN
mkg-41075	310	16	.	.	PUNCT
mkg-41075	311	1	asian	asian	PROPN
mkg-41075	311	2	pac	pac	PROPN
mkg-41075	311	3	j	j	PROPN
mkg-41075	311	4	cancer	cancer	PROPN
mkg-41075	311	5	prev	prev	NOUN
mkg-41075	311	6	.	.	PROPN
mkg-41075	311	7	2018	2018	NUM
mkg-41075	311	8	;	;	PUNCT
mkg-41075	312	1	19(7	19(7	NUM
mkg-41075	312	2	):	):	PUNCT
mkg-41075	312	3	1779–83	1779–83	NUM
mkg-41075	312	4	.	.	PUNCT
mkg-41075	313	1	45	45	NUM
mkg-41075	313	2	.	.	PUNCT
mkg-41075	313	3	gonzalez	gonzalez	PROPN
mkg-41075	313	4	-	-	PUNCT
mkg-41075	313	5	moles	mole	NOUN
mkg-41075	313	6	.	.	PUNCT
mkg-41075	314	1	substance	substance	NOUN
mkg-41075	314	2	p	p	NOUN
mkg-41075	314	3	and	and	CCONJ
mkg-41075	314	4	nk-1r	nk-1r	ADJ
mkg-41075	314	5	expression	expression	NOUN
mkg-41075	314	6	in	in	ADP
mkg-41075	314	7	oral	oral	ADJ
mkg-41075	314	8	precancerous	precancerous	ADJ
mkg-41075	314	9	epithelium	epithelium	NOUN
mkg-41075	314	10	.	.	PUNCT
mkg-41075	315	1	oncol	oncol	PROPN
mkg-41075	315	2	rep	rep	PROPN
mkg-41075	315	3	.	.	PROPN
mkg-41075	315	4	2009	2009	NUM
mkg-41075	315	5	;	;	PUNCT
mkg-41075	315	6	22(6	22(6	NUM
mkg-41075	315	7	):	):	PUNCT
mkg-41075	315	8	1325–31	1325–31	NUM
mkg-41075	315	9	.	.	PUNCT
mkg-41075	316	1	46	46	NUM
mkg-41075	316	2	.	.	PUNCT
mkg-41075	317	1	miguel	miguel	PROPN
mkg-41075	317	2	afp	afp	PROPN
mkg-41075	317	3	,	,	PUNCT
mkg-41075	317	4	embaló	embaló	NOUN
mkg-41075	317	5	b	b	NUM
mkg-41075	317	6	,	,	PUNCT
mkg-41075	317	7	alves	alves	PROPN
mkg-41075	317	8	dias	dias	PROPN
mkg-41075	317	9	hb	hb	PROPN
mkg-41075	317	10	,	,	PUNCT
mkg-41075	317	11	rivero	rivero	PROPN
mkg-41075	317	12	erc	erc	PROPN
mkg-41075	317	13	.	.	PUNCT
mkg-41075	318	1	immunohistochemical	immunohistochemical	ADJ
mkg-41075	318	2	expression	expression	NOUN
mkg-41075	318	3	of	of	ADP
mkg-41075	318	4	mmp-9	mmp-9	ADJ
mkg-41075	318	5	,	,	PUNCT
mkg-41075	318	6	timp-1	timp-1	NUM
mkg-41075	318	7	,	,	PUNCT
mkg-41075	318	8	and	and	CCONJ
mkg-41075	318	9	vimentin	vimentin	NOUN
mkg-41075	318	10	and	and	CCONJ
mkg-41075	318	11	its	its	PRON
mkg-41075	318	12	correlation	correlation	NOUN
mkg-41075	318	13	with	with	ADP
mkg-41075	318	14	inflammatory	inflammatory	ADJ
mkg-41075	318	15	reaction	reaction	NOUN
mkg-41075	318	16	and	and	CCONJ
mkg-41075	318	17	clinical	clinical	ADJ
mkg-41075	318	18	parameters	parameter	NOUN
mkg-41075	318	19	in	in	ADP
mkg-41075	318	20	oral	oral	ADJ
mkg-41075	318	21	epithelial	epithelial	ADJ
mkg-41075	318	22	dysplasia	dysplasia	NOUN
mkg-41075	318	23	.	.	PUNCT
mkg-41075	319	1	appl	appl	PROPN
mkg-41075	319	2	immunohistochem	immunohistochem	PROPN
mkg-41075	319	3	mol	mol	ADP
mkg-41075	319	4	morphol	morphol	NOUN
mkg-41075	319	5	.	.	PUNCT
mkg-41075	320	1	2021	2021	NUM
mkg-41075	320	2	;	;	PUNCT
mkg-41075	320	3	29(5	29(5	NUM
mkg-41075	320	4	):	):	PUNCT
mkg-41075	320	5	382–9	382–9	PROPN
mkg-41075	320	6	.	.	PROPN
mkg-41075	320	7	47	47	NUM
mkg-41075	320	8	.	.	PUNCT
mkg-41075	321	1	yu	yu	PROPN
mkg-41075	321	2	t	t	PROPN
mkg-41075	321	3	,	,	PUNCT
mkg-41075	321	4	tang	tang	PROPN
mkg-41075	322	1	q	q	PROPN
mkg-41075	322	2	,	,	PUNCT
mkg-41075	322	3	chen	chen	PROPN
mkg-41075	322	4	x	x	PROPN
mkg-41075	322	5	,	,	PUNCT
mkg-41075	322	6	fan	fan	PROPN
mkg-41075	322	7	w	w	PROPN
mkg-41075	322	8	,	,	PUNCT
mkg-41075	322	9	zhou	zhou	PROPN
mkg-41075	322	10	z	z	PROPN
mkg-41075	322	11	,	,	PUNCT
mkg-41075	322	12	huang	huang	PROPN
mkg-41075	322	13	w	w	PROPN
mkg-41075	322	14	,	,	PUNCT
mkg-41075	322	15	liang	liang	PROPN
mkg-41075	322	16	f.	f.	PROPN
mkg-41075	322	17	tgf‐β1	tgf‐β1	PROPN
mkg-41075	322	18	and	and	CCONJ
mkg-41075	322	19	il‐17a	il‐17a	PROPN
mkg-41075	322	20	comediate	comediate	VERB
mkg-41075	322	21	the	the	DET
mkg-41075	322	22	protumor	protumor	NOUN
mkg-41075	322	23	phenotype	phenotype	NOUN
mkg-41075	322	24	of	of	ADP
mkg-41075	322	25	neutrophils	neutrophil	NOUN
mkg-41075	322	26	to	to	PART
mkg-41075	322	27	regulate	regulate	VERB
mkg-41075	322	28	the	the	DET
mkg-41075	322	29	epithelial‐mesenchymal	epithelial‐mesenchymal	ADJ
mkg-41075	322	30	transition	transition	NOUN
mkg-41075	322	31	in	in	ADP
mkg-41075	322	32	oral	oral	ADJ
mkg-41075	322	33	squamous	squamous	ADJ
mkg-41075	322	34	cell	cell	NOUN
mkg-41075	322	35	carcinoma	carcinoma	NOUN
mkg-41075	322	36	.	.	PUNCT
mkg-41075	323	1	j	j	PROPN
mkg-41075	323	2	oral	oral	ADJ
mkg-41075	323	3	pathol	pathol	NOUN
mkg-41075	323	4	med	me	VERB
mkg-41075	323	5	.	.	PUNCT
mkg-41075	323	6	2021	2021	NUM
mkg-41075	323	7	;	;	PUNCT
mkg-41075	323	8	50(4	50(4	NUM
mkg-41075	323	9	):	):	PUNCT
mkg-41075	323	10	353–61	353–61	PROPN
mkg-41075	323	11	.	.	PROPN
mkg-41075	323	12	48	48	NUM
mkg-41075	323	13	.	.	PUNCT
mkg-41075	323	14	tabatabaeifar	tabatabaeifar	PROPN
mkg-41075	323	15	s	s	PROPN
mkg-41075	323	16	,	,	PUNCT
mkg-41075	323	17	larsen	larsen	PROPN
mkg-41075	323	18	mj	mj	PROPN
mkg-41075	323	19	,	,	PUNCT
mkg-41075	323	20	larsen	larsen	PROPN
mkg-41075	323	21	sr	sr	PROPN
mkg-41075	323	22	,	,	PUNCT
mkg-41075	323	23	kruse	kruse	PROPN
mkg-41075	323	24	ta	ta	PROPN
mkg-41075	323	25	,	,	PUNCT
mkg-41075	323	26	thomassen	thomassen	PROPN
mkg-41075	323	27	m	m	PROPN
mkg-41075	323	28	,	,	PUNCT
mkg-41075	323	29	sørensen	sørensen	PROPN
mkg-41075	323	30	ja	ja	PROPN
mkg-41075	323	31	.	.	PUNCT
mkg-41075	324	1	investigating	investigate	VERB
mkg-41075	324	2	a	a	DET
mkg-41075	324	3	case	case	NOUN
mkg-41075	324	4	of	of	ADP
mkg-41075	324	5	possible	possible	ADJ
mkg-41075	324	6	field	field	NOUN
mkg-41075	324	7	cancerization	cancerization	NOUN
mkg-41075	324	8	in	in	ADP
mkg-41075	324	9	oral	oral	ADJ
mkg-41075	324	10	squamous	squamous	ADJ
mkg-41075	324	11	cell	cell	NOUN
mkg-41075	324	12	carcinoma	carcinoma	NOUN
mkg-41075	324	13	by	by	ADP
mkg-41075	324	14	the	the	DET
mkg-41075	324	15	use	use	NOUN
mkg-41075	324	16	of	of	ADP
mkg-41075	324	17	next	next	ADJ
mkg-41075	324	18	-	-	PUNCT
mkg-41075	324	19	generation	generation	NOUN
mkg-41075	324	20	sequencing	sequencing	NOUN
mkg-41075	324	21	.	.	PUNCT
mkg-41075	325	1	oral	oral	ADJ
mkg-41075	325	2	oncol	oncol	ADJ
mkg-41075	325	3	.	.	PUNCT
mkg-41075	326	1	2017	2017	NUM
mkg-41075	326	2	;	;	PUNCT
mkg-41075	326	3	68	68	NUM
mkg-41075	326	4	:	:	PUNCT
mkg-41075	326	5	74–80	74–80	NUM
mkg-41075	326	6	.	.	NOUN
mkg-41075	326	7	49	49	NUM
mkg-41075	326	8	.	.	PUNCT
mkg-41075	327	1	pérez	pérez	NOUN
mkg-41075	327	2	-	-	PUNCT
mkg-41075	327	3	ruiz	ruiz	NOUN
mkg-41075	327	4	e	e	NOUN
mkg-41075	327	5	,	,	PUNCT
mkg-41075	327	6	gutiérrez	gutiérrez	PROPN
mkg-41075	327	7	v	v	PROPN
mkg-41075	327	8	,	,	PUNCT
mkg-41075	327	9	muñoz	muñoz	PROPN
mkg-41075	327	10	m	m	PROPN
mkg-41075	327	11	,	,	PUNCT
mkg-41075	327	12	oliver	oliver	PROPN
mkg-41075	327	13	j	j	PROPN
mkg-41075	327	14	,	,	PUNCT
mkg-41075	327	15	sánchez	sánchez	PROPN
mkg-41075	327	16	m	m	PROPN
mkg-41075	327	17	,	,	PUNCT
mkg-41075	327	18	gálvezcarvajal	gálvezcarvajal	PROPN
mkg-41075	327	19	l	l	NOUN
mkg-41075	327	20	,	,	PUNCT
mkg-41075	327	21	rueda	rueda	PROPN
mkg-41075	327	22	-	-	NOUN
mkg-41075	327	23	domínguez	domínguez	NOUN
mkg-41075	327	24	a	a	PRON
mkg-41075	327	25	,	,	PUNCT
mkg-41075	327	26	barragán	barragán	NOUN
mkg-41075	327	27	i.	i.	PROPN
mkg-41075	327	28	liquid	liquid	PROPN
mkg-41075	327	29	biopsy	biopsy	NOUN
mkg-41075	327	30	as	as	ADP
mkg-41075	327	31	a	a	DET
mkg-41075	327	32	tool	tool	NOUN
mkg-41075	327	33	for	for	ADP
mkg-41075	327	34	the	the	DET
mkg-41075	327	35	characterisation	characterisation	NOUN
mkg-41075	327	36	and	and	CCONJ
mkg-41075	327	37	early	early	ADJ
mkg-41075	327	38	detection	detection	NOUN
mkg-41075	327	39	of	of	ADP
mkg-41075	327	40	the	the	DET
mkg-41075	327	41	field	field	NOUN
mkg-41075	327	42	cancerization	cancerization	NOUN
mkg-41075	327	43	copyright	copyright	NOUN
mkg-41075	327	44	©	©	ADP
mkg-41075	327	45	2023	2023	NUM
mkg-41075	327	46	dental	dental	ADJ
mkg-41075	327	47	journal	journal	NOUN
mkg-41075	327	48	(	(	PUNCT
mkg-41075	327	49	majalah	majalah	PROPN
mkg-41075	327	50	kedokteran	kedokteran	PROPN
mkg-41075	327	51	gigi	gigi	PROPN
mkg-41075	327	52	)	)	PUNCT
mkg-41075	328	1	p	p	X
mkg-41075	328	2	-	-	PUNCT
mkg-41075	328	3	issn	issn	NOUN
mkg-41075	328	4	:	:	PUNCT
mkg-41075	328	5	1978	1978	NUM
mkg-41075	328	6	-	-	SYM
mkg-41075	328	7	3728	3728	NUM
mkg-41075	328	8	;	;	PUNCT
mkg-41075	328	9	e	e	X
mkg-41075	328	10	-	-	PUNCT
mkg-41075	328	11	issn	issn	ADJ
mkg-41075	328	12	:	:	PUNCT
mkg-41075	328	13	2442	2442	NUM
mkg-41075	328	14	-	-	SYM
mkg-41075	328	15	9740	9740	NUM
mkg-41075	328	16	.	.	PUNCT
mkg-41075	329	1	accredited	accredit	VERB
mkg-41075	329	2	no	no	INTJ
mkg-41075	329	3	.	.	PROPN
mkg-41075	330	1	158	158	NUM
mkg-41075	330	2	/	/	SYM
mkg-41075	330	3	e	e	NOUN
mkg-41075	330	4	/	/	SYM
mkg-41075	330	5	kpt/2021	kpt/2021	NOUN
mkg-41075	330	6	.	.	PUNCT
mkg-41075	331	1	open	open	ADJ
mkg-41075	331	2	access	access	NOUN
mkg-41075	331	3	under	under	ADP
mkg-41075	331	4	cc	cc	NOUN
mkg-41075	331	5	-	-	PUNCT
mkg-41075	331	6	by	by	ADP
mkg-41075	331	7	-	-	PUNCT
mkg-41075	331	8	sa	sa	NOUN
mkg-41075	331	9	license	license	NOUN
mkg-41075	331	10	.	.	PUNCT
mkg-41075	332	1	available	available	ADJ
mkg-41075	332	2	at	at	ADP
mkg-41075	332	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-41075	332	4	doi	doi	NOUN
mkg-41075	332	5	:	:	PUNCT
mkg-41075	332	6	10.20473	10.20473	NUM
mkg-41075	332	7	/	/	SYM
mkg-41075	332	8	j.djmkg.v56.i3.p189–196	j.djmkg.v56.i3.p189–196	PROPN
mkg-41075	332	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	PROPN
mkg-41075	332	10	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	PROPN
mkg-41075	332	11	196	196	NUM
mkg-41075	332	12	puspasari	puspasari	PROPN
mkg-41075	332	13	et	et	PROPN
mkg-41075	332	14	al	al	PROPN
mkg-41075	332	15	.	.	PROPN
mkg-41075	332	16	dent	dent	PROPN
mkg-41075	332	17	.	.	PUNCT
mkg-41075	333	1	j.	j.	PROPN
mkg-41075	333	2	(	(	PUNCT
mkg-41075	333	3	majalah	majalah	PROPN
mkg-41075	333	4	kedokteran	kedokteran	PROPN
mkg-41075	333	5	gigi	gigi	PROPN
mkg-41075	333	6	)	)	PUNCT
mkg-41075	333	7	2023	2023	NUM
mkg-41075	333	8	september	september	PROPN
mkg-41075	333	9	;	;	PUNCT
mkg-41075	333	10	56(3	56(3	NUM
mkg-41075	333	11	):	):	PUNCT
mkg-41075	333	12	189–196	189–196	NUM
mkg-41075	333	13	effect	effect	NOUN
mkg-41075	333	14	in	in	ADP
mkg-41075	333	15	patients	patient	NOUN
mkg-41075	333	16	with	with	ADP
mkg-41075	333	17	oral	oral	ADJ
mkg-41075	333	18	cavity	cavity	NOUN
mkg-41075	333	19	carcinoma	carcinoma	NOUN
mkg-41075	333	20	.	.	PUNCT
mkg-41075	334	1	biomedicines	biomedicine	NOUN
mkg-41075	334	2	.	.	PUNCT
mkg-41075	335	1	2021	2021	NUM
mkg-41075	335	2	;	;	PUNCT
mkg-41075	335	3	9(10	9(10	NUM
mkg-41075	335	4	):	):	PUNCT
mkg-41075	335	5	1478	1478	NUM
mkg-41075	335	6	.	.	PUNCT
mkg-41075	336	1	50	50	NUM
mkg-41075	336	2	.	.	PUNCT
mkg-41075	336	3	gabusi	gabusi	PROPN
mkg-41075	336	4	a	a	PRON
mkg-41075	336	5	,	,	PUNCT
mkg-41075	336	6	morandi	morandi	PROPN
mkg-41075	336	7	l	l	PROPN
mkg-41075	336	8	,	,	PUNCT
mkg-41075	336	9	asioli	asioli	PROPN
mkg-41075	336	10	s	s	PROPN
mkg-41075	336	11	,	,	PUNCT
mkg-41075	336	12	foschini	foschini	PROPN
mkg-41075	336	13	mp	mp	PROPN
mkg-41075	336	14	.	.	PROPN
mkg-41075	336	15	oral	oral	ADJ
mkg-41075	336	16	field	field	NOUN
mkg-41075	336	17	cancerization	cancerization	NOUN
mkg-41075	336	18	:	:	PUNCT
mkg-41075	336	19	history	history	NOUN
mkg-41075	336	20	and	and	CCONJ
mkg-41075	336	21	future	future	ADJ
mkg-41075	336	22	perspectives	perspective	NOUN
mkg-41075	336	23	.	.	PUNCT
mkg-41075	337	1	pathologica	pathologica	PROPN
mkg-41075	337	2	.	.	PUNCT
mkg-41075	338	1	2017	2017	NUM
mkg-41075	338	2	;	;	PUNCT
mkg-41075	338	3	109(1	109(1	NUM
mkg-41075	338	4	):	):	PUNCT
mkg-41075	338	5	60–5	60–5	NUM
mkg-41075	338	6	.	.	PUNCT
mkg-41075	339	1	51	51	NUM
mkg-41075	339	2	.	.	PUNCT
mkg-41075	340	1	van	van	PROPN
mkg-41075	340	2	oijen	oijen	PROPN
mkg-41075	340	3	mg	mg	PROPN
mkg-41075	340	4	,	,	PUNCT
mkg-41075	340	5	slootweg	slootweg	VERB
mkg-41075	340	6	pj	pj	PROPN
mkg-41075	340	7	.	.	PROPN
mkg-41075	340	8	oral	oral	ADJ
mkg-41075	340	9	field	field	NOUN
mkg-41075	340	10	cancerization	cancerization	NOUN
mkg-41075	340	11	:	:	PUNCT
mkg-41075	340	12	carcinogeninduced	carcinogeninduce	VERB
mkg-41075	340	13	independent	independent	ADJ
mkg-41075	340	14	events	event	NOUN
mkg-41075	340	15	or	or	CCONJ
mkg-41075	340	16	micrometastatic	micrometastatic	ADJ
mkg-41075	340	17	deposits	deposit	NOUN
mkg-41075	340	18	?	?	PUNCT
mkg-41075	341	1	cancer	cancer	NOUN
mkg-41075	341	2	epidemiol	epidemiol	PROPN
mkg-41075	341	3	biomarkers	biomarker	NOUN
mkg-41075	341	4	prev	prev	X
mkg-41075	341	5	.	.	PUNCT
mkg-41075	341	6	2000	2000	NUM
mkg-41075	341	7	;	;	PUNCT
mkg-41075	342	1	9(3	9(3	NUM
mkg-41075	342	2	):	):	PUNCT
mkg-41075	342	3	249–56	249–56	NUM
mkg-41075	342	4	.	.	PUNCT
mkg-41075	343	1	52	52	NUM
mkg-41075	343	2	.	.	PUNCT
mkg-41075	344	1	nelem	nelem	NOUN
mkg-41075	344	2	-	-	PUNCT
mkg-41075	344	3	colturato	colturato	NOUN
mkg-41075	344	4	cb	cb	PROPN
mkg-41075	344	5	,	,	PUNCT
mkg-41075	344	6	cury	cury	PROPN
mkg-41075	344	7	pm	pm	PROPN
mkg-41075	344	8	,	,	PUNCT
mkg-41075	344	9	pereira	pereira	PROPN
mkg-41075	344	10	tm	tm	PROPN
mkg-41075	344	11	,	,	PUNCT
mkg-41075	344	12	cosso	cosso	PROPN
mkg-41075	344	13	is	be	AUX
mkg-41075	344	14	,	,	PUNCT
mkg-41075	344	15	pivato	pivato	VERB
mkg-41075	344	16	k	k	NOUN
mkg-41075	344	17	,	,	PUNCT
mkg-41075	344	18	volpato	volpato	PROPN
mkg-41075	344	19	ler	ler	PROPN
mkg-41075	344	20	,	,	PUNCT
mkg-41075	344	21	borges	borge	NOUN
mkg-41075	344	22	ah	ah	INTJ
mkg-41075	344	23	.	.	PUNCT
mkg-41075	345	1	sextuple	sextuple	PROPN
mkg-41075	345	2	tumors	tumor	NOUN
mkg-41075	345	3	in	in	ADP
mkg-41075	345	4	head	head	NOUN
mkg-41075	345	5	and	and	CCONJ
mkg-41075	345	6	neck	neck	NOUN
mkg-41075	345	7	area	area	NOUN
mkg-41075	345	8	:	:	PUNCT
mkg-41075	345	9	evidence	evidence	NOUN
mkg-41075	345	10	of	of	ADP
mkg-41075	345	11	field	field	NOUN
mkg-41075	345	12	cancerization	cancerization	NOUN
mkg-41075	345	13	.	.	PUNCT
mkg-41075	346	1	case	case	NOUN
mkg-41075	346	2	rep	rep	NOUN
mkg-41075	346	3	pathol	pathol	NOUN
mkg-41075	346	4	.	.	PUNCT
mkg-41075	347	1	2018	2018	NUM
mkg-41075	347	2	;	;	PUNCT
mkg-41075	347	3	2018	2018	NUM
mkg-41075	347	4	:	:	PUNCT
mkg-41075	347	5	8428395	8428395	NUM
mkg-41075	347	6	.	.	PUNCT
mkg-41075	348	1	53	53	NUM
mkg-41075	348	2	.	.	PUNCT
mkg-41075	349	1	fortuna	fortuna	PROPN
mkg-41075	349	2	g	g	PROPN
mkg-41075	349	3	,	,	PUNCT
mkg-41075	349	4	mignogna	mignogna	PROPN
mkg-41075	349	5	md	md	PROPN
mkg-41075	349	6	.	.	PROPN
mkg-41075	349	7	oral	oral	ADJ
mkg-41075	349	8	field	field	NOUN
mkg-41075	349	9	cancerization	cancerization	NOUN
mkg-41075	349	10	.	.	PUNCT
mkg-41075	350	1	can	can	AUX
mkg-41075	350	2	med	med	VERB
mkg-41075	350	3	assoc	assoc	PROPN
mkg-41075	350	4	j.	j.	PROPN
mkg-41075	350	5	2011	2011	NUM
mkg-41075	350	6	;	;	PUNCT
mkg-41075	350	7	183(14	183(14	NUM
mkg-41075	350	8	):	):	PUNCT
mkg-41075	350	9	1622–1622	1622–1622	NUM
mkg-41075	350	10	.	.	PUNCT
mkg-41075	351	1	54	54	NUM
mkg-41075	351	2	.	.	PUNCT
mkg-41075	352	1	bansal	bansal	NOUN
mkg-41075	352	2	r	r	PROPN
mkg-41075	352	3	,	,	PUNCT
mkg-41075	352	4	nayak	nayak	PROPN
mkg-41075	352	5	b	b	PROPN
mkg-41075	352	6	,	,	PUNCT
mkg-41075	352	7	bhardwaj	bhardwaj	PROPN
mkg-41075	352	8	s	s	PROPN
mkg-41075	352	9	,	,	PUNCT
mkg-41075	352	10	vanajakshi	vanajakshi	PROPN
mkg-41075	352	11	c	c	PROPN
mkg-41075	352	12	,	,	PUNCT
mkg-41075	352	13	das	das	PROPN
mkg-41075	352	14	p	p	X
mkg-41075	352	15	,	,	PUNCT
mkg-41075	352	16	somayaji	somayaji	ADJ
mkg-41075	352	17	n	n	CCONJ
mkg-41075	352	18	,	,	PUNCT
mkg-41075	352	19	sharma	sharma	PROPN
mkg-41075	352	20	s.	s.	PROPN
mkg-41075	352	21	cancer	cancer	PROPN
mkg-41075	352	22	stem	stem	NOUN
mkg-41075	352	23	cells	cell	NOUN
mkg-41075	352	24	and	and	CCONJ
mkg-41075	352	25	field	field	NOUN
mkg-41075	352	26	cancerization	cancerization	NOUN
mkg-41075	352	27	of	of	ADP
mkg-41075	352	28	head	head	NOUN
mkg-41075	352	29	and	and	CCONJ
mkg-41075	352	30	neck	neck	NOUN
mkg-41075	352	31	cancer	cancer	NOUN
mkg-41075	352	32	an	an	DET
mkg-41075	352	33	update	update	NOUN
mkg-41075	352	34	.	.	PUNCT
mkg-41075	353	1	j	j	PROPN
mkg-41075	353	2	fam	fam	PROPN
mkg-41075	353	3	med	me	VERB
mkg-41075	353	4	prim	prim	PROPN
mkg-41075	353	5	care	care	NOUN
mkg-41075	353	6	.	.	PUNCT
mkg-41075	354	1	2020	2020	NUM
mkg-41075	354	2	;	;	PUNCT
mkg-41075	354	3	9(7	9(7	NUM
mkg-41075	354	4	):	):	PUNCT
mkg-41075	354	5	3178–82	3178–82	NUM
mkg-41075	354	6	.	.	PUNCT
mkg-41075	355	1	55	55	NUM
mkg-41075	355	2	.	.	PUNCT
mkg-41075	356	1	pirlog	pirlog	NOUN
mkg-41075	356	2	r	r	NOUN
mkg-41075	356	3	,	,	PUNCT
mkg-41075	356	4	cismaru	cismaru	NOUN
mkg-41075	356	5	a	a	DET
mkg-41075	356	6	,	,	PUNCT
mkg-41075	356	7	nutu	nutu	ADJ
mkg-41075	356	8	a	a	DET
mkg-41075	356	9	,	,	PUNCT
mkg-41075	356	10	berindan	berindan	ADJ
mkg-41075	356	11	-	-	PUNCT
mkg-41075	356	12	neagoe	neagoe	ADJ
mkg-41075	356	13	i.	i.	PROPN
mkg-41075	356	14	field	field	PROPN
mkg-41075	356	15	cancerization	cancerization	NOUN
mkg-41075	356	16	in	in	ADP
mkg-41075	356	17	nsclc	nsclc	NOUN
mkg-41075	356	18	:	:	PUNCT
mkg-41075	356	19	a	a	DET
mkg-41075	356	20	new	new	ADJ
mkg-41075	356	21	perspective	perspective	NOUN
mkg-41075	356	22	on	on	ADP
mkg-41075	356	23	micrornas	microrna	NOUN
mkg-41075	356	24	in	in	ADP
mkg-41075	356	25	macrophage	macrophage	ADJ
mkg-41075	356	26	polarization	polarization	NOUN
mkg-41075	356	27	.	.	PUNCT
mkg-41075	357	1	int	int	PROPN
mkg-41075	357	2	j	j	PROPN
mkg-41075	357	3	mol	mol	ADP
mkg-41075	357	4	sci	sci	PROPN
mkg-41075	357	5	.	.	PROPN
mkg-41075	357	6	2021	2021	NUM
mkg-41075	357	7	;	;	PUNCT
mkg-41075	357	8	22(2	22(2	NUM
mkg-41075	357	9	):	):	PUNCT
mkg-41075	357	10	746	746	NUM
mkg-41075	357	11	.	.	PUNCT
mkg-41075	358	1	56	56	NUM
mkg-41075	358	2	.	.	PUNCT
mkg-41075	359	1	liao	liao	PROPN
mkg-41075	359	2	z	z	PROPN
mkg-41075	359	3	,	,	PUNCT
mkg-41075	359	4	tan	tan	PROPN
mkg-41075	359	5	zw	zw	PROPN
mkg-41075	359	6	,	,	PUNCT
mkg-41075	359	7	zhu	zhu	PROPN
mkg-41075	359	8	p	p	X
mkg-41075	359	9	,	,	PUNCT
mkg-41075	359	10	tan	tan	PROPN
mkg-41075	359	11	ns	ns	NOUN
mkg-41075	359	12	.	.	PUNCT
mkg-41075	359	13	cancer	cancer	NOUN
mkg-41075	359	14	-	-	PUNCT
mkg-41075	359	15	associated	associate	VERB
mkg-41075	359	16	fibroblasts	fibroblast	NOUN
mkg-41075	359	17	in	in	ADP
mkg-41075	359	18	tumor	tumor	NOUN
mkg-41075	359	19	microenvironment	microenvironment	NOUN
mkg-41075	359	20	–	–	PUNCT
mkg-41075	359	21	accomplices	accomplice	NOUN
mkg-41075	359	22	in	in	ADP
mkg-41075	359	23	tumor	tumor	NOUN
mkg-41075	359	24	malignancy	malignancy	NOUN
mkg-41075	359	25	.	.	PUNCT
mkg-41075	360	1	cell	cell	NOUN
mkg-41075	360	2	immunol	immunol	NOUN
mkg-41075	360	3	.	.	PUNCT
mkg-41075	361	1	2019	2019	NUM
mkg-41075	361	2	;	;	PUNCT
mkg-41075	361	3	343	343	NUM
mkg-41075	361	4	:	:	SYM
mkg-41075	361	5	103729	103729	NUM
mkg-41075	361	6	.	.	PUNCT
mkg-41075	362	1	57	57	NUM
mkg-41075	362	2	.	.	PUNCT
mkg-41075	363	1	liao	liao	PROPN
mkg-41075	363	2	z	z	PROPN
mkg-41075	363	3	,	,	PUNCT
mkg-41075	363	4	chua	chua	PROPN
mkg-41075	363	5	d	d	PROPN
mkg-41075	363	6	,	,	PUNCT
mkg-41075	363	7	tan	tan	PROPN
mkg-41075	363	8	ns	ns	NOUN
mkg-41075	363	9	.	.	PROPN
mkg-41075	363	10	reactive	reactive	ADJ
mkg-41075	363	11	oxygen	oxygen	NOUN
mkg-41075	363	12	species	specie	NOUN
mkg-41075	363	13	:	:	PUNCT
mkg-41075	363	14	a	a	DET
mkg-41075	363	15	volatile	volatile	ADJ
mkg-41075	363	16	driver	driver	NOUN
mkg-41075	363	17	of	of	ADP
mkg-41075	363	18	field	field	NOUN
mkg-41075	363	19	cancerization	cancerization	NOUN
mkg-41075	363	20	and	and	CCONJ
mkg-41075	363	21	metastasis	metastasis	NOUN
mkg-41075	363	22	.	.	PUNCT
mkg-41075	364	1	mol	mol	ADP
mkg-41075	364	2	cancer	cancer	NOUN
mkg-41075	364	3	.	.	PUNCT
mkg-41075	365	1	2019	2019	NUM
mkg-41075	365	2	;	;	PUNCT
mkg-41075	365	3	18(1	18(1	NUM
mkg-41075	365	4	):	):	PUNCT
mkg-41075	365	5	65	65	NUM
mkg-41075	365	6	.	.	X
mkg-41075	366	1	58	58	NUM
mkg-41075	366	2	.	.	PUNCT
mkg-41075	367	1	graham	graham	PROPN
mkg-41075	367	2	ta	ta	PROPN
mkg-41075	367	3	,	,	PUNCT
mkg-41075	367	4	mcdonald	mcdonald	PROPN
mkg-41075	367	5	sa	sa	PROPN
mkg-41075	367	6	,	,	PUNCT
mkg-41075	367	7	wright	wright	PROPN
mkg-41075	367	8	na	na	PROPN
mkg-41075	367	9	.	.	PROPN
mkg-41075	367	10	field	field	NOUN
mkg-41075	367	11	cancerization	cancerization	NOUN
mkg-41075	367	12	in	in	ADP
mkg-41075	367	13	the	the	DET
mkg-41075	367	14	gi	gi	PROPN
mkg-41075	367	15	tract	tract	NOUN
mkg-41075	367	16	.	.	PUNCT
mkg-41075	368	1	futur	futur	PROPN
mkg-41075	368	2	oncol	oncol	ADJ
mkg-41075	368	3	.	.	PUNCT
mkg-41075	369	1	2011	2011	NUM
mkg-41075	369	2	;	;	PUNCT
mkg-41075	370	1	7(8	7(8	NUM
mkg-41075	370	2	):	):	PUNCT
mkg-41075	370	3	981–93	981–93	NUM
mkg-41075	370	4	.	.	PUNCT
mkg-41075	371	1	59	59	NUM
mkg-41075	371	2	.	.	PUNCT
mkg-41075	371	3	gadaleta	gadaleta	PROPN
mkg-41075	371	4	e	e	PROPN
mkg-41075	371	5	,	,	PUNCT
mkg-41075	371	6	thorn	thorn	NOUN
mkg-41075	371	7	gj	gj	PROPN
mkg-41075	371	8	,	,	PUNCT
mkg-41075	371	9	ross‐adams	ross‐adam	VERB
mkg-41075	371	10	h	h	PROPN
mkg-41075	371	11	,	,	PUNCT
mkg-41075	371	12	jones	jones	PROPN
mkg-41075	371	13	lj	lj	PROPN
mkg-41075	371	14	,	,	PUNCT
mkg-41075	371	15	chelala	chelala	PROPN
mkg-41075	371	16	c.	c.	PROPN
mkg-41075	371	17	field	field	PROPN
mkg-41075	371	18	cancerization	cancerization	NOUN
mkg-41075	371	19	in	in	ADP
mkg-41075	371	20	breast	breast	NOUN
mkg-41075	371	21	cancer	cancer	NOUN
mkg-41075	371	22	.	.	PUNCT
mkg-41075	372	1	j	j	PROPN
mkg-41075	372	2	pathol	pathol	NOUN
mkg-41075	372	3	.	.	PUNCT
mkg-41075	373	1	2022	2022	NUM
mkg-41075	373	2	;	;	PUNCT
mkg-41075	373	3	257(4	257(4	NUM
mkg-41075	373	4	):	):	PUNCT
mkg-41075	373	5	561–74	561–74	NUM
mkg-41075	373	6	.	.	PUNCT
mkg-41075	374	1	copyright	copyright	NOUN
mkg-41075	374	2	©	©	ADP
mkg-41075	374	3	2023	2023	NUM
mkg-41075	374	4	dental	dental	ADJ
mkg-41075	374	5	journal	journal	NOUN
mkg-41075	374	6	(	(	PUNCT
mkg-41075	374	7	majalah	majalah	PROPN
mkg-41075	374	8	kedokteran	kedokteran	PROPN
mkg-41075	374	9	gigi	gigi	PROPN
mkg-41075	374	10	)	)	PUNCT
mkg-41075	375	1	p	p	X
mkg-41075	375	2	-	-	PUNCT
mkg-41075	375	3	issn	issn	NOUN
mkg-41075	375	4	:	:	PUNCT
mkg-41075	375	5	1978	1978	NUM
mkg-41075	375	6	-	-	SYM
mkg-41075	375	7	3728	3728	NUM
mkg-41075	375	8	;	;	PUNCT
mkg-41075	375	9	e	e	X
mkg-41075	375	10	-	-	PUNCT
mkg-41075	375	11	issn	issn	ADJ
mkg-41075	375	12	:	:	PUNCT
mkg-41075	375	13	2442	2442	NUM
mkg-41075	375	14	-	-	SYM
mkg-41075	375	15	9740	9740	NUM
mkg-41075	375	16	.	.	PUNCT
mkg-41075	376	1	accredited	accredit	VERB
mkg-41075	376	2	no	no	INTJ
mkg-41075	376	3	.	.	PROPN
mkg-41075	377	1	158	158	NUM
mkg-41075	377	2	/	/	SYM
mkg-41075	377	3	e	e	NOUN
mkg-41075	377	4	/	/	SYM
mkg-41075	377	5	kpt/2021	kpt/2021	NOUN
mkg-41075	377	6	.	.	PUNCT
mkg-41075	378	1	open	open	ADJ
mkg-41075	378	2	access	access	NOUN
mkg-41075	378	3	under	under	ADP
mkg-41075	378	4	cc	cc	NOUN
mkg-41075	378	5	-	-	PUNCT
mkg-41075	378	6	by	by	ADP
mkg-41075	378	7	-	-	PUNCT
mkg-41075	378	8	sa	sa	NOUN
mkg-41075	378	9	license	license	NOUN
mkg-41075	378	10	.	.	PUNCT
mkg-41075	379	1	available	available	ADJ
mkg-41075	379	2	at	at	ADP
mkg-41075	379	3	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	NOUN
mkg-41075	379	4	doi	doi	NOUN
mkg-41075	379	5	:	:	PUNCT
mkg-41075	379	6	10.20473	10.20473	NUM
mkg-41075	379	7	/	/	SYM
mkg-41075	379	8	j.djmkg.v56.i3.p189–196	j.djmkg.v56.i3.p189–196	PROPN
mkg-41075	379	9	https://e-journal.unair.ac.id/mkg/index	https://e-journal.unair.ac.id/mkg/index	PROPN
mkg-41075	379	10	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	https://doi.org/10.20473/j.djmkg.v56.i3.p189-196	ADV